"PUBMed ID","rs# or other ID","Gene symbol","Hg18 Chromosome","Hg19 Chromosome","Hg18 Genomic Coordinate of SNP","Hg19 Genomic Coordinate of SNP","Hg18 Genomic Region","Hg19 Genomic Region","Hg18 Distance from TSS","Hg19 Distance from TSS","Mutation","P-value(s)","Q-value(s)","Authors","Year","Type of Study","Journal","Ethnicity/Race","Sample Type","Number of Women with PE (after filtering, actually in study)","PE Women Details","Number of offspring from PE mothers","Number of Controls (actually in study)","Control Women Details","Number of offspring from control mothers","Initial Inclusion Criteria for Cases (have all details)","Controls Inclusion/Exclusion Criteria","PE % Primigravidae","Controls % Primigravidae","PE Phenotype Exclusion Criteria","PE Maternal Age (years)","Controls Maternal Age (years)","PE Maternal weight (kg)","Controls Maternal weight (kg)","PE Maternal height (cm)","Controls Maternal height (cm)","PE Maternal BMI (kg/m^2)","Controls Maternal BMI (kg/m^2)","PE Offspring birth weight (g)","Control Offspring birth weight (g)","PE Gestational Age (weeks)","Controls Gestational Age (weeks)","Proteinuria Definition","Systolic blood pressure >= ? mm Hg (e.g. 140)","Diastolic blood pressure >= ? mm Hg (e.g. 90)","Additional PE Criteria"
"8513325","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268*T* (M235*T*)","_","_","Ward K et al. (Tomoda S)","1993","Candidate gene approach","Nature Genetics","Caucasian, Japanese","maternal blood","63","45 (32 primigravidae) Caucasian; 18 (13 primigravidae) Japanese","_","651","571 Caucasian, 80 Japanese","_","Pregnancy-induced hypertension cases with singleton pregnancies delivered at greater than 20 weeks (Caucasians).   ","Exclusion: Offspring < 2,500 grams; diastolic blood pressure > 85; systolic blood pressure > 140; CHT; renal disease; Same as exclusion in cases for Japanese, patients with premature deliveries","71","_","HT, CHT, HELLP; HT, diabetic nephropathy, other renal disease (Japanese)","_","_","_","_","_","_","_","_","_","_","_","_","Standard definition from American College of Obstetrics and Gynecology, Technical Bulletin, 91 (1986)","140","85","Standard definition from American College of Obstetrics and Gynecology, Technical Bulletin, 91 (1986)"
"9192280","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/*T*","<0.004 genotype, <0.02 allele","_","Sohda S et al. (Kubo T)","1997","Candidate gene approach","Journal of Medical Genetics","Japanese, Asian","_","67","_","_","98","98 normal pregnant women, 260 healthy adults","_","_","_","_","_","_","31.0 +/- 5.3","30.6 +/- 4.3","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"9241730","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/*T*","_","_","Grandone E et al. (Di Minno G)","1997","Candidate gene approach","Journal of Thrombosis and Haemostasis","_","_","96","_","_","129","_","_","_","_","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"9241730","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/*A*","_","_","Grandone E et al. (Di Minno G)","1997","Candidate gene approach","Journal of Thrombosis and Haemostasis","_","_","96","_","_","129","_","_","_","_","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"9616877","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/A","NS","_","Dizon-Townson DS et al. (Ward K)","1998","Candidate gene approach","Journal of Reproductive Immunology","Caucasian 94%, Hispanic 3%, Asian 2%, Black <1%, Native American <1%","_","131","Severe PE","_","41","_","_","Included only severe PE","Inclusion: normotensive gravidas.  No patients were specifically excluded or included  based on age, race, medical history, or obstetric history","_","_","HT, renal disease, insulin-dependent diabetes","25 (min, max : 15,39)","_","_","_","_","_","_","_","_","_","33 (min, max : 21,42)","_",">= 500 mg in 24 hrs or 3+ -4+","140","90","(1) a systolic blood pressure of 160 mmHg or greater, or a diastolic blood pressure of 110 mmHg or greater on two occasions at least 6 h apart, (2) proteinuria of at least 5 g in a 24-h period (or 3 - 4 based on semiquantitative analysis), (3) oliguria, a 24-h urinary output of less than 400-500 ml, (4) cerebral or visual disturbances, (5) pulmonary edema or cyanosis, (6) epigastric or right upper quadrant pain, (7) impaired liver function of unclear etiology, and:or (8) thrombocytopenia."
"10329869","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/*A*","_","_","van Pampus MG et al. (Buller HR)","1999","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian, Dutch","_","345","158 severe PE, 164 HELLP, 23 history of eclampsia","_","67","_","_","Included only severe PE or HELLP"," healthy, fertile women with normal menstrual cycles, not taking oral contraceptives, who had completed their pregnancies uneventfully. All women with ahistory of any perinatal complications, such as preterm labor, fetal death, or miscarriage, were excluded.","81","44","HT, renal disease, vascular disease, diabetes","_","20-40","_","_","_","_","_","_","_","_","<36","_","urinary protein concentration >= 0.5 g/L","140","110","_"
"10373212","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","O'Shaughnessy KM et al. (Morris NH)","1999","Candidate gene approach","Hypertension","Caucasian, Northern European, British, East Anglian","maternal blood sample","283","230 primagravidae, 149 had severe PE, 25 developed HELLP","_","200","Caucasian northern europian","_","Proteinuric and hypertensive occurring after 20 weeks of gestation with at least a 25-mm Hg rise in diastolic blood pressure. Conditions were resolved by 3 months postpartum.","Normotensive women with no history of preeclampsia and <50 years old at screening","81.3","_","No participants had a multiple-birth pregnancy, concurrent diabetes, renal disease, or essential hypertension","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg/24 hours or at least ++ of proteinuria on a dip stick","140","90","_"
"10373212","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","O'Shaughnessy KM et al. (Morris NH)","1999","Candidate gene approach","Hypertension","Caucasian, Northern European, British, East Anglian","maternal blood sample","283","230 primagravidae, 149 had severe PE, 25 developed HELLP","_","200","Caucasian northern europian","_","Proteinuric and hypertensive occurring after 20 weeks of gestation with at least a 25-mm Hg rise in diastolic blood pressure. Conditions were resolved by 3 months postpartum.","Normotensive women with no history of preeclampsia and <50 years old at screening","81.3","_","No participants had a multiple-birth pregnancy, concurrent diabetes, renal disease, or essential hypertension","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg/24 hours or at least ++ of proteinuria on a dip stick","140","90","_"
"10521764","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","De Groot CJ et al. (Rosendaal FR.Source)","1999","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian ","_","163","Caucasian 96%","_","163","Caucasian 96%","_"," rise of blood pressure in pregnancy, late-pregnancy hypertension, proteinuria ","Inclusion: first pregnancy, no rise in blood pressure, no hypertension or proteinuria, similar age (+/-5 years), no biologic relationship, and a delivery date as close as possible to the delivery date of a patient. Exclusion: same as patient","100","100","Multigravidae, CHT, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis ","28","28","_","_","_","_","_","_","_","_","34.6","39.4",">= 2+ [100 mg/dL] on a voided specimen or >= 1+ [30 mg/dL] on a catheterized specimen; 30-100 mg/dL vs <30 for controls","140","90","Rise in blood pressure (>= 30 mm Hg systolic or >= 20 mm Hg diastolic over first 20 weeks)"
"10521764","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","De Groot CJ et al. (Rosendaal FR.Source)","1999","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian ","_","163","Caucasian 96%","_","163","Caucasian 96%","_"," rise of blood pressure in pregnancy, late-pregnancy hypertension, proteinuria ","Inclusion: first pregnancy, no rise in blood pressure, no hypertension or proteinuria, similar age (+/-5 years), no biologic relationship, and a delivery date as close as possible to the delivery date of a patient. Exclusion: same as patient","100","100","Multigravidae, CHT, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis ","28","28","_","_","_","_","_","_","_","_","34.6","39.4",">= 2+ [100 mg/dL] on a voided specimen or >= 1+ [30 mg/dL] on a catheterized specimen; 30-100 mg/dL vs <30 for controls","140","90","Rise in blood pressure (>= 30 mm Hg systolic or >= 20 mm Hg diastolic over first 20 weeks)"
"10549971","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","0.27 CC, 0.36 CT, 0.49 TT, 0.16 C, 0.28 T","_","Chikosi AB et al. (Rom L)","1999","Candidate gene approach","British Journal of Obstetrics and Gynaecology","South African, Black","_","105","_","_","110","_","_","Re-eclampsia was defined as a blood pressure of > 140/90 mmHg on two separateoccasions six hours apart and at least 300 mg/day of proteinuria in the second half of pregnancy. Only indigenous Zulu women were included in the study.","Women with a history of hypertension in a previous pregnancy were excludedfrom the control group","43","49","Women with known endocrine or metabolic disorders and those with known non-indigenous, non-Zulu relatives were excluded from the study","_","_","_","_","_","_","_","_","_","_","_","_","at least 300 mg/day of pro-teinuria in the second half of pregnancy","140","90","_"
"10636447","rs1801177","LPL","8","8","19849987","19805707","coding","coding","9126","9126","D36*N* (D9*N*)","0.02","_","Hubel CA et al. (Ferrell RE)","1999","Candidate gene approach","Clinical Genetics","Caucasian","maternal blood sample","100","_","_","211","_","_","Inclusion: hypertension, proteinuria, and hyperuricemia, and reversal of hypertension and proteinuria after delivery","Inclusion:normotensive","","","","","","","","","","","","","","","","","","",""
"10636447","rs268","LPL","8","8","19857808","19813528","coding","coding","16947","16947","N318*S* (N291*S*)","0.008","_","Hubel CA et al. (Ferrell RE)","1999","Candidate gene approach","Clinical Genetics","Caucasian","maternal blood sample","100","_","_","211","_","_","Inclusion: hypertension, proteinuria, and hyperuricemia, and reversal of hypertension and proteinuria after delivery","Inclusion:normotensive","","","","","","","","","","","","","","","","","","",""
"10655155","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","_","_","Rajkovic A et al. (Williams MA)","2000","Candidate gene approach","Molecular Genetics and Metabolism","African, Zimbabwean","_","171","138 PE, 33 eclampsia","_","185","_","_","Inclusion: PE or eclampsia","Exclusion: Pregnancy-induced HT","_","_","_","17 (<19), 132 (19-34), 23 (>=35)","28 (<19), 146 (19-34), 11 (>=35)","_","_","_","_","27.1 +/- 4.4","25.3 +/- 3.8","_","_","36.3 +/- 2.9","38.5 +/- 3.2","urine protein concentration of 0.1 g/L or more ","140","90","Sustained 15 mm Hg diastolic rise or a 30 mm Hg rise in systolic blood pressure.  If first trimester blood pressures were unknown 6h or more blood pressure of 140/90 mmHg.  Proteinuria concentration was in 2 random specimens collected at least 4 hours apart. "
"10694185","rs41271499 ","AGT","1","1","228913092","230846469","coding","coding","3867","3867","L43F (L10F)","NS","_","Curnow KM et al. (August P)","2000","Candidate gene approach","Journal of Hypertension","Caucasian, Black, Asian, Chinese, Egyptian, Hispanic, Filipino","maternal blood","32","6 HELLP, Caucasian >50%, Black 33%, 2 Asian, Chinese, 1 Egyptian, 1 Hispanic, 1 Filipino","_","_","_","_","HELLP or at least one feature of severe PE required, diastolic pressure < 80 mmHg before 20 weeks","_","100","_","HT or vascular condition (essential hypertension, secondary hypertension, diabetes, renal disease)","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg/24 h in the absence of urinary tract infection. Serum uric acid levels were > 6 mg/dl.","140","90, 110 (severe)","Pre-eclampsia was defined as the development of a persistent elevation "
"10694185","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)","NS","_","Curnow KM et al. (August P)","2000","Candidate gene approach","Journal of Hypertension","Caucasian, Black, Asian, Chinese, Egyptian, Hispanic, Filipino","maternal blood","32","6 HELLP, Caucasian >50%, Black 33%, 2 Asian, Chinese, 1 Egyptian, 1 Hispanic, 1 Filipino","_","_","_","_","HELLP or at least one feature of severe PE required, diastolic pressure < 80 mmHg before 20 weeks","_","100","_","HT or vascular condition (essential hypertension, secondary hypertension, diabetes, renal disease)","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg/24 h in the absence of urinary tract infection. Serum uric acid levels were > 6 mg/dl.","140","90, 110 (severe)","Pre-eclampsia was defined as the development of a persistent elevation "
"10862840","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/*A*","_","_","Kupferminc MJ et al. (Lessing JB)","2000","Candidate gene approach","Obstetrics and Gynecology","Israeli, Caucasian, Ashkenazi","_","63","25 Ashkenazi, 38 non-Ashkenazi","_","126","50 Ashkenazi, 76 non-ashkenazi; 68 primiparous","_","Severe PE required; HELLP and eclampsia not excluded","No history of thromboembolic event; each PE case matched with two appropriate control women ( +/- 2 yrs in age) ","86","54","Thromboembolic event history","_","_","_","_","_","_","_","_","1463 +/- 632","3411 +/- 414","32 +/- 4.0","39.5 +/- 1.4","> 5 g/24 hours","160","110","platelet count less than 100,000/mm^3, presence of hemolysis, elevated liver enzymes (ie, serum aminotransferase concentrations), and low platelets"
"10862840","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/*T*","0.008","_","Kupferminc MJ et al. (Lessing JB)","2000","Candidate gene approach","Obstetrics and Gynecology","Israeli, Caucasian, Ashkenazi","_","63","25 Ashkenazi, 38 non-Ashkenazi","_","126","50 Ashkenazi, 76 non-ashkenazi; 68 primiparous","_","Severe PE required; HELLP and eclampsia not excluded","No history of thromboembolic event; each PE case matched with two appropriate control women ( +/- 2 yrs in age) ","86","54","Thromboembolic event history","_","_","_","_","_","_","_","_","1463 +/- 632","3411 +/- 414","32 +/- 4.0","39.5 +/- 1.4","> 5 g/24 hours","160","110","platelet count less than 100,000/mm^3, presence of hemolysis, elevated liver enzymes (ie, serum aminotransferase concentrations), and low platelets"
"10862840","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/*A*","0.001","_","Kupferminc MJ et al. (Lessing JB)","2000","Candidate gene approach","Obstetrics and Gynecology","Israeli, Caucasian, Ashkenazi","_","63","25 Ashkenazi, 38 non-Ashkenazi","_","126","50 Ashkenazi, 76 non-ashkenazi; 68 primiparous","_","Severe PE required; HELLP and eclampsia not excluded","No history of thromboembolic event; each PE case matched with two appropriate control women ( +/- 2 yrs in age) ","86","54","Thromboembolic event history","_","_","_","_","_","_","_","_","1463 +/- 632","3411 +/- 414","32 +/- 4.0","39.5 +/- 1.4","> 5 g/24 hours","160","110","platelet count less than 100,000/mm^3, presence of hemolysis, elevated liver enzymes (ie, serum aminotransferase concentrations), and low platelets"
"10965192","rs1801131","MTHFR","1","1","11777062","11854475","coding","coding","11640","11685","A/C","NS","_","Kaiser T et al. (Moses EK)","2000","Candidate gene approach","Gynecologic and Obstetric Investigation (Human Heredity)","Caucasian, British, Anglo-Saxon,1 Maltese, 2 Italian","maternal blood","147","114 PE, 33 eclampsia","_","109","_","_","Severe PE definition here is normal PE elsewhere. PE features in first and not subsequent pregnancies","_","100","_","_","_","_","_","_","_","_","_","_","_","_","_","_","10.3 g/l in a 24-hour specimen, or at least 2+ dipstick proteinuria on a random urine collection","140","90","Severe PE : 1)A rise from baseline systolic blood pressure of at least 25 mm Hg and/or a rise from baseline diastolic pressure of at least 15 mm Hg.  or 2) systolic pressure >=140mm Hg and/or diastolic pressure >=90mm HG on at least 2 occasions 6 h or more apart"
"11096266","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Kaiser T et al. (Moses EK)","2001","Candidate gene approach","Gynecologic and Obstetric Investigation (Human Heredity)","Caucasian, British, Anglo-Saxon,1 Maltese, 2 Italian","_","147","114 PE, 33 eclampsia","_","109","_","_","Severe PE definition here is normal PE elsewhere. PE features in first and not subsequent pregnancies","_","100","_","_","_","_","_","_","_","_","_","_","_","_","_","_","10.3 g/l in a 24-hour specimen, or at least 2+ dipstick proteinuria on a random urine collection","140","90","Severe PE : 1)A rise from baseline systolic blood pressure of at least 25 mm Hg and/or a rise from baseline diastolic pressure of at least 15 mm Hg.  or 2) systolic pressure >=140mm Hg and/or diastolic pressure >=90mm HG on at least 2 occasions 6 h or more apart"
"11283205","rs1051740","EPHX1","1","1","224086255","226019632","coding","coding","6657","21836","Y113H","NS","_","Zusterzeel PL et al. (Steegers EA)","2001","Candidate gene approach","Journal of Medical Genetics","Dutch, Caucasian","maternal blood","181","96 HELLP, 87 without HELLP; 67 primiparous HELLP, 83 primiparous without HELLP","_","151","_","_","_","Exclusion: pregnant; diabetes or renal, hepatic, haematological, pre-existing hypertensive, or cardiovascular disease who had experienced normal normotensive pregnancies only (median number of pregnancies 2, range 1 to 4)","79","86","_","28 (19-40) (HELLP); 28 (19-39) (without HELLP); median values","30 (18-42) median","_","_","_","_","_","_","_","_","31 +/- 5","_","> 0.3 g/l in a 24 hour urine collection period","_","110","occurrence after 20 weeks gestation of a diastolic blood pressure greater than 90 mm Hg on two or more occasions at least four hours apart with proteinuria "
"11283205","rs2234922","EPHX1","1","1","224093028","226026405","coding","coding","13430","28609","H139R ","NS","_","Zusterzeel PL et al. (Steegers EA)","2001","Candidate gene approach","Journal of Medical Genetics","Dutch, Caucasian","maternal blood","181","96 HELLP, 87 without HELLP; 67 primiparous HELLP, 83 primiparous without HELLP","_","151","_","_","_","Exclusion: pregnant; diabetes or renal, hepatic, haematological, pre-existing hypertensive, or cardiovascular disease who had experienced normal normotensive pregnancies only (median number of pregnancies 2, range 1 to 4)","79","86","_","28 (19-40) (HELLP); 28 (19-39) (without HELLP); median values","30 (18-42) median","_","_","_","_","_","_","_","_","31 +/- 5","_","> 0.3 g/l in a 24 hour urine collection period","_","110","occurrence after 20 weeks gestation of a diastolic blood pressure greater than 90 mm Hg on two or more occasions at least four hours apart with proteinuria "
"11339912","rs16944","IL1B","2","2","113311337","113594866","upstream","upstream","-510","-510","C/T","NS","_","Hefler LA et al. (Gregg AR)","2001","Candidate gene approach","Obstetrics and Gynecology","Hispanic","maternal blood","69","_","_","47","_","_","_","Inclusion: Gravida >= 2 (normal pregnancy), one previous term delivery, no history of PE; Exclusion: essential HT, chronic renal disease, diabetes, platelet disorders, autoimmune conditions","_","0","Womean who had preotein uria and hypertension before 20 weeks gestation, or women with other medical conditions that could cause proteinuria and hypertension","24 (21-30) median (range)","25 (23-29.7) median (range)","_","_","_","_","_","_","_","_","37.1 (35.1-39.42)","39.8 (38.7-40.4)","one 24-hour urine collection with a total protein excretion of at least .3 g","_","_","Blood pressure was considered elevated when systolic BP was at least "
"11349190","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Kim YJ et al. (Merrill DC)","2001","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian","maternal blood or cheeck swab","281","193 severe PE, 21 HELLP","_","360","_","_","Mild or severe PE","Inclusion: >= 2 term pregnancies unaffected by PE, no family history of PE, no CHT","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","1+ reading on dipstick or > 300 mg/24-h urine sample; >5 g protein detected in a 24-hour period or a 4+ reading on dipstick (severe)","140, 160 (severe)","90, 110 (severe)","Severe PE met criteria of one or more of (1) diastolic bp or systolic bp, (2) proteinuria, (3) thrombocytopenia, with <100,000 platelets/mL; (4) oliguria, with <400 mL urine produced in 24 hours; (5) pulmonary edema; and (6) elevated aspartate aminotransferase or alanine aminotransferase activity; HELLP considered thrombocytopenia "
"11349190","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Kim YJ et al. (Merrill DC)","2001","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian","maternal blood or cheeck swab","281","193 severe PE, 21 HELLP","_","360","_","_","Mild or severe PE","Inclusion: >= 2 term pregnancies unaffected by PE, no family history of PE, no CHT","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","1+ reading on dipstick or > 300 mg/24-h urine sample; >5 g protein detected in a 24-hour period or a 4+ reading on dipstick (severe)","140, 160 (severe)","90, 110 (severe)","Severe PE met criteria of one or more of (1) diastolic bp or systolic bp, (2) proteinuria, (3) thrombocytopenia, with <100,000 platelets/mL; (4) oliguria, with <400 mL urine produced in 24 hours; (5) pulmonary edema; and (6) elevated aspartate aminotransferase or alanine aminotransferase activity; HELLP considered thrombocytopenia "
"11483920","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Livingston JC et al. (Sibai BM)","2001","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian, Black","_","110","12 eclampsia, 21 HELLP, 104 proteinuria; 63 Black, 47 Caucasian","92","97","62 Black, 35 caucasian","_","Severe PE required (which included eclampsia and HELLP)","Excluded: history of PE","_","_","CHT, diabetes mellitus, preexisting renal disease, history of thromboembolism, multifetal gestation, or major fetal congenital anomaly.","24.5 +/- 7.7","24.4 +/- 6.2","_","_","_","_","_","_","_","_","34.3 +/- 5.1","35.6 +/- 4.8","> 300 mg in a 24-hour urine collection","160","110","Severe preeclampsia was defined as severe hypertension (systolic blood pressure >=160 mm Hg or diastolic blood pressure >=110 mm Hg) in the presence of proteinuria (n = 104)"
"11483920","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Livingston JC et al. (Sibai BM)","2001","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian, Black","_","110","12 eclampsia, 21 HELLP, 104 proteinuria; 63 Black, 47 Caucasian","92","97","62 Black, 35 caucasian","_","Severe PE required (which included eclampsia and HELLP)","Excluded: history of PE","_","_","CHT, diabetes mellitus, preexisting renal disease, history of thromboembolism, multifetal gestation, or major fetal congenital anomaly.","24.5 +/- 7.7","24.4 +/- 6.2","_","_","_","_","_","_","_","_","34.3 +/- 5.1","35.6 +/- 4.8","> 300 mg in a 24-hour urine collection","160","110","Severe preeclampsia was defined as severe hypertension (systolic blood pressure >=160 mm Hg or diastolic blood pressure >=110 mm Hg) in the presence of proteinuria (n = 104)"
"11483920","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Livingston JC et al. (Sibai BM)","2001","Candidate gene approach","American Journal of Obstetrics and Gynecology","Caucasian, Black","_","110","12 eclampsia, 21 HELLP, 104 proteinuria; 63 Black, 47 Caucasian","92","97","62 Black, 35 caucasian","_","Severe PE required (which included eclampsia and HELLP)","Excluded: history of PE","_","_","CHT, diabetes mellitus, preexisting renal disease, history of thromboembolism, multifetal gestation, or major fetal congenital anomaly.","24.5 +/- 7.7","24.4 +/- 6.2","_","_","_","_","_","_","_","_","34.3 +/- 5.1","35.6 +/- 4.8","> 300 mg in a 24-hour urine collection","160","110","Severe preeclampsia was defined as severe hypertension (systolic blood pressure >=160 mm Hg or diastolic blood pressure >=110 mm Hg) in the presence of proteinuria (n = 104)"
"11531629","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Lauszus FF et al. (Klebe JG)","2001","Candidate gene approach","Acta Obstetricia et Gynecologica Scandinavica","Caucasian, Northern European","peripheral blood leukocytes","46","46 of 233 studied (all with diabetes) developed PE","_","_","_","_","Insulin-dependent diabetes mellitus","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg in previously normo- and microalbuminuric women","_","90","In macroalbuminuricwomen preeclampsia was diagnosed when albuminexcretion and uric acid increased significantly(three- and twofold, respectively"
"11576577","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/A","NS","_","Lachmeijer et al. (ten Kate LP)","2001","Candidate gene approach","Obstetrics and Gynecology","Caucasian, Northern European, Dutch 95%","_","233","150 families; 101 in unrelated PE group; 75 strict index women; 65 strict sisters group; 48% PE, 1% eclampsia, 32% HELLP, 19% PIH","_","98","51 male, 47 female","_","History of HT in pregnancy, sib-pair families affected by eclampsia, (severe) PE, HELLP, PIH ","Inclusion: unrelated, Dutch students and staff (previously published control group)","_","_","_","29 (17-43)","_","_","_","_","_","_","_","2476 (320 - 4635)","_","36 +/- 1 (24 - 42)","_",">= 300 mg per 24 hours, or at least twice 11 on","","",""
"11593097","rs5370","EDN1","6","6","12404240","12296254","coding","coding","5726","5726","K198N","_","_","Barden AE et al. (Van Bockxmeer FM)","2001","Candidate gene approach, retrospective study","Journal of Hypertension","Caucasian, Asian, Aboriginal","maternal blood","72","Caucasian 93%, Asian 13%, Aboriginal 3%","_","81","_","_"," Included only if blood pressure returned to normal levels by 6 months post-partum without continuing proteinuria.","Inclusion : blood pressure < 130/80 mmHg after 20 weeks gestation and no major medical conditions","_","_","History of HT or renal disease excluded.","29.8 +/- .8","29.2 +/- .8","_","_","_","_","30.8 +/- .8","26.7 +/- .4","_","_","_","_",">= 300 mg per 24 hrs, 2+ on dipstick","158","103","_"
"11711487","rs1801177","LPL","8","8","19849987","19805707","coding","coding","9126","9126","D36N (D9N)","NS","_","Kim YJ et al. (Merrill DC)","2001","Candidate gene approach","Hypertension","Caucasian","whole blood, cheek swab sample","250","12 HELLP","106","265","_","_","Mild preeclampsia, defined as mild hypertension plus proteinuriam, severe preeclampsia, or HELLP","Inclusion : women who had undergone >=2 term pregnancies unaffected by preeclampsia  Exclusion :  family history of preeclampsia, chronic hypertension","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","Mild preclampsia: 1+ on dipstick or 300 mg/24 h urine, Severe preclampsia: >=5 g/24 h or 4+ on dipstick","140","90","Severe preeclampsia was defined as the presence of >=1 of the following: (1) high blood pressure, >=160/110 mm Hg on 2 occasions >=4 hours apart; (2) proteinuria, >=5 g/24 h or 4+ on dipstick; (3) thrombocytopenia, <100 000 platelets per milliliter; (4) oliguria, <400 mL/24 h; (5) pulmonary edema; or (6) elevated liver enzymes (SGOT/PT). A severe variant of preeclampsia called HELLP syndrome (hemolysis, elevated liver enzyme, low platelets) was defined by thrombocytopenia (<100 000 platelets per milliliter), SGOT/PT (>70), and hemolysis (as demonstrated by any of the following: total bilirubin >1.2 mg/dL, serum lactate dehydrogenase >=600 U/L, and hemolytic anemia on smear). Nulliparous preeclampsia was defined as preeclampsia in the first pregnancy progressing beyond 20 weeks. Multiparous preeclampsia was defined as the absence of preeclampsia in the first pregnancy beyond 20 weeks but preeclampsia diagnosed in a subsequent pregnancy."
"11711487","rs268","LPL","8","8","19857808","19813528","coding","coding","16947","16947","N318S (N291S)","NS","_","Kim YJ et al. (Merrill DC)","2001","Candidate gene approach","Hypertension","Caucasian","whole blood, cheek swab sample","250","12 HELLP","106","265","_","_","Mild preeclampsia, defined as mild hypertension plus proteinuriam, severe preeclampsia, or HELLP","Inclusion : women who had undergone >=2 term pregnancies unaffected by preeclampsia  Exclusion :  family history of preeclampsia, chronic hypertension","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_","Mild preclampsia: 1+ on dipstick or 300 mg/24 h urine, Severe preclampsia: >=5 g/24 h or 4+ on dipstick","140","90","Severe preeclampsia was defined as the presence of >=1 of the following: (1) high blood pressure, >=160/110 mm Hg on 2 occasions >=4 hours apart; (2) proteinuria, >=5 g/24 h or 4+ on dipstick; (3) thrombocytopenia, <100 000 platelets per milliliter; (4) oliguria, <400 mL/24 h; (5) pulmonary edema; or (6) elevated liver enzymes (SGOT/PT). A severe variant of preeclampsia called HELLP syndrome (hemolysis, elevated liver enzyme, low platelets) was defined by thrombocytopenia (<100 000 platelets per milliliter), SGOT/PT (>70), and hemolysis (as demonstrated by any of the following: total bilirubin >1.2 mg/dL, serum lactate dehydrogenase >=600 U/L, and hemolytic anemia on smear). Nulliparous preeclampsia was defined as preeclampsia in the first pregnancy progressing beyond 20 weeks. Multiparous preeclampsia was defined as the absence of preeclampsia in the first pregnancy beyond 20 weeks but preeclampsia diagnosed in a subsequent pregnancy."
"11776341","rs1042579","THBD","20","20","22976723","23028723","coding","coding","1578","1578","A473V (A455V)","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","133","Severe PE","_","224","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1042713","ADRB2","5","5","148186632","148206439","coding","coding","284","284","G16R","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","134","Severe PE","_","225","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1042714","ADRB2","5","5","148186665","148206472","coding","coding","317","317","E27Q    ","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","135","Severe PE","_","226","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs118203906","F5","1","1","_","169524536","_","coding","_","31233","R334T","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","137","Severe PE","_","228","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs16874954","PLA2G7","6","6","46785056","46677098","coding","coding","26054","26332","V279F","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","138","Severe PE","_","229","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1695","GSTP1","11","11","67109264","67352688","coding","coding","1403","1623","I105V","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","139","Severe PE","_","230","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","140","Severe PE","_","231","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","141","Severe PE","_","232","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1799998","CYP11B2","8","8","143996601","143999599","upstream","upstream","-340","-340","C/T","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","142","Severe PE","_","233","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/A","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","143","Severe PE","_","234","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1801131","MTHFR","1","1","11777062","11854475","coding","coding","11640","11685","A/C","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","144","Severe PE","_","235","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685"," C/*T*","0.008","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","145","Severe PE","_","236","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs1801483","GCGR","17","17","_","79767714","_","coding","_","5705","G40S","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","146","Severe PE","_","237","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs429358","APOE","19","19","50103780","45411940","coding","coding","2902","2902","C/T","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","147","Severe PE","_","238","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs4961","ADD1","4","4","2876504","2906706","coding","coding","61123","61123","G460W","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","148","Severe PE","_","239","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs4994","ADRB3 (B3AR)","8","8","37942954","37823797","coding","coding","37943341","37824184","W64R","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","149","Severe PE","_","240","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs5186","AGTR1","3","3","149942677","148459987","3'UTR","3'UTR","44330","44330","A/C","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","150","Severe PE","_","241","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs5361","SELE","1","1","167967683","169701059","coding","coding","2161","2161","S149R","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","151","Severe PE","_","242","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs5370","EDN1","6","6","12404240","12296254","coding","coding","5726","5726","K198N","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","152","Severe PE","_","243","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs5443","GNB3","12","12","6825135","6954874","coding","coding","5500","5500","C/T","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","153","Severe PE","_","244","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs5498","ICAM1","19","19","10256682","10395682","coding","coding","14166","14166","K469E","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","154","Severe PE","_","245","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs6020","F5","1","1","167785735","169519111","coding","coding","36658","36658","R513*K* (R485*K*)","0.007","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","155","Severe PE","_","246","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","156","Severe PE","_","247","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs6065","GP1BA","17","17","4777160","4836380","coding","coding","789","789","T161M","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","157","Severe PE","_","248","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs61886492","FOLH1","11","11","49142849","49186273","coding","coding","43949","43949","H475Y","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","158","Severe PE","_","249","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11776341","rs7412","APOE","19","19","50103918","45412078","coding","coding","3040","3040","C/T","NS","_","Watanabe H et al. (Arinami T)","2001","Candidate gene approach","Journal of Thrombosis and Haemostasis","Japanese","maternal blood","159","Severe PE","_","250","_","_","Required severe PE, defined by the criteria of the American College of Obstetricians and Gynecologists","_","_","_","History of HT and renal disease.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Severe PE criteria based on ACOG (1996)"
"11826024","rs1695","GSTP1","11","11","67109264","67352688","coding","coding","1403","1623","I105*V*","Mothers = .005; Fathers = .0001; Offspring = 0.0006","_","Zusterzeel PL et al. (Steegers EA)","2002","Candidate gene approach","Journal of Medical Genetics","Dutch","blood sample collected by venepuncture (maternal, paternal); buccal cell samples from offspring","113","_","113","168","168 women and 149 men","_","the occurrence after 20 weeks' gestation of a diastolic blood pressure greater than 90 mm Hg and concordant proteinuria","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","urinary protein greater than 0.3 g/l in a 24 hour collection period or a protein/creatinine ratio greater than 0.3 g/10 mmol","_","90","_"
"11888101","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Currie L et al. (Ridgway J)","2002","Candidate gene approach; Prospective cohort study","BJOG: An International Journal of Obstetrics & Gynaecology","Caucasian","cheek swab sample","48","46 Cuacasian","48","46","43 Caucasian","46","Severe pre-eclampsia.","delivery >37 weeks of gestation; no caesarean section; normal vaginal delivery (no forceps or vacuum extraction); no complications during pregnancy; no fetal abnormalities; no hypertension; no proteinuria during pregnancy; no pre-existing illness.","79","76","IUGR, mild preeclampsia, essential hypertension, ","29","29","_","_","_","_","27.7","23.4","1985","3495","34.14","40.14",">=300mg/24h or >=2+ dipstick","165","108","Severe pre-eclampsia was defined as sustained hypertension developing after 20 weeks of gestation and the presence of at least one of the following: diastolic blood pressure >=110mmHg; systolic blood presssure >=170mmHg; proteinuria; elevated alanine aminotransferase; intrauterine growth restriction; visual disturbances; persistent headaches; epigastric pain; eclampsia; elevated creatinine; hyperreflexia; clonus; thrombocytopenia; disseminated intravascular coagulation."
"11950065","rs1046712","F5","1","1","167777098","169510474","coding","coding","45295","45295","L1302I ","0.64","_","Watanabe H et al. (Arinami T)","2002","Candidate gene approach","Journal of Human Genetics","Japanese","peripheral blood leukocytes","133","_","_","224","Age-matched pregnant controls","_","Preeclampsia as based on the criteria of the American College of Obstetricians and Gynecologists(1996).","Healthy, without hypertension, renal disease, proteinuria.  Did not experience preeclampsia.  ","_","_","History of hypertensian or renal disease","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"11950065","rs6018","F5","1","1","167778501","169511877","coding","coding","43892","43892","N789T","0.3","_","Watanabe H et al. (Arinami T)","2002","Candidate gene approach","Journal of Human Genetics","Japanese","peripheral blood leukocytes","133","_","_","224","Age-matched pregnant controls","_","Preeclampsia as based on the criteria of the American College of Obstetricians and Gynecologists(1996).","Healthy, without hypertension, renal disease, proteinuria.  Did not experience preeclampsia.  ","_","_","History of hypertensian or renal disease","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"11950065","rs6020","F5","1","1","167785735","169519111","coding","coding","36658","36658","R513*K* (R485*K*)","0.02","_","Watanabe H et al. (Arinami T)","2002","Candidate gene approach","Journal of Human Genetics","Japanese","peripheral blood leukocytes","133","_","_","224","Age-matched pregnant controls","_","Preeclampsia as based on the criteria of the American College of Obstetricians and Gynecologists(1996).","Healthy, without hypertension, renal disease, proteinuria.  Did not experience preeclampsia.  ","_","_","History of hypertensian or renal disease","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"11950065","rs6033","F5","1","1","167788476","169521852","coding","coding","33917","33917","M385*T*","0.05","_","Watanabe H et al. (Arinami T)","2002","Candidate gene approach","Journal of Human Genetics","Japanese","peripheral blood leukocytes","133","_","_","224","Age-matched pregnant controls","_","Preeclampsia as based on the criteria of the American College of Obstetricians and Gynecologists(1996).","Healthy, without hypertension, renal disease, proteinuria.  Did not experience preeclampsia.  ","_","_","History of hypertensian or renal disease","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"11961379","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","D'Elia AV et al. (Damante G)","2002","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","_","58","_","_","74","_","_","Preeclampsia diagnosed in last trimester of pregnancy. ","Include normotensive woemn.  Exclude diabetes, renal disease, primary hypertension, or other systemetic diseases.  Negative for lupus anticoagulant and anticardiolipin antibodies.  ","_","_","All patients were screened for diabetes mellitus, renal disease, primary hypertension or any other systemic disease and, if present, were excluded from the study. All subjects were negative for lupus anticoagulant and anticardiolipin antibodies.","31.3 +/- 4.2","32.1 +/- 4.9","_","_","_","_","_","_","_","_","34.0 +/- 2.9","39.3 +/- 1.4",">0.3 g/24 h","140","90","Systolic blood pressure was 1140 mm Hg and diastolic bloodpressure 190 mm Hg. In all patients proteinuria was higher than0.3 g/24 h."
"11961379","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","D'Elia AV et al. (Damante G)","2002","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","_","58","_","_","74","_","_","Preeclampsia diagnosed in last trimester of pregnancy. ","Include normotensive woemn.  Exclude diabetes, renal disease, primary hypertension, or other systemetic diseases.  Negative for lupus anticoagulant and anticardiolipin antibodies.  ","_","_","All patients were screened for diabetes mellitus, renal disease, primary hypertension or any other systemic disease and, if present, were excluded from the study. All subjects were negative for lupus anticoagulant and anticardiolipin antibodies.","31.3 +/- 4.2","32.1 +/- 4.9","_","_","_","_","_","_","_","_","34.0 +/- 2.9","39.3 +/- 1.4",">0.3 g/24 h","140","90","Systolic blood pressure was 1140 mm Hg and diastolic bloodpressure 190 mm Hg. In all patients proteinuria was higher than0.3 g/24 h."
"11961379","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","_","_","D'Elia AV et al. (Damante G)","2002","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","_","58","_","_","74","_","_","Preeclampsia diagnosed in last trimester of pregnancy. ","Include normotensive woemn.  Exclude diabetes, renal disease, primary hypertension, or other systemetic diseases.  Negative for lupus anticoagulant and anticardiolipin antibodies.  ","_","_","All patients were screened for diabetes mellitus, renal disease, primary hypertension or any other systemic disease and, if present, were excluded from the study. All subjects were negative for lupus anticoagulant and anticardiolipin antibodies.","31.3 +/- 4.2","32.1 +/- 4.9","_","_","_","_","_","_","_","_","34.0 +/- 2.9","39.3 +/- 1.4",">0.3 g/24 h","140","90","Systolic blood pressure was 1140 mm Hg and diastolic bloodpressure 190 mm Hg. In all patients proteinuria was higher than0.3 g/24 h."
"12037698","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","NS","_","Raijmakers MT et al. (Peters WH)","2002","Candidate gene approach","Journal of Human Hypertension","_","whole blood sample","48","women with pre-eclampsia (n = 40), HELLP syndrome (n = 9) or women with HELLP complicated by pregnancy-induced hypertension or pre-eclampsia (n = 46)","_","78","_","_","Severe pre-eclampsia was defined according to the ISSHP criteria, being a pregnancy-induced hypertension (diastolic blood pressure 110 mm Hg on two or more occasions, each more than 4 h apart) with proteinuria (protein/creatinine ratio 0.30 g/10 mmol). The HELLP syndrome was biochemically characterised by the simultaneous occurrence of haemolysis (lactic dehydrogenase level >600 IU/L), elevated liver enzymes (both aspartate and alanine aminotransferase activity >70 IU/L) and low platelets (thrombocyte count under 100  109/L).","Women with at least one normotensive pregnancy","47.2","21.8","_","31 (20-37)","32 (22-42)","_","_","_","_","_","_","_","_","36.0 +/- 0.3","37.3 +/- 0.3","protein/creatinine ratio >=0.30 g/10 mmol","_","110","_"
"12037698","rs4673","CYBA","16","16","87240736","88713235","coding","coding","4222","4222","C/T","NS","NS","Raijmakers MT et al. (Peters WH)","2002","Candidate gene approach","Journal of Human Hypertension","_","whole blood sample","48","women with pre-eclampsia (n = 40), HELLP syndrome (n = 9) or women with HELLP complicated by pregnancy-induced hypertension or pre-eclampsia (n = 46)","_","78","_","_","Severe pre-eclampsia was defined according to the ISSHP criteria, being a pregnancy-induced hypertension (diastolic blood pressure 110 mm Hg on two or more occasions, each more than 4 h apart) with proteinuria (protein/creatinine ratio 0.30 g/10 mmol). The HELLP syndrome was biochemically characterised by the simultaneous occurrence of haemolysis (lactic dehydrogenase level >600 IU/L), elevated liver enzymes (both aspartate and alanine aminotransferase activity >70 IU/L) and low platelets (thrombocyte count under 100  109/L).","Women with at least one normotensive pregnancy","47.2","21.8","_","31 (20-37)","32 (22-42)","_","_","_","_","_","_","_","_","36.0 +/- 0.3","37.3 +/- 0.3","protein/creatinine ratio >=0.30 g/10 mmol","_","110","_"
"12044341","rs1143634","IL1B","2","2","113306860","113590389","coding","coding","3967","3967","C/T","NS","_","Lachmeijer AM et al. (ten Kate LP)","2002","Candidate gene approach","Hypertension Pregnancy","Dutch","Peripheral leukocytes","332","133 with either eclampsia, preeclampsia or HELLP syndrome, 101 with preeclampsia only, and 63 with HELLP syndrome only.  233 met strict critereia.  ","_","104","57 male, 47 female","_","Severe or mild PE","_","90","_","Multiple pregnancies, history of essential hypertension, diabetes or renal disease","_","_","_","_","_","_","_","_","_","_","_","_",">= .3g/24 hr, or >=1g/24 hr if severe","_","90, or 110 if severe","Preeclampsia was defined as a diastolic blood pressure(BP) of at least 90 mm Hg with an increment of at least 20 mm Hg from a firsttrimester diastolic BP measurement and significant proteinuria (300 mg/24 hr or atleast twice 1+ on dipstick). Preeclampsia was called severe when the diastolic BPwas 110 mm Hg and proteinuria 1000 mg/24 hr. The absolute BP levels had to beobserved on at least two occasions, more than 6 hr apart."
"12044341","rs16944","IL1B","2","2","113311337","113594866","upstream","upstream","-510","-510","C/T","NS","_","Lachmeijer AM et al. (ten Kate LP)","2002","Candidate gene approach","Hypertension Pregnancy","Dutch","Peripheral leukocytes","332","133 with either eclampsia, preeclampsia or HELLP syndrome, 101 with preeclampsia only, and 63 with HELLP syndrome only.  233 met strict critereia.  ","_","104","57 male, 47 female","_","Severe or mild PE","_","90","_","Multiple pregnancies, history of essential hypertension, diabetes or renal disease","_","_","_","_","_","_","_","_","_","_","_","_",">= .3g/24 hr, or >=1g/24 hr if severe","_","90, or 110 if severe","Preeclampsia was defined as a diastolic blood pressure(BP) of at least 90 mm Hg with an increment of at least 20 mm Hg from a firsttrimester diastolic BP measurement and significant proteinuria (300 mg/24 hr or atleast twice 1+ on dipstick). Preeclampsia was called severe when the diastolic BPwas 110 mm Hg and proteinuria 1000 mg/24 hr. The absolute BP levels had to beobserved on at least two occasions, more than 6 hr apart."
"12052604","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","_","_","Prasmusinto D et al. (van der Ven K)","2002","Candidate gene approach","Obstetrics & Gynecology","European, Indonesian","blood sample","81","41 Indonesian, 40 German/Croatian","61","99","27 Indonesian, 72 German/Croatian","61","Definition of preeclampsia based on recommendations of the Consensus Report of the American Working Group on High Blood Pressure in Pregnancy and of the Working Group of the German Society of Obstetrics and Gynecology. ","Patients with hemolysis, elevated liver enzymes, low platelets syndrome were not included in the study. ","62","39","Patients with hemolysis, elevated liver enzymes, low platelets syndrome were not included in the study. Absence of preexistent hypertension, proteinuria, and edema, as well as diabetes, chronic kidney, hepatic, or vascular disease.","29","29.2","_","_","_","_","_","_","Indonesian : 2765 +/- 630   German/Croation : 2414 +/- 974","Indonesian : 3124 +/- 368   German/Croation : 3581 +/- 503","37.15","39.35","protein excretion of 0.3 g or more in a 24-hour specimen or repeated dipsticks of 30 mg/dL (which correlates to 1+ dipsticks in commercial kits) in two random urine specimens collected more than 4 hours apart.","Increase of 30 (if unknown, then 140)","Increase of 10 (if unknown, then 90)","1. Increase of systolic blood pressure of 30 mm Hg or higher "
"12099552","rs1799724","TNF","6","6","31650460","31542481","upstream","upstream","-868","-868","C/T","_","_","Heiskanen J et al. (Heinonen S)","2002","Candidate gene approach","Journal of Assisted Reproduction and Genetics","Finnish","peripheral blood sample","133","_","_","115","_","_","Preeclampsia was dened as the development ofhypertension and new-onset proteinuria (>300 mgof urinary protein in 24 h) in women with noproteinuria at baseline","_","_","_","_","28.8 +/- 6.4","28.7 +/- 5.4","_","_","_","_","_","_","_","_","_","_",">300 mg of urinary protein in 24 h","140","90","_"
"12151156","rs1800790","FGB","4","4","155703157","155483707","upstream","upstream","-424","-424","G/A","NS","_","Laasanen J et al. (Heinonen S)","2002","Candidate gene approach","European Journal of Human Genetics","_","_","133","_","_","115","_","_","Preeclampsia was defined as the development of hypertension and new_onset proteinuria. Women with chronic hypertension were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg of urinary protein in 24 hours","140","90","_"
"12173035","rs1051740","EPHX1","1","1","224086255","226019632","coding","coding","6657","21836","*Y*113H",".01 (When paired with *H*139R","_","Laasanen J et al. (Heinonen S)","2002","Candidate gene approach","European Journal of Human Genetics","_","_","133","_","_","115","_","_","Preeclampsia was defined as the development of hypertension and new_onset proteinuria. Women with chronic hypertension were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg of urinary protein in 24 hours","140","90","_"
"12173035","rs2234922","EPHX1","1","1","224093028","226026405","coding","coding","13430","28609","*H*139R",".01 (When paired with *Y*113H","_","Laasanen J et al. (Heinonen S)","2002","Candidate gene approach","European Journal of Human Genetics","_","_","133","_","_","115","_","_","Preeclampsia was defined as the development of hypertension and new_onset proteinuria. Women with chronic hypertension were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg of urinary protein in 24 hours","140","90","_"
"12175441","rs429358","APOE","19","19","50103780","45411940","coding","coding","2902","2902","C/T","_","_","Francoual J et al. (Frydman R)","2002","Candidate gene approach","Hypertension Pregnancy","Caucasian","blood sample","49","included 40 women with severe preeclampsia (of which 16 had HELLP syndrome). 93% Caucasian","_","55","87.5% Caucasian","_","PE or Sever PE","Control patients were normotensive, non-preeclamptic pregnancies throughoutgestation, and without proteinuria or hyperuricemia. In this group, no patient had aprior history of chronic hypertension, diabetes, or renal or cardiovascular disease.","72","54","_","29.9 +/- 5.4","32.4 +/- 4.8","_","_","_","_","22.8 +/- 4","21 +/- 3","_","_","31.1 +/- 3.3","38.5 +/- 3.1",">0.3 g/24 hr","140","90","Preeclampsia was defined as diastolic blood pressure > 90 mm Hg and systolic blood pressure > 140 mm Hg with proteinuria >0.3 g/24 hr on both of two occasions at least 4 hr apart in patients normotensive before 20 weeks of gestation. Severe preeclampsia was defined asdiastolic blood pressure of at least 110 mm Hg, on two occasions 4 hr apart, or when hypertension was complicated by oliguria (<400 mL/24 hr), pulmonary edema, proteinuria >5 g/24 hr, elevated liver enzyme activities (double normal values), orthrombocytopenia (two platelet counts < 100,000 mm'') associated or not with hemolysiselevated liver enzymes and low platelets (HELLP) syndrome in the absence of other known causes."
"12175441","rs7412","APOE","19","19","50103918","45412078","coding","coding","3040","3040","C/T","_","_","Francoual J et al. (Frydman R)","2002","Candidate gene approach","Hypertension Pregnancy","Caucasian","blood sample","49","included 40 women with severe preeclampsia (of which 16 had HELLP syndrome). 93% Caucasian","_","55","87.5% Caucasian","_","PE or Sever PE","Control patients were normotensive, non-preeclamptic pregnancies throughoutgestation, and without proteinuria or hyperuricemia. In this group, no patient had aprior history of chronic hypertension, diabetes, or renal or cardiovascular disease.","72","54","_","29.9 +/- 5.4","32.4 +/- 4.8","_","_","_","_","22.8 +/- 4","21 +/- 3","_","_","31.1 +/- 3.3","38.5 +/- 3.1",">0.3 g/24 hr","140","90","Preeclampsia was defined as diastolic blood pressure > 90 mm Hg and systolic blood pressure > 140 mm Hg with proteinuria >0.3 g/24 hr on both of two occasions at least 4 hr apart in patients normotensive before 20 weeks of gestation. Severe preeclampsia was defined asdiastolic blood pressure of at least 110 mm Hg, on two occasions 4 hr apart, or when hypertension was complicated by oliguria (<400 mL/24 hr), pulmonary edema, proteinuria >5 g/24 hr, elevated liver enzyme activities (double normal values), orthrombocytopenia (two platelet counts < 100,000 mm'') associated or not with hemolysiselevated liver enzymes and low platelets (HELLP) syndrome in the absence of other known causes."
"12297717","rs1042579","THBD","20","20","22976723","23028723","coding","coding","1578","1578","A473V (A455V)","_","_","Borg AJ et al (Moses EK)","2002","Candidate gene approach","Gynecologic and Obstetric Investigation","Australian, New Zealander, Caucasian","blood sample","142","25 had been diagnosed as eclamptic, 117 as pre-eclamptic. ","_","138","_","_","_","_","100","100","_","_","_","_","_","_","_","_","_","_","_","_","_","0.3 g/l in 24hr","140","90","Diagnosis was based on clinical assessment using criteria of the Australasian Society for the Study of Hypertension in Pregnancy. That is, if a pregnant woman experienced an increaseof 625 mm Hg above baseline systolic blood pressure and/or an increase of 615 mm Hg above baseline diastolic blood pressure; hada persistent systolic blood pressure of 6140 mm Hg and/or diastolicblood pressure of 690 mm Hg; and had a level of proteinuria of10.3 g/l in a 24-hour specimen, she was said to have had pre-eclampsia. If these symptoms were accompanied by either convulsions orunconsciousness in the perinatal period she was classified as havinghad eclampsia."
"12324185","rs117490878","PPARA","_","22","_","46594318","_","coding","_","47820","P12A","NS","_","Laasanen J et al. (Heinonen S)","2002","Candidate gene approach","European Journal of Human Genetics","_","_","133","_","_","115","_","_","Preeclampsia was defined as the development of hypertension and new_onset proteinuria. Women with chronic hypertension were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg of urinary protein in 24 hours","140","90","_"
"12417054","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268*T* (M235*T*)","_","_","Procopciuc L et al. (Puscas M)","2002","Candidate gene approach","Journal of Cellular and Molecular Medicine","Caucasian, European, Romanian","maternal blood","14","8 mild PE, 1 PE with HT, and 5 severe PE.  6 had familial history of hypertension","_","6","None taking oral contraceptives.","_","_","History of HT excluded.","_","_","_","26 +/- 5","29  +/-  5","_","_","_","_","_","_","_","_","_","_",".3g/24 hr","Severe : 160","Severe : 110","severe pre-eclampsia have one or more of thefollowing symptoms: systolic blood pressure > 160 mm Hg and/ordiastolic blood pressure > 110 mm Hg; proteinuria > 300 mg/day; elevated levels of serum aminotransferase; persistent headaches; thrombocytopenia.  Mild pre-eclampsia is defined as hypertensiondeveloping after 20 weeks of pregnancy, withoutother symptoms; blood pressure is returning tonormal within a few months post partum."
"12576245","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268*T* (M235*T*)","< 0.001 (both Maternal and Fetal)","_","Zhang XQ et al (Ward K)","2003","Candidate gene approach","Obstetrics and Gynecology","_","maternal blood, fetal blood","60","All had intrauterine growth restrictions, also 174 additional with only intrauterine growth restrictions","_","400","_","240","_","Infant birthweights between fifth and 95th percentiles","86.7","60.2","Women with chronic hypertension, renal disease, diabetes mellitus, or fetal abnormalities were excluded from the study","25.2 +/- 6.3 (IUGR + PE)","25.6 +/- 6","_","_","_","_","_","_","1954 +/- 742 (IUGR + PE)","3296 +/- 552","33.5 +/- 3.8 (IUGR + PE)","39.1  +/-  2",".5g/24 hr or 3+ dipstick","140","90","Preeclampsia was defined as the development of new-onset hypertension of at least 140/90 with postpartum resolution and either more than 500 mg of protein in 24 hours or a new 3+ dipstick without infection in a pregnant woman with a singleton pregnancy"
"12628278","rs1042579","THBD","20","20","22976723","23028723","coding","coding","1578","1578","A473V (A455V)","NS","_","Hira B et al. (Moodley J)","2003","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","South African ","lymphocytic DNA","100"," 50 patients with documented severe pre-eclampsia and 50 patients with eclampsia ","50","110","_","100","_","Excluded antenatal, intrapartum or postpartum complications, specifically looking for hypertension","_","_","_","26 (18-43) (severe PE), 24 (15-34) (Eclampsia)","25 (13-42)","_","_","_","_","_","_","2100 (600-4200) severe preeclampisa, 2000 (800-3100) eclampsia","3100 (2000-4900)","32 (20-41) Severe PE, 32 (26-35) Eclampsia","37 (30-42)","3+ dipstick","160","110","severe pre-eclampsia was defined by a BP >160/110 mmHg, +++ proteinuria on dipstick and a platelet count <=150 _ 109/L.  eclampsia was defined as pre-eclampsia associated with seizures"
"12628278","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Hira B et al. (Moodley J)","2003","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","South African ","lymphocytic DNA","100"," 50 patients with documented severe pre-eclampsia and 50 patients with eclampsia ","50","110","_","100","_","Excluded antenatal, intrapartum or postpartum complications, specifically looking for hypertension","_","_","_","26 (18-43) (severe PE), 24 (15-34) (Eclampsia)","25 (13-42)","_","_","_","_","_","_","2100 (600-4200) severe preeclampisa, 2000 (800-3100) eclampsia","3100 (2000-4900)","32 (20-41) Severe PE, 32 (26-35) Eclampsia","37 (30-42)","3+ dipstick","160","110","severe pre-eclampsia was defined by a BP >160/110 mmHg, +++ proteinuria on dipstick and a platelet count <=150 _ 109/L.  eclampsia was defined as pre-eclampsia associated with seizures"
"12628278","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Hira B et al. (Moodley J)","2003","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","South African ","lymphocytic DNA","100"," 50 patients with documented severe pre-eclampsia and 50 patients with eclampsia ","50","110","_","100","_","Excluded antenatal, intrapartum or postpartum complications, specifically looking for hypertension","_","_","_","26 (18-43) (severe PE), 24 (15-34) (Eclampsia)","25 (13-42)","_","_","_","_","_","_","2100 (600-4200) severe preeclampisa, 2000 (800-3100) eclampsia","3100 (2000-4900)","32 (20-41) Severe PE, 32 (26-35) Eclampsia","37 (30-42)","3+ dipstick","160","110","severe pre-eclampsia was defined by a BP >160/110 mmHg, +++ proteinuria on dipstick and a platelet count <=150 _ 109/L.  eclampsia was defined as pre-eclampsia associated with seizures"
"12681883","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","_","_","Powers RW et al. (Roberts JM)","_","Candidate gene approach","_","_","_","27","24 met absolute increased blood pressure criteria","_","30","_","_","_","_","100","100","_","27 +/- 4.5","23.7 +/- 5.0","_","_","_","_","25.1 +/- 3.6","22.2 +/- 4.0","_","_","35.1 +/- 3.8","39.4 +/- 1.8",">.3g/24 hr, or >2+ on a voided or >1+ on catheterized random urin sample","140","90","Gestational hypertension was defined as an absolute blood pressure of "
"12699878","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","_","_","Hakli T et al. (Heinonen S)","2003","Candidate gene approach; retrospective data collection","Journal of the Society for Gynecologic Investigation","Eastern Finland","Peripheral blood lymphocytes","132","_","_","113","the controls originated from a regional population ","_","_","No clinical signs of PE","100","0","Excluded women with chronic hypertension","28.8","28.7","_","_","_","_","24.9","22.3","2285","3494","34.7","39.8",">.3 mg of urinary proteinin 24 hours","140","90","Preeclampsia was defined as the development of hypertension and new-onset proteinuria. Hypertension was defined according to current guidelines thataccept 140 and/or 90 mmHg of systolic and diastolic pressure, respectively, or higher, as hypertension, when measured on two consecutive occasions at least 24 hours apart."
"12867761","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","NS","_","Yoshimura T et al. (Okamura H)","2003","Candidate gene approach","Gynecologic and Obstetric Investigation","Bangladeshi","_","112","_","_","119","_","_","Severe PE: by means of the strict criteria of","","","","","","","","","","","","","","","","","","","",""
"12867763","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Fabbro D et al. (Damante G)","2003","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","blood sample","52","None of the preeclamptic women suffered from the severe form of preeclampsia. 19 primigravidae","_","80","55 primigravidae","_","_","All patients were screened for diabetes mellitus, renal disease,primary hypertension, or any other systemic disease and, if present,were excluded from the study. All subjects were negative for lupusanticoagulant and anticardiolipin antibodies. All subjects had normal values of antithrombin III and coagulation proteins C and S","_","_","_","32. +/- B4.0","33.4 +/- 4.2","_","_","_","_","_","_","_","_","34.7 +/- 2.2","39.6 +/- 1.7","> 0.3 g/24 h","140","90","_"
"12867763","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Fabbro D et al. (Damante G)","2003","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","blood sample","52","None of the preeclamptic women suffered from the severe form of preeclampsia. 19 primigravidae","_","80","55 primigravidae","_","_","All patients were screened for diabetes mellitus, renal disease,primary hypertension, or any other systemic disease and, if present,were excluded from the study. All subjects were negative for lupusanticoagulant and anticardiolipin antibodies. All subjects had normal values of antithrombin III and coagulation proteins C and S","_","_","_","32. +/- B4.0","33.4 +/- 4.2","_","_","_","_","_","_","_","_","34.7 +/- 2.2","39.6 +/- 1.7","> 0.3 g/24 h","140","90","_"
"12867763","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Fabbro D et al. (Damante G)","2003","Candidate gene approach","Gynecologic and Obstetric Investigation","Italian","blood sample","52","None of the preeclamptic women suffered from the severe form of preeclampsia. 19 primigravidae","_","80","55 primigravidae","_","_","All patients were screened for diabetes mellitus, renal disease,primary hypertension, or any other systemic disease and, if present,were excluded from the study. All subjects were negative for lupusanticoagulant and anticardiolipin antibodies. All subjects had normal values of antithrombin III and coagulation proteins C and S","_","_","_","32. +/- B4.0","33.4 +/- 4.2","_","_","_","_","_","_","_","_","34.7 +/- 2.2","39.6 +/- 1.7","> 0.3 g/24 h","140","90","_"
"12932862","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268*T* (M235*T*)","0.02","_","Bouba I et al. (Georgiou I)","2003","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","Caucasian, European, Greek","maternal blood","41","_","_","102","_","_","_","Required at least two pregnancies with no history of PE.","_","_","Excluded HT or cardiovascular disease.","31 (21-45)","29 (17-48)","_","_","_","_","_","_","2043 +/- 856 ","3162.15 +/- 477.5","34.32 +/- 3.6","38.96 +/- 1.2",">300 mg/l in a random specimen or an excretion of >300 mg per 24 h after 20 weeks","140","90","_"
"14638622","rs1695","GSTP1","11","11","67109264","67352688","coding","coding","1403","1623","I105V","0.26","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs1800471","TGFB1","19","19","46550715","41858875","coding","coding","941","956","R25P","0.71","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/A","0.36","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs4762","AGT","1","1","228912599","230845976","coding","coding","4360","4360","T207*M* (T174*M*)","0.003"," 0.01 (for number of candidate polymorphisms = 5)","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs5186","AGTR1","3","3","149942677","148459987","3'UTR","3'UTR","44330","44330","A/C","0.53","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","0.35","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs693","APOB","2","2","21085699","21232194","coding","coding","34751","34751","T2488T","0.87","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14638622","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)"," 0.015 in HELLP subset;  .19 in general","_","Levesque S et al. (Rousseau F)","2003","Candidate gene approach","Hypertension","Caucasian, French-Canadian","maternal blood","180","38% PE only, 14% HELLP, 3% eclamptic, 45% severe PE","_","310","_","_","PE and CHT","_","_","100","Gestational HT without proteinuria.","26 +/- 5","26 +/- 5","_","_","_","_","25 +/- 5","24 +/- 5","_","_","_","_",">=0.3 g/L in a 24-hour urine collection or >=1+, using Albustix on random urine analysis","_","90","Severe preeclampsia included any of the following: eclampsia, proteinuria >3 g/L, diastolic blood pressure >=110 mm Hg, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), elevated liver enzymes, intrauterine growth restriction, thrombocytopenia, pulmonary edema, oliguria (<500 mL/24 h), oligohydramnios, and absent or reversed umbilical artery end-diastolic blood flow by Doppler velocimetry. HELLP syndrome was characterized by hemolysis, platelet count <100_109/L, and elevated liver enzymes (>42 U/L AST, >63 U/L ALT). Eclampsia was confirmed by seizures complicating preeclampsia."
"14719182","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","_","_","Ohta K et al. (Tamashiro H)","2003","Candidate gene approach","Seminars in Thrombosis and Hemostasis","Japanese","_","131","110 patients with severe HP.  HP was diagnosed when at least one of the following criteria was met[23]: Proteinuria, which appears in PE, was defined as the urinary protein excretion >= 30 mg/dL (1+ on dipstick) in a random determination. Severe HP was defined as blood pressure >= 160/110 mm Hg, or proteinuria >= 2.0 g/day (on dipstick, 2+ or 3+ at a random qualitative examination), or pulmonary edema. ","_","237","_","_","_","women who had not experienced HT, proteinuria, or edema during their pregnancy and for 1 month after delivery. Women with hemolysis, liver dysfunction, and low platelets (HELLP) syndrome; renal disease; diabetes mellitus; amniotic volume abnormalities; or fetal anomalies were excluded from this study. ","_","_","_","29.9 +/- 0.5","29.1 +/- 0.3","_","_","_","_","22.5 +/- 0.4","21.3 +/- 0.2","2515 +/- 70","3137 +/- 21","36.9 +/- 0.3","39.1 +/- 0.1","_","_","_","Women with blood pressure >= 140/90 mm Hg and proteinuria before 20 weeks of gestation or at 4 weeks after delivery were excluded from the HP subjects, because they may have had latent hypertensive or renal disease."
"14746952","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","_","_","Prasmusinto D et al. (van der Ven K)","2004","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","German, Croatian, Indonesian","blood sample","82","40 preeclamptic Germans, 42 preeclamptic Indonesians","62","116"," 72 control Germans, 44 control Indonesians","81","Hypertension and proteinuria. The onset of first symptoms had to occur beyond 20 weeks of gestation from last menstrual period and symptoms had to have regressed at 6 weeks post delivery. Patients with preexistent hypertension, proteinuria and edema and also diabetes, chronic kidney, hepatic or vascular disease were excluded from the study. Patients with HELLP syndrome (hemolysis, elevated liver values and low platelet counts) were also excluded from the study.","Absence of symptoms of elevated blood pressure, proteinuria and edema and absence of the predisposing diseases listed above.","_","_","_","_","_","_","_","_","_","_","_","2564 +/- 1064 Germans, 2792 +/- 618 Indonesians","3476 +/- 644 Germans, 3077 +/- 379 Indonesians","36.9 +/- 4.1 Germans, 38.1 +/- 3.2 Indonesians","38.8 +/- 2.4 Germans, 39.5 +/- 1.2 Indonesians","_","_","_","_"
"14746952","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/*A*",".05 in Germans/Croatians, NS in indonesians","_","Prasmusinto D et al. (van der Ven K)","2004","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","German, Croatian, Indonesian","blood sample","82","40 preeclamptic Germans, 42 preeclamptic Indonesians","62","116"," 72 control Germans, 44 control Indonesians","81","Hypertension and proteinuria. The onset of first symptoms had to occur beyond 20 weeks of gestation from last menstrual period and symptoms had to have regressed at 6 weeks post delivery. Patients with preexistent hypertension, proteinuria and edema and also diabetes, chronic kidney, hepatic or vascular disease were excluded from the study. Patients with HELLP syndrome (hemolysis, elevated liver values and low platelet counts) were also excluded from the study.","Absence of symptoms of elevated blood pressure, proteinuria and edema and absence of the predisposing diseases listed above.","_","_","_","_","_","_","_","_","_","_","_","2564 +/- 1064 Germans, 2792 +/- 618 Indonesians","3476 +/- 644 Germans, 3077 +/- 379 Indonesians","36.9 +/- 4.1 Germans, 38.1 +/- 3.2 Indonesians","38.8 +/- 2.4 Germans, 39.5 +/- 1.2 Indonesians","_","_","_","_"
"15042014","rs4994","ADRB3 (B3AR)","8","8","37942954","37823797","coding","coding","37943341","37824184","W64R"," 0.17 (genotype);  0.19 (allele)","_","Malina AN et al. (Roberts JM)","2004","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian 82%, Black 16%, Pacific Islander 2%, Hispanic 0.3%","maternal blood","173","143 Caucasian, 26 Black, 3 Pacific Islander, 1 Hispanic","_","179","145 Caucasian, 30 Black, 4 Pacific Islander","_",">= 1 normotensive pregnancies.","_","_","_","_","27 +/- 0.5","25.4 +/- 0.5","_","_","_","_","25.7 +/- 0.5","23.8 +/- 0.4","_","_","35.1 +/- 0.3","39 +/- 0.2",">300 mg/l per 24-h or >= 2+ on dipstick","140","90","Blood pressure after 20 weeks' gestation that was increased either 30 mm Hg systolic or 15 mm Hg diastolic over the average of all blood pressures before 20 weeks. Required hyperuricemia of greater than 1 SD for gestational age."
"15082899","rs4762","AGT","1","1","228912599","230845976","coding","coding","4360","4360","T207M (T174M)","NS","_","Choi H, Kang JY et al. (Park JB)","2004","Candidate gene approach","Journal of Korean Medical Science","Asian,  Korean","maternal blood (leukocytes)","90","Family history of HT 41%","_","98","Family history of HT 26%","_","_","_","69","67","Mild PE, renal disease, overt cardiac disease, serum creatinine >150 mol/L or the presence of other systemic disease.","30.2 +/- 4.5","30.9 +/- 4.7","54.1 +/- 7.4","53.1 +/- 5.8","_","_","21.8 +/- 3.4","22 +/- 2.8","_","_","36.2 +/- 3.5","39.7 +/- 1.0","1 g/L (or 2+ dipstick), with or without edema, after 20 weeks","140","90","_"
"15082899","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)","NS","_","Choi H, Kang JY et al. (Park JB)","2004","Candidate gene approach","Journal of Korean Medical Science","Asian,  Korean","maternal blood (leukocytes)","90","Family history of HT 41%","_","98","Family history of HT 26%","_","_","_","69","67","Mild PE, renal disease, overt cardiac disease, serum creatinine >150 mol/L or the presence of other systemic disease.","30.2 +/- 4.5","30.9 +/- 4.7","54.1 +/- 7.4","53.1 +/- 5.8","_","_","21.8 +/- 3.4","22 +/- 2.8","_","_","36.2 +/- 3.5","39.7 +/- 1.0","1 g/L (or 2+ dipstick), with or without edema, after 20 weeks","140","90","_"
"15085177","rs1800891","IL10","1","1","205015188","206948565","upstream","upstream","-2726","-2726","G/*A*","_","_","de Groot CJ et al. (Huizinga TW)","2004","Candidate gene approach","Genes Immunology","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"15091001","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Camilleri RS et al. (Cohen H)","2004","Candidate gene approach; retrospective case-control study","Blood Coagulation Fibrinolysis","Caucasian, Afro-Caribbean, Asian","blood sample","147","Caucasian (n = 90), Afro-Caribbean (n = 28), Asian (n = 14) and individuals with other ethnicities (n = 15) (age range, 17-55 years; median age, 33 years).","_","100","at least one successful pregnancy and included individuals with one miscarriage, provided they had a history of at least one full-term, normal delivery (age range, 17-42 years; median age, 33 years)","_","Only those cases with severe and significant pre-eclampsia were included. Women with a history of obstetric complications, IUGR, unexplained IUFD, placental abruption, severe pre-eclampsia and eclampsia, unexplained stillbirth or neonatal death were included in the study","Women excluded from the normal cohort were those with a history of two or more miscarriages, pregnancy complications (placental abruption, IUGR or IUFD, preterm pre-eclampsia or eclampsia, spontaneous pre-term delivery) or a personal or family history of thromboembolic disease. Women with chronic hypertension, diabetes, connective tissue disorder, chronic renal disease or haemoglobinopathy were also excluded. ","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg per 24 h","160","110","_"
"15091001","rs1800790","FGB","4","4","155703157","155483707","upstream","upstream","-424","-424","G/A","0.5716","_","Camilleri RS et al. (Cohen H)","2004","Candidate gene approach; retrospective case-control study","Blood Coagulation Fibrinolysis","Caucasian, Afro-Caribbean, Asian","blood sample","147","Caucasian (n = 90), Afro-Caribbean (n = 28), Asian (n = 14) and individuals with other ethnicities (n = 15) (age range, 17-55 years; median age, 33 years).","_","100","at least one successful pregnancy and included individuals with one miscarriage, provided they had a history of at least one full-term, normal delivery (age range, 17-42 years; median age, 33 years)","_","Only those cases with severe and significant pre-eclampsia were included. Women with a history of obstetric complications, IUGR, unexplained IUFD, placental abruption, severe pre-eclampsia and eclampsia, unexplained stillbirth or neonatal death were included in the study","Women excluded from the normal cohort were those with a history of two or more miscarriages, pregnancy complications (placental abruption, IUGR or IUFD, preterm pre-eclampsia or eclampsia, spontaneous pre-term delivery) or a personal or family history of thromboembolic disease. Women with chronic hypertension, diabetes, connective tissue disorder, chronic renal disease or haemoglobinopathy were also excluded. ","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg per 24 h","160","110","_"
"15091001","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Camilleri RS et al. (Cohen H)","2004","Candidate gene approach; retrospective case-control study","Blood Coagulation Fibrinolysis","Caucasian, Afro-Caribbean, Asian","blood sample","147","Caucasian (n = 90), Afro-Caribbean (n = 28), Asian (n = 14) and individuals with other ethnicities (n = 15) (age range, 17-55 years; median age, 33 years).","_","100","at least one successful pregnancy and included individuals with one miscarriage, provided they had a history of at least one full-term, normal delivery (age range, 17-42 years; median age, 33 years)","_","Only those cases with severe and significant pre-eclampsia were included. Women with a history of obstetric complications, IUGR, unexplained IUFD, placental abruption, severe pre-eclampsia and eclampsia, unexplained stillbirth or neonatal death were included in the study","Women excluded from the normal cohort were those with a history of two or more miscarriages, pregnancy complications (placental abruption, IUGR or IUFD, preterm pre-eclampsia or eclampsia, spontaneous pre-term delivery) or a personal or family history of thromboembolic disease. Women with chronic hypertension, diabetes, connective tissue disorder, chronic renal disease or haemoglobinopathy were also excluded. ","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg per 24 h","160","110","_"
"15091001","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/*A*",".056 in Caucasian patients","_","Camilleri RS et al. (Cohen H)","2004","Candidate gene approach; retrospective case-control study","Blood Coagulation Fibrinolysis","Caucasian, Afro-Caribbean, Asian","blood sample","147","Caucasian (n = 90), Afro-Caribbean (n = 28), Asian (n = 14) and individuals with other ethnicities (n = 15) (age range, 17-55 years; median age, 33 years).","_","100","at least one successful pregnancy and included individuals with one miscarriage, provided they had a history of at least one full-term, normal delivery (age range, 17-42 years; median age, 33 years)","_","Only those cases with severe and significant pre-eclampsia were included. Women with a history of obstetric complications, IUGR, unexplained IUFD, placental abruption, severe pre-eclampsia and eclampsia, unexplained stillbirth or neonatal death were included in the study","Women excluded from the normal cohort were those with a history of two or more miscarriages, pregnancy complications (placental abruption, IUGR or IUFD, preterm pre-eclampsia or eclampsia, spontaneous pre-term delivery) or a personal or family history of thromboembolic disease. Women with chronic hypertension, diabetes, connective tissue disorder, chronic renal disease or haemoglobinopathy were also excluded. ","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","> 300 mg per 24 h","160","110","_"
"15097012","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","_","_","Vefring H et al. (Nilsen ST)","2004","Candidate gene approach","Epidemiology","Norwegian","blood sample","92","_","92","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","1+ on dipstick","_","_","Diastolic blood pressure increase of at least 25 mm Hg and proteinuria 1+ on a semiquantitative dipstick; moderate preeclampsia was an increase of at least 25 mm Hg and proteinuria 2+ on a semiquantitative dipstick. Severe preeclampsia was diastolic blood pressure of at least 110 mm Hg, with an increase in diastolic blood pressure of at least 25 mm Hg, and proteinuria 3+ on a semiquantitative dipstick, or at least 500 mg per 24 hours."
"15097012","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","_","_","Vefring H et al. (Nilsen ST)","2004","Candidate gene approach","Epidemiology","Norwegian","blood sample","92","_","92","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","1+ on dipstick","_","_","Diastolic blood pressure increase of at least 25 mm Hg and proteinuria 1+ on a semiquantitative dipstick; moderate preeclampsia was an increase of at least 25 mm Hg and proteinuria 2+ on a semiquantitative dipstick. Severe preeclampsia was diastolic blood pressure of at least 110 mm Hg, with an increase in diastolic blood pressure of at least 25 mm Hg, and proteinuria 3+ on a semiquantitative dipstick, or at least 500 mg per 24 hours."
"15110896","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","NS","_","Landau R et al. (Smiley RM)","2004","Candidate gene approach","American Journal of Hypertension","Hispanic, Caucasian","_","64","_","_","397","_","_","_","_","_","_","_","28  +/- 7","29  +/- 6","67 +/- 14.5","163.5 +/- 13","_","_","_","_","_","_","_","_",">0.3 g/L or a dipstick proteinuria reading of 2+","140","90","_"
"15163465","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Perez-Mutul J et al. (Martinez-Olivares R)","2004","Candidate gene approach","Archives of Medical Research","Mexican","_","148","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"15294367","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)"," 0.905 nulliparous;  0.745 parous","_","Kim YJ et al. (Pang MG)","2004","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","Asian,  Korean","maternal blood","104","_","_","114","_","_","_","No history of preeclampsia in previous pregnancies, no family history of preeclampsia and no chronic hypertension.","55","61","_","30.6 +/- 5.7","30.8 +/- 3.3","_","_","_","_","_","_","2400 +/- 1100","3300 +/- 400","36.2 +/- 4.4","39 +/- 2.1","_","_","_","_"
"15733879","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","G/A","NS","_","Driul L et al. (Marchesoni D)","2005","Candidate gene approach","International Journal of Gynecology & Obstetrics","_","_","39","32 Women with preeclampsia and abnormal uterine artery Doppler, 16 Women with preeclampsia and normal uterine artery Doppler","_","64","_","_","_","_","68","64","_","32 +/- 4 Abnormal uterine artery Doppler, 32 +/- 5.3 Normal uterine artery Doppler","31.2 +/- 4.7","_","_","_","_","_","_","1387+/-510 abnormal uterine artery Doppler, 2487+/-1020 normal uterine artery Doppler","3100+/-648","31 +/- 3.4 abnormal uterine artery Doppler, 35 +/- 2.8 normal uterine artery Doppler","39.3+/-1.4","_","_","_","_"
"15733879","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/*T*","NS","_","Driul L et al. (Marchesoni D)","2005","Candidate gene approach","International Journal of Gynecology & Obstetrics","_","_","39","32 Women with preeclampsia and abnormal uterine artery Doppler, 16 Women with preeclampsia and normal uterine artery Doppler","_","64","_","_","_","_","68","64","_","32 +/- 4 Abnormal uterine artery Doppler, 32 +/- 5.3 Normal uterine artery Doppler","31.2 +/- 4.7","_","_","_","_","_","_","1387+/-510 abnormal uterine artery Doppler, 2487+/-1020 normal uterine artery Doppler","3100+/-648","31 +/- 3.4 abnormal uterine artery Doppler, 35 +/- 2.8 normal uterine artery Doppler","39.3+/-1.4","_","_","_","_"
"15733879","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","<.05","_","Driul L et al. (Marchesoni D)","2005","Candidate gene approach","International Journal of Gynecology & Obstetrics","_","_","39","32 Women with preeclampsia and abnormal uterine artery Doppler, 16 Women with preeclampsia and normal uterine artery Doppler","_","64","_","_","_","_","68","64","_","32 +/- 4 Abnormal uterine artery Doppler, 32 +/- 5.3 Normal uterine artery Doppler","31.2 +/- 4.7","_","_","_","_","_","_","1387+/-510 abnormal uterine artery Doppler, 2487+/-1020 normal uterine artery Doppler","3100+/-648","31 +/- 3.4 abnormal uterine artery Doppler, 35 +/- 2.8 normal uterine artery Doppler","39.3+/-1.4","_","_","_","_"
"15734083","rs1048943","CYP1A1","15","15","72800037","75012984","coding","coding","4893","4893","I462V","NS","_","Kim YJ et al. (Pang MG)","2005","Candidate gene approach; retrospective, hospital-based case-control study","European Journal of Obstetrics & Gynecology and Reproductive Biology","Japanese, Caucasian, Korean, Hawaiian","blood sample","121","_","_","214","_","_","Preeclampsia: high blood pressure and proteinuria","Exclusion criteria were as follows: altered renal function, diabetes or chronic disease, twin pregnancies, recurrent miscarriages, fetal growth retardation, and abruptio placenta. Women with a history of essential hypertension were excluded from the study.","21.79","31.48","_","30.7 +/- 4.7","31.1 +/- 3.7","_","_","_","_","_","_","_","_","_","_",">=300 mmHg/24 h","140","90","_"
"15734083","rs4646903","CYP1A1","15","15","72798693","75011640","downstream","downstream","6237","6237","A/C/T","NS","_","Kim YJ et al. (Pang MG)","2005","Candidate gene approach; retrospective, hospital-based case-control study","European Journal of Obstetrics & Gynecology and Reproductive Biology","Japanese, Caucasian, Korean, Hawaiian","blood sample","121","_","_","214","_","_","Preeclampsia: high blood pressure and proteinuria","Exclusion criteria were as follows: altered renal function, diabetes or chronic disease, twin pregnancies, recurrent miscarriages, fetal growth retardation, and abruptio placenta. Women with a history of essential hypertension were excluded from the study.","21.79","31.48","_","30.7 +/- 4.7","31.1 +/- 3.7","_","_","_","_","_","_","_","_","_","_",">=300 mmHg/24 h","140","90","_"
"15866085","rs1801131","MTHFR","1","1","11777062","11854475","coding","coding","11640","11685","A/C","NS","_","Also-Rallo E et al. (Grinberg D)","2005","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","43","_","_","122","pregnant women controlled at the Department of Obstetrics and Gynecology of our hospital from the first trimester who completed the pregnancy without complications.","_","_","Exclusion criteria were as follows: pregnant women who did not stop folate supplementation by the 12th week of gestation, special diets implying a folate consumption higher or lower than normal intakes in our geographical area (assessed by a nutritional questionnaire), altered renal function, diabetes or chronic diseases, treatment with antifolate drugs (antiepileptics, metotrexate), twin pregnancies, maternal age above 40 years old, and non-Caucasian ethnic origin.","_","_","_","30.5 (25-40)","30 (19-39)","_","_","_","_","26.3 (19.3-37.2)","25.6 (18.4-38.5)","1273 (695-4320)","1273 (695-4320)","_","_","300 mg/24 h","140","90","_"
"15866085","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685"," C/T","NS","_","Also-Rallo E et al. (Grinberg D)","2005","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","43","_","_","122","pregnant women controlled at the Department of Obstetrics and Gynecology of our hospital from the first trimester who completed the pregnancy without complications.","_","_","Exclusion criteria were as follows: pregnant women who did not stop folate supplementation by the 12th week of gestation, special diets implying a folate consumption higher or lower than normal intakes in our geographical area (assessed by a nutritional questionnaire), altered renal function, diabetes or chronic diseases, treatment with antifolate drugs (antiepileptics, metotrexate), twin pregnancies, maternal age above 40 years old, and non-Caucasian ethnic origin.","_","_","_","30.5 (25-40)","30 (19-39)","_","_","_","_","26.3 (19.3-37.2)","25.6 (18.4-38.5)","1273 (695-4320)","1273 (695-4320)","_","_","300 mg/24 h","140","90","_"
"15866085","rs1801181","CBS","21","21","43353684","44480615","coding","coding","15809","15857","C/T","NS","_","Also-Rallo E et al. (Grinberg D)","2005","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","43","_","_","122","pregnant women controlled at the Department of Obstetrics and Gynecology of our hospital from the first trimester who completed the pregnancy without complications.","_","_","Exclusion criteria were as follows: pregnant women who did not stop folate supplementation by the 12th week of gestation, special diets implying a folate consumption higher or lower than normal intakes in our geographical area (assessed by a nutritional questionnaire), altered renal function, diabetes or chronic diseases, treatment with antifolate drugs (antiepileptics, metotrexate), twin pregnancies, maternal age above 40 years old, and non-Caucasian ethnic origin.","_","_","_","30.5 (25-40)","30 (19-39)","_","_","_","_","26.3 (19.3-37.2)","25.6 (18.4-38.5)","1273 (695-4320)","1273 (695-4320)","_","_","300 mg/24 h","140","90","_"
"15866085","rs1805087","MTR","1","1","235115122","237048499","coding","coding","89919","89919","A/G","NS","_","Also-Rallo E et al. (Grinberg D)","2005","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","43","_","_","122","pregnant women controlled at the Department of Obstetrics and Gynecology of our hospital from the first trimester who completed the pregnancy without complications.","_","_","Exclusion criteria were as follows: pregnant women who did not stop folate supplementation by the 12th week of gestation, special diets implying a folate consumption higher or lower than normal intakes in our geographical area (assessed by a nutritional questionnaire), altered renal function, diabetes or chronic diseases, treatment with antifolate drugs (antiepileptics, metotrexate), twin pregnancies, maternal age above 40 years old, and non-Caucasian ethnic origin.","_","_","_","30.5 (25-40)","30 (19-39)","_","_","_","_","26.3 (19.3-37.2)","25.6 (18.4-38.5)","1273 (695-4320)","1273 (695-4320)","_","_","300 mg/24 h","140","90","_"
"15866085","rs234706","CBS","21","21","43358418","44485349","coding","coding","11075","11123","C/T","NS","_","Also-Rallo E et al. (Grinberg D)","2005","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","43","_","_","122","pregnant women controlled at the Department of Obstetrics and Gynecology of our hospital from the first trimester who completed the pregnancy without complications.","_","_","Exclusion criteria were as follows: pregnant women who did not stop folate supplementation by the 12th week of gestation, special diets implying a folate consumption higher or lower than normal intakes in our geographical area (assessed by a nutritional questionnaire), altered renal function, diabetes or chronic diseases, treatment with antifolate drugs (antiepileptics, metotrexate), twin pregnancies, maternal age above 40 years old, and non-Caucasian ethnic origin.","_","_","_","30.5 (25-40)","30 (19-39)","_","_","_","_","26.3 (19.3-37.2)","25.6 (18.4-38.5)","1273 (695-4320)","1273 (695-4320)","_","_","300 mg/24 h","140","90","_"
"15889386","rs12695924","AGTR1","3","3","149940980","148458290","intron","intron","42633","42633","C/T"," 0.309 Maternal;  0.144 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs12721318","AGTR1","3","3","149940699","148458009","intron","intron","42352","42352","T/A"," 0.410 Maternal;  0.495 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967"," Q298D"," 0.455 Maternal;  0.529 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319"," G/A"," 0.954 Maternal;  0.437 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1800780","NOS3 (eNOS)","7","7","150329562","150698629","intron","intron","10482","10485"," G/A"," 0.724 Maternal;  0.116 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1800781","NOS3 (eNOS)","7","7","150323127","150692194","intron","intron","4047","4050"," G/A"," 0.355 Maternal;  0.431 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1800783","NOS3 (eNOS)","7","7","150320329","150689396","intron","intron","1250","1253"," T/A"," 0.248 Maternal;  0.824 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1801131","MTHFR","1","1","11777062","11854475","coding","coding","11640","11685","A/C"," 0.419 Maternal;  0.141 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T"," 0.723 Maternal;  0.609 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs3736556","AGTR2","X","X","115216362","115302334","intron","intron","377","377","A/*T*"," 0.039 Maternal;  0.720 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs3918188","NOS3 (eNOS)","7","7","150333713","150702780","intron","intron","14634","14637"," C/A"," 0.676 Maternal;  0.557 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs5182","AGTR1","3","3","149942084","148459394","coding","coding","43737","43737","C/T"," 0.848 Maternal;  0.569 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs5186","AGTR1","3","3","149942677","148459987","3'UTR","3'UTR","44330","44330","A/C"," 0.957 Maternal;  0.883 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs5193","AGTR2","X","X","115218851","115304823","3'UTR","3'UTR","2866","2866","G/*T*"," 0.054 Maternal;  0.038 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs5194","AGTR2","X","X","115218857","115304829","3'UTR","3'UTR","2872","2872","G/A"," 0.590 Maternal;  0.655 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A"," 0.779 Maternal;  0.561 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)"," 0.505 Maternal;  0.349 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15889386","rs743506","NOS3 (eNOS)","7","7","150337847","150706914","intron","intron","18768","18771","A/G"," 0.220 Maternal;  0.215 Fetal","_","GOPEC Consortium","2005","Candidate gene approach","American Journal of Human Genetics","Caucasian, European, Western European","maternal blood, paternal blood, fetal blood, parental blood, sibling blood","934","398 maternal triads (woman, parent(s), sibling(s)); 536 fetal triads (woman, partner, offspring)","_","_","_","_","_","_","79.1","_","HT or proteinuria prior to 20 weeks; essential HT, diabetes, renal or cardiac disease, current multiple pregnancy.","29.7 (median)","_","_","_","_","_","27.01","_","2560","_","37","_",">500 mg/L per 24-h or 2+ on dipstick","140","90","_"
"15894829","rs1048315","ESR2","14","14","63762217","64692464","3'UTR","3'UTR","68664","68664","C/T","NS","_","Maruyama A et al. (Yamamoto T)","2004","Candidate gene approach","Hypertension Research","Japanese, Asian","blood sample","84","_","_","160","_","_","PE was dened as an elevation of blood pressure plus proteinuria.","_","62.3","59.1","_","30.8 +/- 5.3","30.2 +/- 4.7","_","_","_","_","26.5 +/- 3.6","24.7 +/- 2.6","1894 +/- 878","3020 +/- 483","34.2 +/- 4.2","38.7 +/- 2.0","The proteinuria criteria were a value greater than 1_ on acatheterized, greater than 2_ on a voided, and greater than300 mg on a 24-h urine specimen, or a protein/creatinine ratio of 0.3.","140","90","_"
"15894829","rs1256030","ESR2","14","14","63816922","64747169","intron","intron","13959","13959","C/T","NS","_","Maruyama A et al. (Yamamoto T)","2004","Candidate gene approach","Hypertension Research","Japanese, Asian","blood sample","84","_","_","160","_","_","PE was dened as an elevation of blood pressure plus proteinuria.","_","62.3","59.1","_","30.8 +/- 5.3","30.2 +/- 4.7","_","_","_","_","26.5 +/- 3.6","24.7 +/- 2.6","1894 +/- 878","3020 +/- 483","34.2 +/- 4.2","38.7 +/- 2.0","The proteinuria criteria were a value greater than 1_ on acatheterized, greater than 2_ on a voided, and greater than300 mg on a 24-h urine specimen, or a protein/creatinine ratio of 0.3.","140","90","_"
"15894829","rs928554","ESR2","14","14","63763947","64694194","downstream","downstream","66934","66934","A/*G*","0.042","_","Maruyama A et al. (Yamamoto T)","2004","Candidate gene approach","Hypertension Research","Japanese, Asian","blood sample","84","_","_","160","_","_","PE was dened as an elevation of blood pressure plus proteinuria.","_","62.3","59.1","_","30.8 +/- 5.3","30.2 +/- 4.7","_","_","_","_","26.5 +/- 3.6","24.7 +/- 2.6","1894 +/- 878","3020 +/- 483","34.2 +/- 4.2","38.7 +/- 2.0","The proteinuria criteria were a value greater than 1_ on acatheterized, greater than 2_ on a voided, and greater than300 mg on a 24-h urine specimen, or a protein/creatinine ratio of 0.3.","140","90","_"
"15905108","rs1801133 ","MTHFR","1","1","11778964","11856377","coding","coding","9738","11685","C/T","NS","_","Davalos IP et al. (Salazar-Paramo M)","2005","Candidate gene approach","Blood Cells, Molecules and Diseases","_","_","33","_","_","62","_","_","Preeclampsia was considered when a pregnant woman developed arterial hypertension after 20th week of pregnancy associated with proteinuria, with or without edema. ","Patients with chronic hypertension, preeclampsia superimposed to chronic hypertension, transient hypertension or other related syndromes were excluded.","_","_","_","26.4","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"15905108","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","G/A","NS","_","Davalos IP et al. (Salazar-Paramo M)","2005","Candidate gene approach","Blood Cells, Molecules and Diseases","_","_","33","_","_","62","_","_","Preeclampsia was considered when a pregnant woman developed arterial hypertension after 20th week of pregnancy associated with proteinuria, with or without edema. ","Patients with chronic hypertension, preeclampsia superimposed to chronic hypertension, transient hypertension or other related syndromes were excluded.","_","_","_","26.4","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"15974297","rs11126985","TCG7L1","2","2","85286780","85433269","intron","intron","_","_","A/G","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs11688000","TACR1","2","2","75146664","75293156","intron","intron","133117","133489","A/G","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs13033165","TCG7L1","2","2","85383575","85530064","intron","intron","_","_","C/T","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs2043229","TCG7L1","2","2","85336513","85483002","intron","intron","_","_","A/G","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs2058860","TACR1","2","2","75252808","75399300","intron","intron","26973","27345","C/T","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs2568197","TCG7L1","2","2","85255468","85401957","intron","intron","_","_","C/T","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs3771827","TACR1","2","2","75215371","75361863","intron","intron","64410","64782","C/T","NS","NS","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs4439987","TACR1","2","2","75140613","75287105","intron","intron","139168","139540","A/G","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"15974297","rs883651","TCG7L1","2","2","85345280","85491769","intron","intron","_","_","A/G","NS","_","Fitzpatrick E et al. (Moses EK)","2004","Candidate gene approach","Human Biology","Australian, New Zealander, Icelandic, Finnish","_","90","13 Eclampsia, 74 Severe PE","_","71","_","_","Women were considered to have severe preeclampsia if they had either (1) an increase from baseline systolic blood pressure of at least 25 mm Hg and/ or an increase from baseline diastolic pressure of at least 15 mm Hg; or (2) the presence of systolic pressure of at least 140 mm Hg and/or the presence of diastolic pressure of at least 90 mm Hg. These levels had to occur on at least two occasions 6 hr apart or more. The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection. Women who met these criteria and experienced convulsions or unconsciousness in the prenatal period were classified as having eclampsia.","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","Women with preexisting hypertension or other medical conditions known to predispose them to preeclampsia were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," The level of proteinuria had to be >0.3 g/L in a 24-hr specimen, or the dipstick proteinuria score had to be >=2 in random urine collection","140","90","_"
"16009421","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","Q298D","NS","_","Kim YJ et al. (Yoo HS)","2006","Candidate gene approach; retrospective, hospital-based, case-control study","Placenta","_","blood sample, placenta tissue sample","126","Placentas were collected from women in uncomplicated full-term and preeclamptic pregnancies, immediately after elective Cesarean sections, or normal spontaneous vaginal delivery. ","_","166","_","_","Preeclampsia: high blood pressure and proteinuria","Exclusion criteria included the following: altered renal function, diabetes or chronic disease, twin pregnancies, recurrent miscarriages, fetal growth retardation, and abruption placenta. All women with a history of essential hypertension were excluded from this study.","21.8","31.5","_"," 30.7 +/- 4.7","31.1 +/- 3.7","_","_","_","_","_","_","_","_","_","_",">=300 mg/24 h","140","90","_"
"16021081","rs1143634","IL1B","2","2","113306860","113590389","coding","coding","3967","3967","C/T","0.905","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16021081","rs17561","IL1A","2","2","113253693","113537222","coding","coding","5749","5749","T/*G*","0.042","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16021081","rs1800587","IL1A","2","2","113259430","113542959","5'UTR","5'UTR","12","12","T/*C*","Black = .035   Caucasian = .025","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16021081","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/*A*","0.011","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16021081","rs1800871","IL10","1","1","205013256","206946633","upstream","upstream","-794","-794","C/T","Black = 0.38 Caucasian = .9","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16021081","rs1800896","IL10","1","1","205013519","206946896","upstream","upstream","-1057","-1057","A/G","Black = .913, Caucasian = .101","_","Haggerty CL et al. (Ness RB)","2005","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","150","Primigravidae","_","661","Primigravidae","_","_","_","100","100","_","26.8 +/- 6.1","23.6 +/- 5.6","_","_","_","_","24.4 +/- 7.9","24.8 +/- 6.4","_","_","_","_",">300 mg/24 hours or >0.3 protein/creatinine ratio or a 1+ on a catheterized specimen or 2+ on a random collection. ","140","90","_"
"16455620","rs1800955","DRD4","11","11","626783","636783","upstream","upstream","-521","-521","C/*T*","0.906 C allele, 0.019 T allele","0.04","Korobochka R et al. (Ohei G)","2006","Candidate gene approach","Molecular Human Reproduction","_","blood sample of patient, mother, father","50","_","_","_","_","_","Diagnostic criteria for PE were elevated blood pressure >140/90 in the second half of pregnancy and proteinuria defined as at least 0.3 g of protein in a 24 h urine specimen. Because a 24 h urine specimen was not a criterion in our trial, we used a semiquantitative dipstick measure of 1+ or greater to indicate proteinuria at a level of at least 0.3 g per day.","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","100","100","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","_","_","_","_","_","_","_","_","_","_","_","_","at least 0.3 g of protein in a 24 h urine specimen.","140","90","_"
"16455620","rs747302","DRD4","11","11","626688","636688","upstream","upstream","-616","-616","C/G","0.813 C allele, 0.404 G allele","_","Korobochka R et al. (Ohei G)","2006","Candidate gene approach","Molecular Human Reproduction","_","blood sample of patient, mother, father","50","_","_","_","_","_","Diagnostic criteria for PE were elevated blood pressure >140/90 in the second half of pregnancy and proteinuria defined as at least 0.3 g of protein in a 24 h urine specimen. Because a 24 h urine specimen was not a criterion in our trial, we used a semiquantitative dipstick measure of 1+ or greater to indicate proteinuria at a level of at least 0.3 g per day.","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","100","100","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","_","_","_","_","_","_","_","_","_","_","_","_","at least 0.3 g of protein in a 24 h urine specimen.","140","90","_"
"16455620","rs936461","DRD4","11","11","626495","636495","upstream","upstream","-809","-809","A/G","0.101 A allele, 0.753 G allele","NS","Korobochka R et al. (Ohei G)","2006","Candidate gene approach","Molecular Human Reproduction","_","blood sample of patient, mother, father","50","_","_","_","_","_","Diagnostic criteria for PE were elevated blood pressure >140/90 in the second half of pregnancy and proteinuria defined as at least 0.3 g of protein in a 24 h urine specimen. Because a 24 h urine specimen was not a criterion in our trial, we used a semiquantitative dipstick measure of 1+ or greater to indicate proteinuria at a level of at least 0.3 g per day.","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","100","100","Exclusion criteria were chronic hypertension or other states that could have a confounding effect on pre-eclampsia (such as autoimmune diseases, diabetes etc.)","_","_","_","_","_","_","_","_","_","_","_","_","at least 0.3 g of protein in a 24 h urine specimen.","140","90","_"
"16517614","rs2010963","VEGFA","6","6","43846327","43738349","5'UTR","5'UTR","154","154","C/*G*","0.039","_","Banyasz I et al. (Rigo J Jr)","2006","Candidate gene approach","Molecular Human Reproduction","Hungarian, Caucasian","venous blood sample","84","Severe PE","_","96","_","_","Criteria for severe PE were as follows: blood pressure >160/110 mmHg persisting for at least 6 h; and proteinuria >5 g/day after the 20th week of gestation.","_","_","_","_","27.2 +/- 5.5","28.3 +/- 5.2","_","_","_","_","23.6 +/- 4.7","22.4 +/- 4.05","_","_","32.5 +/- 3","40 +/- 1","proteinuria >5 g/day after the 20th week of gestation; proteinuria >=3+ or 4+ tested by dipstick in at least two random urine specimens obtained at least 4 h apart ","160","110","_"
"16517614","rs699947","VEGFA","6","6","43844366","43736388","upstream","upstream","-1307","-1307","A/C","_","_","Banyasz I et al. (Rigo J Jr)","2006","Candidate gene approach","Molecular Human Reproduction","Hungarian, Caucasian","venous blood sample","84","Severe PE","_","96","_","_","Criteria for severe PE were as follows: blood pressure >160/110 mmHg persisting for at least 6 h; and proteinuria >5 g/day after the 20th week of gestation.","_","_","_","_","27.2 +/- 5.5","28.3 +/- 5.2","_","_","_","_","23.6 +/- 4.7","22.4 +/- 4.05","_","_","32.5 +/- 3","40 +/- 1","proteinuria >5 g/day after the 20th week of gestation; proteinuria >=3+ or 4+ tested by dipstick in at least two random urine specimens obtained at least 4 h apart ","160","110","_"
"16542455","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","363798","363798","G/T","NS","_","Yu CK et al. (Hingorani AD)","2006","Meta-analysis, Candidate gene approach","BMC Pregnancy Childbirth","_","blood sample","89","_","_","349","_","_","Two recordings of diastolic blood pressure of 90 mmHg or higher at least fours hours apart or one recording of diastolic blood pressure of at least 120 mmHg or higher, in previously normotensive women, and urine protein excretion of at least 300 mg in 24 hours or two readings of 2+ or higher on dipstick analysis of midstream or catheter urine specimens if no 24 hour collection was available.","Nulliparous women with uncomplicated pregnancies served as controls.","_","_","Patients with chronic hypertension, pre-gestational diabetes and chronic renal disease were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"16681991","rs2298668","PRCP","11","11","82241941","82564293","coding","coding","47264","47264","E112*D*","SIgnificant when women have chronic hypertension","_","Wang L et al. (Wang X)","2006","Candidate gene approach","American Journal of Obstetrics & Gynecology","Black","blood sample","125","Includes women with eclampsia and HELLP syndrome.Cases were defined as women who were delivered of singleton, live, low birth weight infants (<2500 g) or preterm infants (<37 weeks of gestation)","_","1040","control subjects were matched for age and ethnicity and were defined as women who were delivered of singleton, live, term infants with a birth weight of >2500 g","_","_","Multiple-gestation pregnancies (twins or higher) or newborn infants with major birth defects were excluded","_","_"," Women with gestational hypertension, defined as elevated blood pressure without proteinuria or other systemic manifestations, were excluded from the analysis","29.0 +/- 7.2","28.0 +/- 6.5","74.2 +/- 18.5","69.8 +/- 17.0","164.1 +/- 6.6","163.7 +/- 6.7","_","_","_","_","35.4 +/- 4.0","38.0 +/- 3.5","urine dipstick testing (proteinuria of at least 1+ on dipstick testing) ","140","90","_"
"16681991","rs4459610","ACE","17","17","58938451","61584719","downstream","downstream","30286","30298","K715N","0.838","_","Wang L et al. (Wang X)","2006","Candidate gene approach","American Journal of Obstetrics & Gynecology","Black","blood sample","125","Includes women with eclampsia and HELLP syndrome.Cases were defined as women who were delivered of singleton, live, low birth weight infants (<2500 g) or preterm infants (<37 weeks of gestation)","_","1040","control subjects were matched for age and ethnicity and were defined as women who were delivered of singleton, live, term infants with a birth weight of >2500 g","_","_","Multiple-gestation pregnancies (twins or higher) or newborn infants with major birth defects were excluded","_","_"," Women with gestational hypertension, defined as elevated blood pressure without proteinuria or other systemic manifestations, were excluded from the analysis","29.0 +/- 7.2","28.0 +/- 6.5","74.2 +/- 18.5","69.8 +/- 17.0","164.1 +/- 6.6","163.7 +/- 6.7","_","_","_","_","35.4 +/- 4.0","38.0 +/- 3.5","urine dipstick testing (proteinuria of at least 1+ on dipstick testing) ","140","90","_"
"16681991","rs4762 ","AGT","1","1","228912599","230845976","coding","coding","4360","4360","T207M (T174M)","0.39","_","Wang L et al. (Wang X)","2006","Candidate gene approach","American Journal of Obstetrics & Gynecology","Black","blood sample","125","Includes women with eclampsia and HELLP syndrome.Cases were defined as women who were delivered of singleton, live, low birth weight infants (<2500 g) or preterm infants (<37 weeks of gestation)","_","1040","control subjects were matched for age and ethnicity and were defined as women who were delivered of singleton, live, term infants with a birth weight of >2500 g","_","_","Multiple-gestation pregnancies (twins or higher) or newborn infants with major birth defects were excluded","_","_"," Women with gestational hypertension, defined as elevated blood pressure without proteinuria or other systemic manifestations, were excluded from the analysis","29.0 +/- 7.2","28.0 +/- 6.5","74.2 +/- 18.5","69.8 +/- 17.0","164.1 +/- 6.6","163.7 +/- 6.7","_","_","_","_","35.4 +/- 4.0","38.0 +/- 3.5","urine dipstick testing (proteinuria of at least 1+ on dipstick testing) ","140","90","_"
"16681991","rs699","AGT","1","1","228912416","230845793","coding","coding","4543","4543","M268T (M235T)","0.718","_","Wang L et al. (Wang X)","2006","Candidate gene approach","American Journal of Obstetrics & Gynecology","Black","blood sample","125","Includes women with eclampsia and HELLP syndrome.Cases were defined as women who were delivered of singleton, live, low birth weight infants (<2500 g) or preterm infants (<37 weeks of gestation)","_","1040","control subjects were matched for age and ethnicity and were defined as women who were delivered of singleton, live, term infants with a birth weight of >2500 g","_","_","Multiple-gestation pregnancies (twins or higher) or newborn infants with major birth defects were excluded","_","_"," Women with gestational hypertension, defined as elevated blood pressure without proteinuria or other systemic manifestations, were excluded from the analysis","29.0 +/- 7.2","28.0 +/- 6.5","74.2 +/- 18.5","69.8 +/- 17.0","164.1 +/- 6.6","163.7 +/- 6.7","_","_","_","_","35.4 +/- 4.0","38.0 +/- 3.5","urine dipstick testing (proteinuria of at least 1+ on dipstick testing) ","140","90","_"
"16809377","rs1364657","ACVR2A","2","2","148334736","148618266","intron","intron","15697","15697","A/G","0.78383","_","Moses EK et al. (Brennecke SP)","2006","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","placenta tissue sample","87","34 pedigrees: 26 Australian, 8 New Zealander; 87 women with sever PE or E","_","71","_","_","Pregnant women were considered to have severe PE if they had (i) a rise from baseline systolic blood pressure of at least 25 mmHg and/or a rise from baseline diastolic pressure of at least 15 mmHg or (ii) the presence of a systolic pressure of at least 140 mmHg and/or a diastolic pressure of at least 90 mmHg. These levels had to occur on at least two occasions 6 h or more apart.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"16809377","rs1364658","ACVR2A","2","2","148324277","148607807","intron","intron","5238","5238","C/G","0.04261","_","Moses EK et al. (Brennecke SP)","2006","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","placenta tissue sample","87","34 pedigrees: 26 Australian, 8 New Zealander; 87 women with sever PE or E","_","71","_","_","Pregnant women were considered to have severe PE if they had (i) a rise from baseline systolic blood pressure of at least 25 mmHg and/or a rise from baseline diastolic pressure of at least 15 mmHg or (ii) the presence of a systolic pressure of at least 140 mmHg and/or a diastolic pressure of at least 90 mmHg. These levels had to occur on at least two occasions 6 h or more apart.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"16809377","rs1424954","ACVR2A","2","2","148317263","148600793","upstream","upstream","-1776","-1776","A/G","0.00696","_","Moses EK et al. (Brennecke SP)","2006","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","placenta tissue sample","87","34 pedigrees: 26 Australian, 8 New Zealander; 87 women with sever PE or E","_","71","_","_","Pregnant women were considered to have severe PE if they had (i) a rise from baseline systolic blood pressure of at least 25 mmHg and/or a rise from baseline diastolic pressure of at least 15 mmHg or (ii) the presence of a systolic pressure of at least 140 mmHg and/or a diastolic pressure of at least 90 mmHg. These levels had to occur on at least two occasions 6 h or more apart.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"16809377","rs1895694","ACVR2A","2","2","148336215","148619745","intron","intron","17176","17176","A/G","0.05397","<0.05","Moses EK et al. (Brennecke SP)","2006","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","placenta tissue sample","87","34 pedigrees: 26 Australian, 8 New Zealander; 87 women with sever PE or E","_","71","_","_","Pregnant women were considered to have severe PE if they had (i) a rise from baseline systolic blood pressure of at least 25 mmHg and/or a rise from baseline diastolic pressure of at least 15 mmHg or (ii) the presence of a systolic pressure of at least 140 mmHg and/or a diastolic pressure of at least 90 mmHg. These levels had to occur on at least two occasions 6 h or more apart.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"16809377","rs7608216","MAP4K3","2","2","39343354","39489850","intron","intron","174369","174369","C/T","0.86709","NS","Moses EK et al. (Brennecke SP)","2006","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","placenta tissue sample","87","34 pedigrees: 26 Australian, 8 New Zealander; 87 women with sever PE or E","_","71","_","_","Pregnant women were considered to have severe PE if they had (i) a rise from baseline systolic blood pressure of at least 25 mmHg and/or a rise from baseline diastolic pressure of at least 15 mmHg or (ii) the presence of a systolic pressure of at least 140 mmHg and/or a diastolic pressure of at least 90 mmHg. These levels had to occur on at least two occasions 6 h or more apart.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"16963292","rs1799889","SERPINE1","7","7","100556430","100769710","upstream","upstream","-668","-668","-/A/G","0.242 4G/4G, 0.379 4G","_","Dalmaz CA et al. (Roisenberg I)","2006","Candidate gene approach","Blood Cells, Molecules and Diseases","Brazilian","blood sample","75","_","_","145","_","_","Preeclampsia was defined as the presence of hypertension associated with proteinuria after the 20th week of gestation in women known to be normotensive beforehand. Hypertension was defined as a blood pressure of at least 140 mm Hg (systolic) and/or 90 mm Hg (diastolic) on two occasions of up to 46 h apart. The blood pressure was measured on the right arm and with the patient always in the seated position. Proteinuria was defined as urinary excretion of 300 mg or more of protein in 24 h.","no rise in blood pressure, no hypertension or proteinuria, similar age (+/- 2 years), no biological relationship and a delivery date as close as possible to the delivery date(s) of the patient group and with a follow up for at least 3 months after delivery. All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","_","_","All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","27.8 +/- 7.5","27.3 +/- 7.2","_","_","_","_","31.4 +/- 3.9","27.9 +/- 4.6","_","_","35.6 +/- 3.4","38.3 +/- 3.4","urinary excretion of 300 mg or more of protein in 24 h","140","90","_"
"16963292","rs1799963","F2","11","11","46717630","46761054","3'UTR","3'UTR","20312","20312","A/*G*","0.047 genotype GG, 0.019 allele G","_","Dalmaz CA et al. (Roisenberg I)","2006","Candidate gene approach","Blood Cells, Molecules and Diseases","Brazilian","blood sample","75","_","_","145","_","_","Preeclampsia was defined as the presence of hypertension associated with proteinuria after the 20th week of gestation in women known to be normotensive beforehand. Hypertension was defined as a blood pressure of at least 140 mm Hg (systolic) and/or 90 mm Hg (diastolic) on two occasions of up to 46 h apart. The blood pressure was measured on the right arm and with the patient always in the seated position. Proteinuria was defined as urinary excretion of 300 mg or more of protein in 24 h.","no rise in blood pressure, no hypertension or proteinuria, similar age (+/- 2 years), no biological relationship and a delivery date as close as possible to the delivery date(s) of the patient group and with a follow up for at least 3 months after delivery. All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","_","_","All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","27.8 +/- 7.5","27.3 +/- 7.2","_","_","_","_","31.4 +/- 3.9","27.9 +/- 4.6","_","_","35.6 +/- 3.4","38.3 +/- 3.4","urinary excretion of 300 mg or more of protein in 24 h","140","90","_"
"16963292","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","0.104","_","Dalmaz CA et al. (Roisenberg I)","2006","Candidate gene approach","Blood Cells, Molecules and Diseases","Brazilian","blood sample","75","_","_","145","_","_","Preeclampsia was defined as the presence of hypertension associated with proteinuria after the 20th week of gestation in women known to be normotensive beforehand. Hypertension was defined as a blood pressure of at least 140 mm Hg (systolic) and/or 90 mm Hg (diastolic) on two occasions of up to 46 h apart. The blood pressure was measured on the right arm and with the patient always in the seated position. Proteinuria was defined as urinary excretion of 300 mg or more of protein in 24 h.","no rise in blood pressure, no hypertension or proteinuria, similar age (+/- 2 years), no biological relationship and a delivery date as close as possible to the delivery date(s) of the patient group and with a follow up for at least 3 months after delivery. All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","_","_","All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","27.8 +/- 7.5","27.3 +/- 7.2","_","_","_","_","31.4 +/- 3.9","27.9 +/- 4.6","_","_","35.6 +/- 3.4","38.3 +/- 3.4","urinary excretion of 300 mg or more of protein in 24 h","140","90","_"
"16963292","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","A/G","0.268 genotype GA, 0.269 allele G","_","Dalmaz CA et al. (Roisenberg I)","2006","Candidate gene approach","Blood Cells, Molecules and Diseases","Brazilian","blood sample","75","_","_","145","_","_","Preeclampsia was defined as the presence of hypertension associated with proteinuria after the 20th week of gestation in women known to be normotensive beforehand. Hypertension was defined as a blood pressure of at least 140 mm Hg (systolic) and/or 90 mm Hg (diastolic) on two occasions of up to 46 h apart. The blood pressure was measured on the right arm and with the patient always in the seated position. Proteinuria was defined as urinary excretion of 300 mg or more of protein in 24 h.","no rise in blood pressure, no hypertension or proteinuria, similar age (+/- 2 years), no biological relationship and a delivery date as close as possible to the delivery date(s) of the patient group and with a follow up for at least 3 months after delivery. All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","_","_","All women who had chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer or thrombosis were not included in the study.","27.8 +/- 7.5","27.3 +/- 7.2","_","_","_","_","31.4 +/- 3.9","27.9 +/- 4.6","_","_","35.6 +/- 3.4","38.3 +/- 3.4","urinary excretion of 300 mg or more of protein in 24 h","140","90","_"
"17071538","rs1137100","LEPR","1","1","65809028","66036440","coding","coding","150123","150310","A/*G*","<0.03","_","Rigo J et al. (Ver A)","2006","Candidate gene approach","Gynecology Endocrinology","_","peripheral blood sample","124","Severely PE patients","_","107","_","_","Severe pre-eclampsia was defined as new-onset, persistent hypertension (>=160 /110 mmHg occurring on at least two occasions >4 h apart) and new-onset proteinuria (>=1000 mg/24 h) after the 20th gestational week, in the absence of urinary tract infection. ","One hundred and seven healthy, volunteer preg- nant women with uneventful pregnancies served as control group. ","74","57","Patients with multiple pregnancies, chronic hypertension, renal disease, gestational diabetes mellitus and autoim- mune disease were excluded from the study.","28 (14-43)","27 (17-44)","_","_","_","_","22.9 (15.9-42.7)","21.9 (16.3-37.9)","1549 +/- 574","3493 +/- 410","33 (24-37)","40 (38-42)","new-onset proteinuria (>=1000 mg/24 h) after the 20th gestational week, in the absence of urinary tract infection. ","160","110","_"
"17137622","rs11575945","A5","4","4","122837194","122617744","5'UTR","_","_","_","A/G","NS","_","Coolman et al. (de Groot CJ)","2007","Candidate gene approach","Placenta","_","blood sample","163","_","_","163","_","_","Preeclampsia was defined by means of strict criteria: as a rise of blood pressure (>=30 mmHg systolic or >=15 mmHg diastolic over values in the first 20 weeks or, if blood pressure was unknown before 20 weeks gestation); late-pregnancy hypertension (defined as an absolute blood pressure >=140/90 mmHg); and proteinuria (>=2 + [1 g/l] on a voided specimen or >=1 + [0.3 g/l] on a catheterised specimen).","Control subjects were selected according to the following criteria: first pregnancy, no rise in blood pressure, no hypertension or proteinuria, similar age (+/-5 years) and a delivery date as close as possible to the delivery date of the case subject. Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"17137622","rs3025058","MMP3","11","11","102221162","102715952","upstream","upstream","-1610","-1610","-/T","NS","_","Coolman et al. (de Groot CJ)","2007","Candidate gene approach","Placenta","_","blood sample","163","_","_","163","_","_","Preeclampsia was defined by means of strict criteria: as a rise of blood pressure (>=30 mmHg systolic or >=15 mmHg diastolic over values in the first 20 weeks or, if blood pressure was unknown before 20 weeks gestation); late-pregnancy hypertension (defined as an absolute blood pressure >=140/90 mmHg); and proteinuria (>=2 + [1 g/l] on a voided specimen or >=1 + [0.3 g/l] on a catheterised specimen).","Control subjects were selected according to the following criteria: first pregnancy, no rise in blood pressure, no hypertension or proteinuria, similar age (+/-5 years) and a delivery date as close as possible to the delivery date of the case subject. Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"17137622","rs3918242","MMP9","20","20","44069382","44635975","upstream","upstream","-1571","-1571","C/*T*","<0.05","_","Coolman et al. (de Groot CJ)","2007","Candidate gene approach","Placenta","_","blood sample","163","_","_","163","_","_","Preeclampsia was defined by means of strict criteria: as a rise of blood pressure (>=30 mmHg systolic or >=15 mmHg diastolic over values in the first 20 weeks or, if blood pressure was unknown before 20 weeks gestation); late-pregnancy hypertension (defined as an absolute blood pressure >=140/90 mmHg); and proteinuria (>=2 + [1 g/l] on a voided specimen or >=1 + [0.3 g/l] on a catheterised specimen).","Control subjects were selected according to the following criteria: first pregnancy, no rise in blood pressure, no hypertension or proteinuria, similar age (+/-5 years) and a delivery date as close as possible to the delivery date of the case subject. Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","Both cases and controls that had multiple pregnancies, chronic hypertension, renal disease, diabetes, collagen vascular diseases, cancer, or thrombosis before their first pregnancy were excluded from the study.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"17179726","rs1056784","MMP19","12","12","54519579","56233312","coding","coding","3423","3423","C/*T*"," 0.008 offspring (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs1058885","CSF1","1","1","110267988","110466465","coding","coding","13233","13233","C/T"," 0.0086 for Maternal-Fetal interaction model","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs11673460","IL12RB1","19","19","18052371","18191371","intron","intron","6371","6371","C/*A*"," 0.0093 Maternal (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs17639446  ","COL1A1","17","17","45628901","48273902","intron","intron","5098","5098","T/*G*","0.0011 Maternal (additive model)","Not significant","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2071374","IL1A","2","2","113253822","113537351","intron","intron","5620","5620","A/C","0.051","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2141279","COL1A1","17","17","45628462","48273463","intron","intron","5537","5537","C/T","0.103","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2229187","PTGER2","14","14","51863507","52793757","intron","intron","12644","12741","A/*G*"," 0.0082 Maternal (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2274849","IGF2R","6","6","160399871","160479881","intron","intron","89751","89751","A/G"," 0.0082 for Maternal-Fetal interaction model","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2277632","COL1A1","17","17","45618901","48263902","intron","intron","15098","15098","A/G","0.0196","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs2296849","COL4A2","13","13","109942412","111144411","intron","intron","184781","184781","C/G","0.0148","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs256439","THBS4","5","5","79401835","79366079","intron","intron","35089","34910","A/G"," 0.0088 for Maternal-Fetal interaction model","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs3024678","IL4R","16","16","27282196","27374695","coding","coding","49445","49445","C/T"," 0.0036 for Maternal-Fetal interaction model","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs361525","TNF","6","6","31651079","31543100","upstream","upstream","-249","-249","G/*A*"," 0.0086 offspring (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs3783550 ","IL1A","2","2","113249355","113532884","intron","intron","10087","10087","A/*C*","0.0014 maternal (additive model)","Not significant","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs421177","COL4A2","13","13","109942565","111144564","intron","intron","184934","184934","C/T","0.0177","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs4251923","PLAUR","19","19","48844842","44153002","3'UTR","3'UTR","21500","21496","G/*A*","0.0008 offspring (additive model)","Not significant","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs454078","IL1RN","2","2","113605263","113888792","intron","intron","3655","3655","A/*T*"," 0.0085 offspring (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs5742620","IGF1","12","12","101393729","102869599","intron","intron","4779","4779","C/*A*",".0035 for Maternal-Fetal interaction model","Not significant.","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17179726","rs9622979","PDGFB","22","22","37959554","39629608","intron","intron","11382","11349","C/*T*"," 0.0020 offspring (additive model)","_","Goddard KA et al. (Kuivaniemi H)","2006","Candidate gene approach","Human Heredity","Hispanic, Chilean","maternal blood, fetal blood","394","_","324","602","_","631","Included if no gestational HT, HELLP, eclampsia.","Excluded PE, eclampsia, HELLP syndrome, preterm premature rupture of membranes, small for gestational age (SGA), large for gestational age, intra-uterine fetal demise, abruption placentae, placenta previa, maternal sepsis, or chorioamnionitis.","_","_","Major fetal anomaly or demise; multifetal pregnancy; serious medical illness (renal disease, congestive heart disease, etc).","27 +/- 7.2","25.3 +/- 6","63.5 +/- 13.2","58.8 +/- 9.6","155.9 +/- 6.2","155.7 +/- 5.8","26.1 +/- 5.2","24.2 +/- 3.7","2611 +/- 832","3446 +/- 284","36.8 +/- 3.1","39.9 +/- 1.13",">300 mg/L per 24-h or >= 2+ dipstick","140","90","_"
"17636229","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","363798","363798","G/*T*","<0.05 Glu/Glu, NS Glu/Asp, <0.05 Asp/Asp","_","Chen LK et al. (Sun WZ)","2007","Candidate gene approach","Reproductive Sciences","Chinese","_","92","_","_","256","_","_","PE was defined after the completion of pregnancy.Women were considered to have PE if they met the1996/2000 American College of Obstetricians andGynecologists criteria for the definition of PE: systolicblood pressure >140 mm Hg or diastolic blood pressure>90 mm Hg, occurring on at least 2 occasions 6 hours apart, with proteinuria >0.3 g/L in a 24-hour specimen or a proteinuria dipstick reading of 2+ on a random urine collection","_","88","87.5","Excluded women with prepregnancy history of essential hypertension or hypertension before 20 weeks gestation.","30.2 +/- 3.9","29.7 +/- 4.4","_","_","_","_","27.4 +/- 6.3","28.4 +/- 9.1","2345 +/- 652","2895 +/- 548","_","_",">0.3 g/L in a 24-hour specimen or a proteinuria dipstick reading of 2+ on a randomurine collection","140","90","_"
"17710577","rs1799724","TNF","6","6","31650460","31542481","upstream","upstream","-868","-868","C/T","0.38 genotype, 0.33 allele","_","Canto-Cetina T et al. (Canto P)","2007","Candidate gene approach","Hypertension Pregnancy","Maya-Mestizo, Mexican","_","105","_","_","200","_","_","Preeclampsia was defined as the development of hypertension and new- onset proteinuria (>300 mg urinary protein in 24 hours) in women without proteinuria at baseline. Hypertension was defined as >= 140 mm Hg systolic and/or >= 90 mm Hg diastolic blood pressure, when measured on two consecu- tive occasions at least 24 hours apart (21). ","Controls were women with uncomplicated pregnancies, admitted for natural or Cesarean child birth, nor- mal length pregnancy with blood pressure within the normal limits of 120/80 mm Hg or less, and without proteinuria.","_","_","Women with previously diagnosed hypertension were excluded from the study.","21.6 +/- 5.5","22.2 +/- 5.4","_","_","_","_","33.5 +/- 5.4","22.5 +/- 3.2","2314.2 +/- 404.78","3086.9 +/- 406.1","_","_","_","_","_","_"
"17710577","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","G/A","0.37 genotype, 0.51 allele","_","Canto-Cetina T et al. (Canto P)","2007","Candidate gene approach","Hypertension Pregnancy","Maya-Mestizo, Mexican","_","105","_","_","200","_","_","Preeclampsia was defined as the development of hypertension and new- onset proteinuria (>300 mg urinary protein in 24 hours) in women without proteinuria at baseline. Hypertension was defined as >= 140 mm Hg systolic and/or >= 90 mm Hg diastolic blood pressure, when measured on two consecu- tive occasions at least 24 hours apart (21). ","Controls were women with uncomplicated pregnancies, admitted for natural or Cesarean child birth, nor- mal length pregnancy with blood pressure within the normal limits of 120/80 mm Hg or less, and without proteinuria.","_","_","Women with previously diagnosed hypertension were excluded from the study.","21.6 +/- 5.5","22.2 +/- 5.4","_","_","_","_","33.5 +/- 5.4","22.5 +/- 3.2","2314.2 +/- 404.78","3086.9 +/- 406.1","_","_","_","_","_","_"
"17826416","rs3025039","VEGF","6","6","43860513","43752535","3'UTR","3'UTR","_","_","C/*T*","0.001","<0.000000511","Shim JY et al. (Kim A)","2007","Candidate gene approach","American Journal of Obstetrics & Gynecology","Korean","peripheral blood sample","110","_","_","209","_","_","The diagnosis of preeclampsia was based on the criteria of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy1 (ie, blood pressure >=140/90 mm Hg that persisted for at least 6 hours and proteinuria of >=1+ (dipstick) or >=300 mg/24 hours after 20 weeks of gestation).","Exclusion criteria in each group included multiple pregnancies, chronic hypertension, chronic renal disease, pregestational or gestational diabetes mellitus, or other underlying medical disease (such as a history of endometriosis, rheumatoid arthritis, and systemic lupus erythematosus).","100","100","Exclusion criteria in each group included multiple pregnancies, chronic hypertension, chronic renal disease, pregestational or gestational diabetes mellitus, or other underlying medical disease (such as a history of endometriosis, rheumatoid arthritis, and systemic lupus erythematosus).","31.1 +/- 3.6","30.3 +/- 3.5","_","_","_","_","22.1 +/- 3.6","20.9 +/- 2.7","1929 +/- 741","3200 +/- 351","34.9 +/- 3.4","38.9 +/- 2.3",">=1+ (dipstick) or >=300 mg/24 hours after 20 weeks of gestation","140","90","_"
"18076363","rs231775","CTLA4","2","2","204440958","204732713","coding","coding","204","202","A/*G*","G allele freq <0.043; AG or GG genotypes <0.024","_","Jaaskelainen E et al. (Heinonen S)","2008","Candidate gene approach","Clinical Chemistry and Laboratory Medicine","Finnish","blood sample","132","132 with preeclampsia, 117 with placental abruption ","_","117","_","_","Preeclampsia was defined as the developmentof hypertension and new-onset proteinuria","_","_","_","_","28.8 (27.7-29.9)","28.7 (27.7-29.7)","_","_","_","_","24.9 (24.0-25.7)","22.3 (21.6-23.0)","2285 (2122-2448)","3494 (3408-3580)","_","_",">300 mg of urinary protein in 24 h","_","_","_"
"18336388","rs1800795","IL6","7","7","22733169","22766644","upstream","upstream","-153","-121","C/G","0.49 C allele, NS","NS","Stonek F et al. (Tempfer C)","2008","Candidate gene approach","American Journal of Reproductive Immunology","Caucasian","buccal sample","259","women at 12 weeks gestation","_","1367","women at 12 weeks gestation","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18396154","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","A/G","0.46 PE, 0.36 HELLP, NS","NS","Molvarec A et al. (Rigo J Jr)","2008","Candidate gene approach","Clinica Chimica Acta","Hungarian, Caucasian","blood sample","140","140 with PE, 69 with HELLP","_","144","_","_","Preeclampsia was defined by increased blood pressure (>= 140 mm Hg systolic or >= 90 mm Hg diastolic on >= 2 occasions at least 6 h apart) that occurred after 20 weeks of gestation in a woman with previously normal blood pressure, accompanied by proteinuria (>= 0.3 g/24 h). Blood pressure returned to normal by 12 weeks postpartum in each preeclamptic study patient. The diagnostic criteria for HELLP syndrome were as follows: serum aspartate aminotransferase (AST) activity > 70 U/l, serum lactate dehydrogenase (LDH) activity > 600 U/l and platelet count < 150,000/_l.","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","69.3 PE, 66.7 HELLP","53.5","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","28.4 +/- 5.8 PE, 29.0 +/- 5.6 HELLP","29.1 +/-  5.0","_","_","_","_","23.1 +/- 4.4 PE, 26.7 +/- 4.4 HELLP","22.3 +/- 4.0","1731 +/- 756 PE, 1264 +/- 652 HELLP","3489 +/- 420","33.3 +/- 3.6 PE, 31.0 +/- 3.7 HELLP","39.6 +/- 1.2",">= 0.3 g/24 h","140","90","_"
"18396154","rs4986790","TLR4","9","9","119515122","120475301","coding","coding","8692","8842","A/G","NS","NS","Molvarec A et al. (Rigo J Jr)","2008","Candidate gene approach","Clinica Chimica Acta","Hungarian, Caucasian","blood sample","140","140 with PE, 69 with HELLP","_","144","_","_","Preeclampsia was defined by increased blood pressure (>= 140 mm Hg systolic or >= 90 mm Hg diastolic on >= 2 occasions at least 6 h apart) that occurred after 20 weeks of gestation in a woman with previously normal blood pressure, accompanied by proteinuria (>= 0.3 g/24 h). Blood pressure returned to normal by 12 weeks postpartum in each preeclamptic study patient. The diagnostic criteria for HELLP syndrome were as follows: serum aspartate aminotransferase (AST) activity > 70 U/l, serum lactate dehydrogenase (LDH) activity > 600 U/l and platelet count < 150,000/_l.","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","69.3 PE, 66.7 HELLP","53.5","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","28.4 +/- 5.8 PE, 29.0 +/- 5.6 HELLP","29.1 +/-  5.0","_","_","_","_","23.1 +/- 4.4 PE, 26.7 +/- 4.4 HELLP","22.3 +/- 4.0","1731 +/- 756 PE, 1264 +/- 652 HELLP","3489 +/- 420","33.3 +/- 3.6 PE, 31.0 +/- 3.7 HELLP","39.6 +/- 1.2",">= 0.3 g/24 h","140","90","_"
"18396154","rs4986791","TLR4","9","9","119515422","120475601","coding","coding","8992","9142","C/T","NS","_","Molvarec A et al. (Rigo J Jr)","2008","Candidate gene approach","Clinica Chimica Acta","Hungarian, Caucasian","blood sample","140","140 with PE, 69 with HELLP","_","144","_","_","Preeclampsia was defined by increased blood pressure (>= 140 mm Hg systolic or >= 90 mm Hg diastolic on >= 2 occasions at least 6 h apart) that occurred after 20 weeks of gestation in a woman with previously normal blood pressure, accompanied by proteinuria (>= 0.3 g/24 h). Blood pressure returned to normal by 12 weeks postpartum in each preeclamptic study patient. The diagnostic criteria for HELLP syndrome were as follows: serum aspartate aminotransferase (AST) activity > 70 U/l, serum lactate dehydrogenase (LDH) activity > 600 U/l and platelet count < 150,000/_l.","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","69.3 PE, 66.7 HELLP","53.5","Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease and renal disease.","28.4 +/- 5.8 PE, 29.0 +/- 5.6 HELLP","29.1 +/-  5.0","_","_","_","_","23.1 +/- 4.4 PE, 26.7 +/- 4.4 HELLP","22.3 +/- 4.0","1731 +/- 756 PE, 1264 +/- 652 HELLP","3489 +/- 420","33.3 +/- 3.6 PE, 31.0 +/- 3.7 HELLP","39.6 +/- 1.2",">= 0.3 g/24 h","140","90","_"
"18651887","rs2243250","IL4","5","5","132037052","132009153","upstream","upstream","-219","-219","C/T","0.055","_","Fraser R et al. (Orsi NM)","2008","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","European, Caucasian","blood sample from the antecubital vein","117","The pre-eclamptic group included 117 women with singleton pregnancies, blood pressure of >=140/90 mmHg (twice on separate occasions >6 hours apart) and proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart; International Society for the Study of Hypertension in Pregnancy definition).","_","146","The control group (n = 146) had uncomplicated singleton term pregnancies (>37 weeks).","_","_"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","100","100"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","29 (16-42)","30 (16-40)","_","_","_","_","_","_","2240 (430-5520)","3440 (2430-5370)","35.6 (25-42)","39.5 (37-42)","proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart","140","90","_"
"18651887","rs3918242","MMP9","20","20","44069382","44635975","upstream","upstream","-1571","-1571","C/T","0.11","_","Fraser R et al. (Orsi NM)","2008","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","European, Caucasian","blood sample from the antecubital vein","117","The pre-eclamptic group included 117 women with singleton pregnancies, blood pressure of >=140/90 mmHg (twice on separate occasions >6 hours apart) and proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart; International Society for the Study of Hypertension in Pregnancy definition).","_","146","The control group (n = 146) had uncomplicated singleton term pregnancies (>37 weeks).","_","_"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","100","100"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","29 (16-42)","30 (16-40)","_","_","_","_","_","_","2240 (430-5520)","3440 (2430-5370)","35.6 (25-42)","39.5 (37-42)","proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart","140","90","_"
"18651887","rs5743708","TLR2","4","4","154845766","154626316","coding","coding","20876","20876","A/G","0.2","_","Fraser R et al. (Orsi NM)","2008","Candidate gene approach","BJOG: An International Journal of Obstetrics & Gynaecology","European, Caucasian","blood sample from the antecubital vein","117","The pre-eclamptic group included 117 women with singleton pregnancies, blood pressure of >=140/90 mmHg (twice on separate occasions >6 hours apart) and proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart; International Society for the Study of Hypertension in Pregnancy definition).","_","146","The control group (n = 146) had uncomplicated singleton term pregnancies (>37 weeks).","_","_"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","100","100"," Exclusion criteria for both groups included essential hypertension, diabetes and autoimmune disease. ","29 (16-42)","30 (16-40)","_","_","_","_","_","_","2240 (430-5520)","3440 (2430-5370)","35.6 (25-42)","39.5 (37-42)","proteinuria (>300 mg/l protein excreted; +/+ dipstick urinalysis, 24 hours apart","140","90","_"
"18712057","rs1695","GSTP1","11","11","67109264","67352688","coding","coding","1403","1623","A/*G*","0.008 genotype, 0.013 allele","_","Canto P et al. (Coral-Vazquez R)","2008","Candidate gene approach","Hypertension research","Maya-Mestizo, Mexican","peripheral blood sample","125","_","_","274","_","_","Preeclampsia was defined as the development of hyperten- sion and proteinuria (>300 mg urinary protein in 24 h) in women with no baseline proteinuria. Hypertension was defined as systolic blood pressure >=140 mmHg and/or dias- tolic blood pressure >=90 mmHg measured on two consecu- tive occasions at least 24 h apart","The control group comprised women with uncompli- cated pregnancy admitted for natural childbirth or caesarean section, with normal-length pregnancy, blood pressure  120/ 80 mmHg, and without proteinuria. Women with previously diagnosed hypertension were excluded from the study. ","_","_","Women with previously diagnosed hypertension were excluded from the study. ","22.0 +/- 5.6","21.9 +/- 5.0","_","_","_","_","33.6 +/- 5.4","22.3 +/- 3.2","2314.4 +/- 391.4","3121.2 +/- 373.2","_","_",">300 mg urinary protein in 24 h","140","90","_"
"18712057","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","0.007 genotype, 0.017 allele","_","Canto P et al. (Coral-Vazquez R)","2008","Candidate gene approach","Hypertension research","Maya-Mestizo, Mexican","peripheral blood sample","125","_","_","274","_","_","Preeclampsia was defined as the development of hyperten- sion and proteinuria (>300 mg urinary protein in 24 h) in women with no baseline proteinuria. Hypertension was defined as systolic blood pressure >=140 mmHg and/or dias- tolic blood pressure >=90 mmHg measured on two consecu- tive occasions at least 24 h apart","The control group comprised women with uncompli- cated pregnancy admitted for natural childbirth or caesarean section, with normal-length pregnancy, blood pressure  120/ 80 mmHg, and without proteinuria. Women with previously diagnosed hypertension were excluded from the study. ","_","_","Women with previously diagnosed hypertension were excluded from the study. ","22.0 +/- 5.6","21.9 +/- 5.0","_","_","_","_","33.6 +/- 5.4","22.3 +/- 3.2","2314.4 +/- 391.4","3121.2 +/- 373.2","_","_",">300 mg urinary protein in 24 h","140","90","_"
"18781190","rs1014064","ACVR2A","2","2","148328623","148612153","intron","intron","9584","9584","A/G","0.0184","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1036739","ACVR1","2","2","158373441","158665195","intron","intron","67179","67179","C/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs10497025","ACVR2A","2","2","148378671","148662201","intron","intron","59632","59632","C/G","0.0586","<0.05","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs10497191","ACVR1","2","2","158375462","158667216","intron","intron","65158","65158","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs10497192","ACVR1","2","2","158379945","158671699","intron","intron","60675","60675","C/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1050951","KYNU","2","2","143463433","143746963","intron","intron","111769","111769","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1051557","CXCR4","2","2","136589622","136873152","coding","coding","2573","2573","C/T"," ","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1052581","RPRM","2","2","154042351","154334105","3'UTR","3'UTR","1217","1217","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1063728","RPRM","2","2","154042744","154334498","3'UTR","3'UTR","824","824","C/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1146031","ACVR1","2","2","158335225","158626979","coding","coding","105395","105395","A/G","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1227307","ACVR2A","2","2","148378774","148662304","intron","intron","59735","59735","A/C"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs12327948","ACVR1","2","2","158377662","158669416","intron","intron","62958","62958","C/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs13224","ACVR2A","2","2","148319153","148602683","5'UTR","5'UTR","114","114","G/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs13406336","ACVR1","2","2","158364207","158655961","coding","coding","76413","76413","C/G","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1424941","ACVR2A","2","2","148359587","148643117","intron","intron","40548","40548","A/G","0.0171","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1424954","ACVR2A","2","2","148317263","148600793","upstream","upstream","-1776","-1776","A/G","0.387","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1438266","KYNU","2","2","143363788","143647318","intron","intron","12124","12124","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1439875","KYNU","2","2","143355038","143638568","intron","intron","3374","3374","G/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1471003","HNMT","2","2","138441471","138725001","intron","intron","3194","3194","A/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16842103","ACVR1","2","2","158367072","158658826","intron","intron","73548","73548","A/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16842105","ACVR1","2","2","158367915","158659669","intron","intron","72705","72705","A/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16842106","ACVR1","2","2","158371885","158663639","intron","intron","68735","68735","A/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16858172","KYNU","2","2","143352973","143636503","intron","intron","1309","1309","A/C","NS","0.39","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16858196","KYNU","2","2","143356116","143639646","intron","intron","4452","4452","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs16858205","KYNU","2","2","143359528","143643058","coding","coding","7864","7864","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs17741978","ACVR2A","2","2","148333849","148617379","intron","intron","14810","14810","C/G","0.0689","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs17742134","ACVR2A","2","2","148343865","148627395","intron","intron","24826","24826","C/T","0.0214","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs17798043","ACVR1","2","2","158371522","158663276","intron","intron","69098","69098","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1895694","ACVR2A","2","2","148336215","148619745","intron","intron","17176","17176","A/G","0.918","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1965812","ACVR1","2","2","158379543","158671297","intron","intron","61077","61077","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs1982494","HNMT","2","2","138445582","138729112","intron","intron","7305","7305","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2033764","RPRM","2","2","154044213","154335967","upstream","upstream","-645","-645","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2113794","ACVR2A","2","2","148339446","148622976","intron","intron","20407","20407","A/C","0.998","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2161983","ACVR2A","2","2","148365855","148649385","intron","intron","46816","46816","C/T","0.0196","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2227861","ACVR1","2","2","158345155","158636909","coding","coding","95465","95465","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2228014","CXCR4","2","2","136589553","136873083","coding","coding","2642","2642","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2288190","ACVR2A","2","2","148374058","148657588","intron","intron","55019","55019","C/T","0.0554","0.08","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2303392","ACVR2A","2","2","148396896","148680426","intron","intron","77857","77857","C/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2304700","KYNU","2","2","143507483","143791013","intron","intron","155819","155819","G/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2304705","KYNU","2","2","143431734","143715264","coding","coding","80070","80070","A/G"," ","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2680880","CXCR4","2","2","136590018","136873548","intron","intron","2177","2177","A/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs2734871","CXCR4","2","2","136586342","136869872","downstream","downstream","5853","5853","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3100719","HNMT","2","2","138480403","138763933","intron","intron","42126","42126","C/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3100725","HNMT","2","2","138459635","138743165","intron","intron","21358","21358","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3113222","HNMT","2","2","138472266","138755796","intron","intron","33989","33989","C/T"," ","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs351675","KYNU","2","2","143428513","143712043","intron","intron","76849","76849","C/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3738927","ACVR1","2","2","158302305","158594059","coding","coding","138315","138315","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3764955","ACVR2A","2","2","148391266","148674796","intron","intron","72227","72227","C/G","0.0327","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3768687","ACVR2A","2","2","148388489","148672019","intron","intron","69450","69450","A/G","0.0214","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3770303","RPRM","2","2","154041808","154333562","intron","intron","1760","1760","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3791244","HNMT","2","2","138448234","138731764","intron","intron","9957","9957","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs3806501","CXCR4","2","2","136593538","136877068","upstream","upstream","-1343","-1343","A/C"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4294956","ACVR1","2","2","158376699","158668453","intron","intron","63921","63921","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4380178","ACVR1","2","2","158376690","158668444","intron","intron","63930","63930","A/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4556933","ACVR1C","2","2","158152134","158443888","coding","coding","41511","41511","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4662304","KYNU","2","2","143358119","143641649","intron","intron","6455","6455","_","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4954391","CXCR4","2","2","136600292","136883822","upstream","upstream","-8097","-8097","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs4954941","HNMT","2","2","138486436","138769966","intron","intron","48159","48159","A/G","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs6429992","KYNU","2","2","143379036","143662566","intron","intron","27372","27372","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs6729964","ACVR1","2","2","158330838","158622592","coding","coding","109782","109782","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs6746788","ACVR1C","2","2","158109350","158401104","coding","coding","84295","84295","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs6751595","ACVR1C","2","2","158097763","158389517","3'UTR","3'UTR","95882","95882","G/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs7561419","ACVR1","2","2","158370034","158661788","intron","intron","70586","70586","C/T"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs7572676","ACVR2A","2","2","148320091","148603621","intron","intron","1052","1052","C/G"," ","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs7594480","ACVR1C","2","2","158098713","158390467","coding","coding","94932","94932","C/T","NS","NS","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs7601098","ACVR2A","2","2","148393083","148676613","intron","intron","74044","74044","C/G","0.538","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"18781190","rs9013","KYNU","2","2","143514658","143798188","coding","coding","162994","162994","C/T","NS","_","Roten LT et al. (Austgulen R)","2009","Candidate gene approach","European Journal of Human Genetics","Australian, New Zealander, Finnish","blood sample","1139","1003 women were registered with one pre-eclamptic pregnancy, 606 of these had pre-eclampsia in their first pregnancy, whereas 397 had pre-eclampsia in a later pregnancy.","_","2269","_","_","Pre-eclampsia was defined as the onset of persistent hypertension (exceeding 140/90 mmHg), in combination with proteinuria (exceeding 300 mg/day) after the 20th week of gestation.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1014064","ACVR2A","2","2","148328623","148612153","intron","intron","9584","9584","A/G","0.427 QTDT, 0.412 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs10497025","ACVR2A","2","2","148378671","148662201","intron","intron","59632","59632","C/G","0.471 QTDT, 0.504 QTLD","NS","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1128919","ACVR2A","2","2","148373586","148657116","coding","coding","54547","54547","A/G","0.427 QTDT, 0.412 QTLD","NS","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs12998729","ACVR2A","2","2","148333761","148617291","intron","intron","14722","14722","A/G","0.428 QTDT, 0.423 QTLD","NS","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs13008497","ACVR2A","2","2","148383230","148666760","intron","intron","64191","64191","C/T","0.428 QTDT, 0.423 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs13026650","ACVR2A","2","2","148390670","148674200","intron","intron","71631","71631","A/G","0.427 QTDT, 0.412 QTLD","NS","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs13430086","ACVR2A","2","2","148403530","148687060","3'UTR","3'UTR","84491","84491","A/T","0.051 QTDT, 0.273 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1364657","ACVR2A","2","2","148334736","148618266","intron","intron","15697","15697","A/G","1 QTDT, 0.818 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1364658","ACVR2A","2","2","148324277","148607807","intron","intron","5238","5238","C/G","0.428 QTDT, 0.423 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1424941","ACVR2A","2","2","148359587","148643117","intron","intron","40548","40548","A/G","0.129 QTDT, 0.642 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1424954","ACVR2A","2","2","148317263","148600793","upstream","upstream","-1776","-1776","A/G","0.427 QTDT,  0.412 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1469211","ACVR2A","2","2","148383304","148666834","intron","intron","64265","64265","A/G","0.129 QTDT, 0.642 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs17692648","ACVR2A","2","2","148404200","148687730","3'UTR","3'UTR","85161","85161","A/C","0.109 QTDT, 0.722 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs17741978","ACVR2A","2","2","148333849","148617379","intron","intron","14810","14810","C/G","0.129 QTDT, 0.642 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs17742134","ACVR2A","2","2","148343865","148627395","intron","intron","24826","24826","C/T","0.129 QTDT, 0.642 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs1895694","ACVR2A","2","2","148336215","148619745","intron","intron","17176","17176","A/G","0.175 QTDT, 0.344 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs2113794","ACVR2A","2","2","148339446","148622976","intron","intron","20407","20407","A/C","0.175 QTDT, 0.344 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs2161983","ACVR2A","2","2","148365855","148649385","intron","intron","46816","46816","C/T","0.614 QTDT, 0.578 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs2288190","ACVR2A","2","2","148374058","148657588","intron","intron","55019","55019","C/T","0.852 QTDT, 0.886 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs2303392","ACVR2A","2","2","148396896","148680426","intron","intron","77857","77857","C/G","0.683 QTDT, 0.573 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs3754541","ACVR2A","2","2","148375064","148658594","intron","intron","56025","56025","C/T","0.129 QTDT, 0.642 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs3764955","ACVR2A","2","2","148391266","148674796","intron","intron","72227","72227","C/G","0.428 QTDT, 0.422 QTLD","<0.05","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs3768687","ACVR2A","2","2","148388489","148672019","intron","intron","69450","69450","A/G","0.427 QTDT, 0.412 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs3820716","ACVR2A","2","2","148396729","148680259","intron","intron","77690","77690","C/T","0.07 QTDT, 0.185 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs6713811","ACVR2A","2","2","148348004","148631534","intron","intron","28965","28965","A/G","0.329 QTDT, 0.346 QTLD","NS","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs6747792","ACVR2A","2","2","148327997","148611527","intron","intron","8958","8958","G/T","0.074 QTDT, 0.67 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs7582403","ACVR2A","2","2","148335223","148618753","intron","intron","16184","16184","A/G","0.286 QTDT, 0.671 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs7601098","ACVR2A","2","2","148393083","148676613","intron","intron","74044","74044","C/G","1 QTDT, 0.818 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19126782","rs929939","ACVR2A","2","2","148343997","148627527","intron","intron","24958","24958","G/T","0.727 QTDT, 0.674 QTLD","_","Fitzpatrick E et al. (Moses EK)","2009","Candidate gene approach","Molecular Human Reproduction","Australian, New Zealander","_","480","74 Austr/NZ PE families","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19133041","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","A/G","NS","_","Bombell S (McGuire W)","2008","Meta-analysis, Candidate gene approach","Australian and New Zealand Journal of Obstetrics and Gynaecology","Caucasian, Black, Mexican","_","1919","_","_","2374","_","_","PE/E was defined a priori using standard criteria including at least a semiquantitative measure of proteinuria. ","The control group consisted of women without a history of PE/E in pregnancy. Studies that used controls recruited from a general population (for example, blood donors) were included but sensitivity analyses without these studies were performed. Cases and controls were matched for ethnic group or the study reported the ethnic ancestry of participants to allow for stratified analysis.","_","_","Studies that included women with pre-existing or gestational hypertension without proteinuria were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19407822","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","A/G","0.24 genotype, 0.16 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19407822","rs1800795","IL6","7","7","22733169","22766644","upstream","upstream","-153","-121","C/G","0.30 genotype, 0.14 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19407822","rs1800871","IL10","1","1","205013256","206946633","upstream","upstream","-794","-794","C/T","0.19 genotype, 0.14 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19407822","rs1800872","IL10","1","1","205013029","206946406","upstream","upstream","-567","-567","A/C","0.19 genotype, 0.14 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19407822","rs1800896","IL10","1","1","205013519","206946896","upstream","upstream","-1057","-1057","A/G","0.67 genotype, 0.53 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19407822","rs2430561","IFNG","12","12","66838786","68552521","intron","intron","1002","1000","*A*/T","0.08 genotype, 0.02 allele","_","de Lima TH et al. (Daher S)","2009","Candidate gene approach","Hypertension Research","Brazilian, Mulatto","venous blood sample","92","92 with PE, 73 with eclampsia","_","101","_","_","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. The diagnoses of PE and E were based on the criteria of the Report of the National High Blood Pressure Education Program.","All women with a single live pregnancy and who were referred to a single hospital (Santa Monica Obstetric Clinic) were eligible. ","_","_","Exclusion criteria were multiple gestation, fetal death, autoimmune disease, diabetes, uterine malformation, in vitro fertilization treatment, placental abruption, any infection, cancer or any other systemic disease, including preexisting hypertension.","23 (19-28)","26 (21-31)","_","_","_","_","23.43 (22.90-25.91)","23.02 (22.36-23.38)","2450 (1760-3100)","3200 (2950-3970)","_","_","_","_","_","_"
"19578876","rs10050860","ERAP1","5","5","96147965","96122209","coding","coding","21683","21683","C/T","Aust/NZ = 0.951; Nowegian = 0.558","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs10062297","LVRN","5","5","115326276","115298377","coding","coding","107","226","C/T","Aust/NZ = NS; Nowegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1056893","ERAP2","5","5","96271194","96245438","coding","coding","30171","33795","C/T","Aust/NZ = 0.014; Nowegian = 0.624","0.018","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs11746232","LNPEP","5","5","96389214","96363458","coding","coding","69303","69303","A/G","Aust/NZ = NS; Nowegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs12520255","LVRN","5","5","115326373","115298474","coding","coding","204","323","C/T","Aust/NZ = NS; Nowegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs12520455","LNPEP","5","5","96365001","96339245","coding","coding","45090","45090","A/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1295686","IL13","5","5","132023741","131995842","intron","intron","1978","1978","A/G","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1295687","IL13","5","5","132022360","131994461","intron","intron","597","597","C/G","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1445708","LVRN","5","5","115326875","115298976","coding","coding","706","825","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1508886","LVRN","5","5","115390046","115362147","3'UTR","3'UTR","63877","63996","A/G","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1560079","LVRN","5","5","115366468","115338569","coding","coding","40299","40418","G/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17087233","LNPEP","5","5","96388090","96362334","coding","coding","68179","68179","C/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17138632","LVRN","5","5","115366856","115338957","coding","coding","40687","40806","G/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17138681","LVRN","5","5","115386035","115358136","coding","coding","59866","59985","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17408150","ERAP2","5","5","96265013","96239257","coding","coding","23990","27614","A/T","Aust/NZ = 0.614; Norwegian = 0.044","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17481856","ERAP1","5","5","96142563","96116807","coding","coding","27085","27085","A/G","Aust/NZ = 0.374; Norwegian = 0.676","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17482536","LVRN","5","5","115348268","115320369","coding","coding","22099","22218","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs17772853","IL4","5","5","132037497","132009598","5'UTR","5'UTR","226","226","C/T","Aust/NZ = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1800474","IL5","5","5","131906946","131879047","coding","coding","167","167","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs1875999","CRHBP","5","5","76300737","76264981","3'UTR","3'UTR","16302","16302","A/G","Aust/NZ = 0.062; Norwegian = 0.052","NS","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs20541","IL13","5","5","132023862","131995963","coding","coding","2099","2099","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2069625","CSF2","5","5","131438406","131410507","coding","coding","1023","1023","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2069744","IL13","5","5","132022567","131994668","intron","intron","804","804","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2069747","IL13","5","5","132023504","131995605","intron","intron","1741","1741","C/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2069818","IL5","5","5","131905422","131877523","coding","coding","1691","1691","A/C","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2070874","IL4","5","5","132037608","132009709","5'UTR","5'UTR","337","337","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2255546","ERAP2","5","5","96274870","96249114","coding","coding","33847","37471","A/G","Aust/NZ = 0.015; Norwegian = 0.513","0.018","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2287927","LNPEP","5","5","96389939","96364183","coding","coding","70028","70028","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2287987","ERAP1","5","5","96155290","96129534","coding","coding","14358","14358","C/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2287988","ERAP2","5","5","96263081","96237325","coding","coding","22058","25682","A/G","Aust/NZ = 0.015; Norwegian = 0.514","0.018","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2303138","LNPEP","5","5","96376465","96350709","coding","coding","56554","56554","A/G","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2548538","ERAP2","5","5","96257897","96232141","coding","coding","16874","20498","A/T","Aust/NZ = 0.015; Norwegian = 0.372","0.018","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs2549782","ERAP2","5","5","96256755","96230999","coding","coding","15732","19356","G/T","Aust/NZ = 0.015; Norwegian = 0.48","0.018","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs25882","CSF2","5","5","131439358","131411459","coding","coding","1975","1975","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs26618","ERAP1","5","5","96156591","96130835","coding","coding","13057","13057","C/T","Aust/NZ = 0.933; Norwegian = 0.752","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs26653","ERAP1","5","5","96165005","96139249","coding","coding","4643","4643","C/G","Aust/NZ = 0.628; Norwegian = 0.062","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs27044","ERAP1","5","5","96144607","96118851","coding","coding","25041","25041","C/G","Aust/NZ = 0.252; Norwegian = 0.762","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs27529","ERAP1","5","5","96152063","96126307","coding","coding","17585","17585","A/G","Aust/NZ = 0.418; Norwegian = 0.075","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs27582","ERAP1","5","5","96123969","96098213","3'UTR","3'UTR","45679","45679","A/G","Aust/NZ = 0.7; Norwegian = 0.514","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs27980","ERAP1","5","5","96123650","96097894","3'UTR","3'UTR","45998","45998","A/C","Aust/NZ = 1; Norwegian = 0.54","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs30187","ERAP1","5","5","96150085","96124329","coding","coding","19563","19563","C/T","Aust/NZ = 0.533; Norwegian = 0.499","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs3212145","IL13","5","5","132022492","131994593","intron","intron","729","729","A/C","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs32897","CRHBP","5","5","76286727","76250971","intron","intron","2292","2292","A/G","Aust/NZ =  0.914; Nowegian =  0.947","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs34750","ERAP1","5","5","96168561","96142805","intron","intron","1087","1087","C/G","Aust/NZ = 0.595; Norwegian = 0.071","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs3733905","ERAP2","5","5","96245316","96219560","coding","coding","4293","7917","C/T","Aust/NZ = 0.633; Norwegian = 0.368","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs3734016","ERAP1","5","5","96165219","96139463","coding","coding","4429","4429","A/G","Aust/NZ = 0.078; Norwegian = 0.196","0.074","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs3797799","LNPEP","5","5","96340833","96315077","coding","coding","20922","20922","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs40401","IL3","5","5","131424376","131396477","coding","coding","131","131","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs469783","ERAP1","5","5","96147279","96121523","coding","coding","22369","22369","C/T","Aust/NZ = 0.477; Norwegian = 0.088","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs4986964","IL4","5","5","132037719","132009820","coding","coding","448","448","C/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs6453267","CRHBP","5","5","76291511","76255755","intron","intron","7076","7076","A/G","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs7712021","LVRN","5","5","115364760","115336861","coding","coding","38591","38710","C/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs7721519","CRHBP","5","5","76298519","76262763","intron","intron","14084","14084","C/T","Aust/NZ = 0.117; Norwegian = 0.016","NS","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs7724126","LVRN","5","5","115363414","115335515","coding","coding","37245","37364","G/T","_","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19578876","rs848","IL13","5","5","132024398","131996499","3'UTR","3'UTR","2635","2635","G/T","Aust/NZ = NS; Norwegian = NS","_","Johnson MP et al. (Moses EK)","2009","Candidate gene approach","Human Genetics","Australian (Caucasian), New Zealander, Norwegian ","_","1329 (1189 Norwegian, 140 Australian)","Australian 140 women coded as affected (20 with eclampsia, 120 with preeclampsia)","_","90","_","_","The development of hypertension and an elevation of protein levels in the urine during pregnancy.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"19587779","rs10490924","CX3CR1","10","10","124204437","124214447","coding ARMS2","coding ARMS2","-84907906","-84891221","G/T","0.33 MM, 0.23 TM","_","Stepanian A et al. (Mandelbrot L)","2009","Candidate gene approach","PLoS One","European, Maghrebian, Caucasian","_","184","_","_","184","_","_","Inclusion criteria were age >=18 years, Caucasian origin (defined as 4 grandparents born in Europe, or in the Maghreb), gestational age >=20 weeks, and PE defined according to the definition of the American College of Obstetricians and Gynecologists (ACOG). PE was defined according to the ACOG as elevated blood pressure (>=140/90 mm Hg) occurring after 20 weeks of gestation with previously normal blood pressure, and proteinuria (>=0.3 g in a 24-hour urine specimen). PE was defined as early if gestational age at diagnosis was <34 weeks.","Controls were normotensive pregnant women; for each PE patient, a control matched for maternal age (+/-2 years), gestational term (+/-2 weeks) and ethnic origin (European or Maghrebian) was included. Controls who developed PE after enrolment were excluded from the study and replaced by another subject matched with the corresponding case.","20","10","Patients with proteinuria occurring before 20 gestational weeks were excluded. ","31.1 +/- 6.0","31.2 +/- 5.5","_","_","_","_","_","_","_","_","33.9 +/- 38","33.7 +/- 3.8",">=0.3 g in a 24-hour urine specimen","140","90","_"
"19587779","rs2536512","SOD3","4","4","24410412","24801314","coding","coding","4230","4230","A/G","0.54 genotype, 0.56 allele","_","Stepanian A et al. (Mandelbrot L)","2009","Candidate gene approach","PLoS One","European, Maghrebian, Caucasian","_","184","_","_","184","_","_","Inclusion criteria were age >=18 years, Caucasian origin (defined as 4 grandparents born in Europe, or in the Maghreb), gestational age >=20 weeks, and PE defined according to the definition of the American College of Obstetricians and Gynecologists (ACOG). PE was defined according to the ACOG as elevated blood pressure (>=140/90 mm Hg) occurring after 20 weeks of gestation with previously normal blood pressure, and proteinuria (>=0.3 g in a 24-hour urine specimen). PE was defined as early if gestational age at diagnosis was <34 weeks.","Controls were normotensive pregnant women; for each PE patient, a control matched for maternal age (+/-2 years), gestational term (+/-2 weeks) and ethnic origin (European or Maghrebian) was included. Controls who developed PE after enrolment were excluded from the study and replaced by another subject matched with the corresponding case.","20","10","Patients with proteinuria occurring before 20 gestational weeks were excluded. ","31.1 +/- 6.0","31.2 +/- 5.5","_","_","_","_","_","_","_","_","33.9 +/- 38","33.7 +/- 3.8",">=0.3 g in a 24-hour urine specimen","140","90","_"
"19587779","rs3732378","CX3CR1","3","3","39282165","39307161","coding","coding","14366","16065","A/G","0.75 II, 0.56 VI","_","Stepanian A et al. (Mandelbrot L)","2009","Candidate gene approach","PLoS One","European, Maghrebian, Caucasian","_","184","_","_","184","_","_","Inclusion criteria were age >=18 years, Caucasian origin (defined as 4 grandparents born in Europe, or in the Maghreb), gestational age >=20 weeks, and PE defined according to the definition of the American College of Obstetricians and Gynecologists (ACOG). PE was defined according to the ACOG as elevated blood pressure (>=140/90 mm Hg) occurring after 20 weeks of gestation with previously normal blood pressure, and proteinuria (>=0.3 g in a 24-hour urine specimen). PE was defined as early if gestational age at diagnosis was <34 weeks.","Controls were normotensive pregnant women; for each PE patient, a control matched for maternal age (+/-2 years), gestational term (+/-2 weeks) and ethnic origin (European or Maghrebian) was included. Controls who developed PE after enrolment were excluded from the study and replaced by another subject matched with the corresponding case.","20","10","Patients with proteinuria occurring before 20 gestational weeks were excluded. ","31.1 +/- 6.0","31.2 +/- 5.5","_","_","_","_","_","_","_","_","33.9 +/- 38","33.7 +/- 3.8",">=0.3 g in a 24-hour urine specimen","140","90","_"
"19592152","rs13181","XPD","19","19","50546758","45854918","coding","coding","_","_","C/T","0.87 Lys/Gln, 0.25 Gln/Gln, 0.59 Combined","_","Vural P et al. (Uysal M)","2009","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","101","_","_","107","_","_","PE was defined as a blood pressure >140/90 mmHg after 20 weeks of gestation on two separated readings at least 6 h apart with proteinuria (>300 mg/L). PE women were primigravida and the gestational age during the sampling was 35 +/- 3 weeks.","At least two live births and who experienced no adverse pregnancy outcome, volunteered as controls. Controls were not on oral contraceptives and were in the follicular phase of the menstrual cycle during sampling. Abortion and autoimmunity were considered as exclusion criteria for the control group. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","100","0","Women with previously diagnosed hypertension were excluded from the study. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","26.7 +/- 5","28.2 +/- 4.1","_","_","_","_","_","_","_","_","_","_",">300 mg/L","140","90","_"
"19592152","rs1799782","XRCC1","19","19","48749413","44057573","coding","coding","22157","22157","C/T","0.60 Arg/Trp, 0.16 Trp/Trp, 0.40 Combined","_","Vural P et al. (Uysal M)","2009","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","101","_","_","107","_","_","PE was defined as a blood pressure >140/90 mmHg after 20 weeks of gestation on two separated readings at least 6 h apart with proteinuria (>300 mg/L). PE women were primigravida and the gestational age during the sampling was 35 +/- 3 weeks.","At least two live births and who experienced no adverse pregnancy outcome, volunteered as controls. Controls were not on oral contraceptives and were in the follicular phase of the menstrual cycle during sampling. Abortion and autoimmunity were considered as exclusion criteria for the control group. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","100","0","Women with previously diagnosed hypertension were excluded from the study. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","26.7 +/- 5","28.2 +/- 4.1","_","_","_","_","_","_","_","_","_","_",">300 mg/L","140","90","_"
"19592152","rs25487","XRCC1","19","19","48747565","44055725","coding","coding","24005","24005","A/G","0.94 Arg/Gln, 0.32 Gln/Gln, 0.71 Combined","NS","Vural P et al. (Uysal M)","2009","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","_","_","101","_","_","107","_","_","PE was defined as a blood pressure >140/90 mmHg after 20 weeks of gestation on two separated readings at least 6 h apart with proteinuria (>300 mg/L). PE women were primigravida and the gestational age during the sampling was 35 +/- 3 weeks.","At least two live births and who experienced no adverse pregnancy outcome, volunteered as controls. Controls were not on oral contraceptives and were in the follicular phase of the menstrual cycle during sampling. Abortion and autoimmunity were considered as exclusion criteria for the control group. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","100","0","Women with previously diagnosed hypertension were excluded from the study. All women (both PE and controls) were not on any medication, were non-smokers and were free from cardiovascular, hepatic, renal, endocrine and metabolic disorders.","26.7 +/- 5","28.2 +/- 4.1","_","_","_","_","_","_","_","_","_","_",">300 mg/L","140","90","_"
"20055790","rs1800470","TGFB1","19","19","46550760","41858920","coding","coding","896","911","*C*/T","0.024","_","Kim SY (Ryu HM)","2010","Candidate gene approach","American Journal of Reproductive Immunology","Korean, Asian","blood sample","164","PE group was divided into three subgroups: (1) mild (n = 47) and severe (n = 117) by disease severity, (2) term (n = 95) and preterm (n = 69) by gestational weeks at delivery, and (3) absence (n = 107) and presence of IUGR (n = 57) by fetal birth weight.","_","182","_","_","PE was defined as hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hr urine collection and/or >=1+ on dipstick testing) after 20 weeks of gestation, according to the Committee Terminology of the American College of Obstetricians and Gynecologists. Severe PE was defined as diastolic blood pressure >=110 mmHg; severe proteinuria (urinary protein excretion >=5 g per 24 hr and/or >=3 + on dipstick testing); evidence of pulmonary edema; seizures; oliguria (<500 mL/day); thrombocytopenia (platelet count <100 000/mL); and severe central nervous system symptoms such as altered mental status, headaches, blurred vision, or blindness.","_","78.1","54.4","Exclusion criteria included major congenital anomalies; prior PE; taking drugs; alcohol consumption; smoking; and pre-existing medical conditions such as diabetes, chronic hypertension, autoimmune disease, or renal disease. ","30.8 +/- 3.8","33.1 +/- 4.1","_","_","_","_","_","_","2504.5 +/- 777.7","3359.9 +/- 436.9","36.4 +/- 3.4","39.1 +/- 1.3","proteinuria (>=300 mg in a 24-hr urine collection and/or >=1+ on dipstick testing) severe proteinuria (urinary protein excretion >=5 g per 24 hr and/or >=3 + on dipstick testing)","140","90","_"
"20070604","rs1063320","HLA-G","6","6","29906727","29798748","3'UTR","3'UTR","3993","3993","C/*G*","0.060, Primiparas 0.008","NS","Larsen MH et al. (Hviid TV)","2010","Candidate gene approach","Tissue Antigens","Danish","blood sample, blood stain on filter paper, or oral swab sample","50","_","_","85","_","_","Inclusion criteria: birth of a single live-born child in 1998 or 1999, the pregnancy or birth was registered in the Danish Hospital Discharge Register with a diagnosis of severe pre-eclampsia or eclampsia (ICD-10 codes O14.1 or O15), and for whom blood samples from the mother and the child were stored in the biobank. In Denmark, the diagnosis of severe pre-eclampsia requires a blood pressure >180/110 mmHg and/or the presence of severe subjective symptoms and/or proteinuria of >=5 g/l. ","For each of the case families, four potential controls were identified to be matched on the following criteria: same year and place of birth as the case child, same parity, and no diagnosis of hypertension, pre-eclampsia or eclampsia (ICD-10 codes O10-O16) registered in the Danish Hospital Discharge Register for the actual pregnancy or birth.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","proteinuria of >=5 g/l","180","110","_"
"20070604","rs1610696","HLA-G","6","6","29906781","29798802","3'UTR","3'UTR","4047","4047","C/G","0.245, Primiparas 0.077","_","Larsen MH et al. (Hviid TV)","2010","Candidate gene approach","Tissue Antigens","Danish","blood sample, blood stain on filter paper, or oral swab sample","50","_","_","85","_","_","Inclusion criteria: birth of a single live-born child in 1998 or 1999, the pregnancy or birth was registered in the Danish Hospital Discharge Register with a diagnosis of severe pre-eclampsia or eclampsia (ICD-10 codes O14.1 or O15), and for whom blood samples from the mother and the child were stored in the biobank. In Denmark, the diagnosis of severe pre-eclampsia requires a blood pressure >180/110 mmHg and/or the presence of severe subjective symptoms and/or proteinuria of >=5 g/l. ","For each of the case families, four potential controls were identified to be matched on the following criteria: same year and place of birth as the case child, same parity, and no diagnosis of hypertension, pre-eclampsia or eclampsia (ICD-10 codes O10-O16) registered in the Danish Hospital Discharge Register for the actual pregnancy or birth.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","proteinuria of >=5 g/l","180","110","_"
"20070604","rs1710","HLA-G","6","6","29906595","29798616","3'UTR","3'UTR","3861","3861","*C*/G","0.094, Primiparas 0.016","_","Larsen MH et al. (Hviid TV)","2010","Candidate gene approach","Tissue Antigens","Danish","blood sample, blood stain on filter paper, or oral swab sample","50","_","_","85","_","_","Inclusion criteria: birth of a single live-born child in 1998 or 1999, the pregnancy or birth was registered in the Danish Hospital Discharge Register with a diagnosis of severe pre-eclampsia or eclampsia (ICD-10 codes O14.1 or O15), and for whom blood samples from the mother and the child were stored in the biobank. In Denmark, the diagnosis of severe pre-eclampsia requires a blood pressure >180/110 mmHg and/or the presence of severe subjective symptoms and/or proteinuria of >=5 g/l. ","For each of the case families, four potential controls were identified to be matched on the following criteria: same year and place of birth as the case child, same parity, and no diagnosis of hypertension, pre-eclampsia or eclampsia (ICD-10 codes O10-O16) registered in the Danish Hospital Discharge Register for the actual pregnancy or birth.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","proteinuria of >=5 g/l","180","110","_"
"20070604","rs66554220","HLA-G","6","6","29906561","29798582","3'UTR","3'UTR","3827","3827","_","0.136, Primiparas 0.019","_","Larsen MH et al. (Hviid TV)","2010","Candidate gene approach","Tissue Antigens","Danish","blood sample, blood stain on filter paper, or oral swab sample","50","_","_","85","_","_","Inclusion criteria: birth of a single live-born child in 1998 or 1999, the pregnancy or birth was registered in the Danish Hospital Discharge Register with a diagnosis of severe pre-eclampsia or eclampsia (ICD-10 codes O14.1 or O15), and for whom blood samples from the mother and the child were stored in the biobank. In Denmark, the diagnosis of severe pre-eclampsia requires a blood pressure >180/110 mmHg and/or the presence of severe subjective symptoms and/or proteinuria of >=5 g/l. ","For each of the case families, four potential controls were identified to be matched on the following criteria: same year and place of birth as the case child, same parity, and no diagnosis of hypertension, pre-eclampsia or eclampsia (ICD-10 codes O10-O16) registered in the Danish Hospital Discharge Register for the actual pregnancy or birth.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","proteinuria of >=5 g/l","180","110","_"
"20070604","rs9380142","HLA-G","6","6","29906772","29798793","3'UTR","3'UTR","4038","4038","*A*/G","0.781, Primiparas 0.546","_","Larsen MH et al. (Hviid TV)","2010","Candidate gene approach","Tissue Antigens","Danish","blood sample, blood stain on filter paper, or oral swab sample","50","_","_","85","_","_","Inclusion criteria: birth of a single live-born child in 1998 or 1999, the pregnancy or birth was registered in the Danish Hospital Discharge Register with a diagnosis of severe pre-eclampsia or eclampsia (ICD-10 codes O14.1 or O15), and for whom blood samples from the mother and the child were stored in the biobank. In Denmark, the diagnosis of severe pre-eclampsia requires a blood pressure >180/110 mmHg and/or the presence of severe subjective symptoms and/or proteinuria of >=5 g/l. ","For each of the case families, four potential controls were identified to be matched on the following criteria: same year and place of birth as the case child, same parity, and no diagnosis of hypertension, pre-eclampsia or eclampsia (ICD-10 codes O10-O16) registered in the Danish Hospital Discharge Register for the actual pregnancy or birth.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","proteinuria of >=5 g/l","180","110","_"
"20178529","rs1800795","IL6","7","7","22733169","22766644","upstream","upstream","-153","-121","C/G","0.68 CG, 0.43 CC, 0.57 CG + CC, 0.47 C allele","_","Vural P et al. (Eroglu H)","2010","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","_","blood sample","101","_","_","95","_","_","PE was defined as onset of hypertension after 20 weeks of gestation with blood pressure >140/90 mmHg on two occasions 6 h apart in the presence of proteinuria (>300 mg/L)","Nonpregnant women who had att least 2 live births and no history of PE. Control women were not taking oral contraceptives and were in the follicular phase of their menstrual cycle during sampling.","100","0","Abortion, autoimmunity, and any history of previous pregnancy complications were considered as exclusion criteria for the control group.","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg/L","140","90","_"
"20178529","rs1800896","IL10","1","1","205013519","206946896","upstream","upstream","-1057","-1057","*A*/G","0.006 AG, 0.01 AA, 0.03 AG + AA, 0.04 A allele","_","Vural P et al. (Eroglu H)","2010","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","_","blood sample","101","_","_","95","_","_","PE was defined as onset of hypertension after 20 weeks of gestation with blood pressure >140/90 mmHg on two occasions 6 h apart in the presence of proteinuria (>300 mg/L)","Nonpregnant women who had att least 2 live births and no history of PE. Control women were not taking oral contraceptives and were in the follicular phase of their menstrual cycle during sampling.","100","0","Abortion, autoimmunity, and any history of previous pregnancy complications were considered as exclusion criteria for the control group.","_","_","_","_","_","_","_","_","_","_","_","_",">300 mg/L","140","90","_"
"20186148","rs1799752","ACE","17","17","58919622","61565890","intron","intron","11457","11469","_","NS","_","Aggarwal PK et al. (Jha V)","2010","Candidate gene approach","Hypertension Research","Indian","blood sample","120","_","_","118","_","_","PE was defined as new onset of elevated blood pressure >=140/90mmHg using a standard mercury sphygmomanometer along with proteinuria >=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions after 20 weeks of gestation in earlier normotensive pregnant women","The normotensive control group had women with uncomplicated gestation and blood pressure <125/85 mm Hg and no proteinuria.","_","_","Subjects were excluded if they had one or more of the following: hypertension before 20 weeks of gestation, diabetes, asthma, heart disease, kidney disease, hematolo- gical disorder, autoimmune disease, urinary tract infection, current or past history of smoking, twin/molar pregnancy and eclampsia.","25.7 +/- 3.8","26.3 +/- 4.0","_","_","_","_","_","_","_","_","_","_",">=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions","140","90","_"
"20186148","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","363798","363798","G/T","NS","_","Aggarwal PK et al. (Jha V)","2010","Candidate gene approach","Hypertension Research","Indian","blood sample","120","_","_","118","_","_","PE was defined as new onset of elevated blood pressure >=140/90mmHg using a standard mercury sphygmomanometer along with proteinuria >=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions after 20 weeks of gestation in earlier normotensive pregnant women","The normotensive control group had women with uncomplicated gestation and blood pressure <125/85 mm Hg and no proteinuria.","_","_","Subjects were excluded if they had one or more of the following: hypertension before 20 weeks of gestation, diabetes, asthma, heart disease, kidney disease, hematolo- gical disorder, autoimmune disease, urinary tract infection, current or past history of smoking, twin/molar pregnancy and eclampsia.","25.7 +/- 3.8","26.3 +/- 4.0","_","_","_","_","_","_","_","_","_","_",">=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions","140","90","_"
"20186148","rs2070744","NOS3 (eNOS)","7","7","150321011","150690078","intron","intron","369830","369830","C/T","NS","_","Aggarwal PK et al. (Jha V)","2010","Candidate gene approach","Hypertension Research","Indian","blood sample","120","_","_","118","_","_","PE was defined as new onset of elevated blood pressure >=140/90mmHg using a standard mercury sphygmomanometer along with proteinuria >=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions after 20 weeks of gestation in earlier normotensive pregnant women","The normotensive control group had women with uncomplicated gestation and blood pressure <125/85 mm Hg and no proteinuria.","_","_","Subjects were excluded if they had one or more of the following: hypertension before 20 weeks of gestation, diabetes, asthma, heart disease, kidney disease, hematolo- gical disorder, autoimmune disease, urinary tract infection, current or past history of smoking, twin/molar pregnancy and eclampsia.","25.7 +/- 3.8","26.3 +/- 4.0","_","_","_","_","_","_","_","_","_","_",">=2+ on dipstick on two occasions at least 6h apart or 4300mg per day on two occasions","140","90","_"
"20223440","rs10000679","VEGFC","4","4","177907957","177670963","intron","intron","42932","42932","G/T","Caucasian = 0.6; Black = 0.14","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10007002","VEGFC","4","4","177858704","177621710","intron","intron","92185","92185","A/G","Caucasian = 0.97; Black = 0.58","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10012721","VEGFC","4","4","177896068","177659074","intron","intron","54821","54821","G/T","Caucasian = 0.5; Black = 0.42","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10121110","ENG","9","9","129642228","130602407","intron","intron","14640","14640","A/G","Caucasian = 0.84; Black = 0.59","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10507386","FLT1","13","13","27926553","29028553","intron","intron","40712","40712","C/T","Caucasian = 0.95; Black = 0.12","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10760503","ENG","9","9","129618224","130578403","intron","intron","38644","38644","A/G","Caucasian = 0.38; Black = 0.79","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs10819309","ENG","9","9","129621543","130581722","intron","intron","35325","35325","A/G","Caucasian = 0.56; Black = 0.87","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs11149520","FLT1","13","13","27883566","28985316","intron","intron","83699","83949","C/G","Caucasian = 0.3; Black = 0.23","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs11792480","ENG","9","9","129637945","130598124","intron","intron","18923","18923","A/G","Caucasian = 0.66; Black = 0.37","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs11838619","FLT1","13","13","27947715","29049715","intron","intron","19550","19550","G/T","Caucasian = mono; Black = 0.12","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs12001427","ENG","9","9","129624851","130585030","intron","intron","32017","32017","C/T","_","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs12428494","FLT1","13","13","27854566","28956566","intron","intron","112699","112699","C/T","Caucasian = mono; Black = 0.62","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs12429309","FLT1","13","13","27777331","28879331","intron","intron","189934","189934","C/T","Caucasian = 0.54; Black = 0.75","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs12584067","FLT1","13","13","27790256","28892256","intron","intron","177009","177009","C/*G*","Caucasian = ; Black = 0.04","Black  = 0.047","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs12858139","FLT1","13","13","27956067","29058067","intron","intron","11198","11198","A/C","Caucasian = 0.52; Black = 0.1","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1408243","FLT1","13","13","27847924","28949924","intron","intron","119341","119341","A/G","Caucasian = 0.42; Black = 0.86","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1408245","FLT1","13","13","27809819","28911819","intron","intron","157446","157446","C/G","Caucasian = 0.51; Black = 0.2","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1485762","VEGFC","4","4","177844724","177607730","intron","intron","106165","106165","C/T","_","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1485766","VEGFC","4","4","177847877","177610883","intron","intron","103012","103012","C/*A*","Caucasian = 0.46; Black = 0.03","Black = 0.026","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1555641","FLT1","13","13","27866467","28968467","intron","intron","100798","100798","A/G","Caucasian = 0.81; Black = 0.25","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1692787","VEGFC","4","4","177878459","177641465","intron","intron","72430","72430","C/T","Caucasian = 0.27; Black = 0.11","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17063598","VEGFC","4","4","177856337","177619343","intron","intron","94552","94552","A/G","Caucasian = mono; Black = 0.15","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086565","FLT1","13","13","27800954","28902954","intron","intron","166311","166311","A/G","Caucasian = mono; Black = 0.66","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086574","FLT1","13","13","27806089","28908089","intron","intron","161176","161176","C/T","Caucasian = mono; Black = 0.38","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086586","FLT1","13","13","27812511","28914511","intron","intron","154754","154754","A/G","Caucasian = mono; Black = 0.31","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086602","FLT1","13","13","27824300","28926300","intron","intron","142965","142965","C/T","Caucasian = mono; Black = 0.72","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086609","FLT1","13","13","27827710","28929710","intron","intron","139555","139555","A/G","Caucasian = 0.89; Black = 0.26","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086620","FLT1","13","13","27862402","28964402","intron","intron","104863","104863","A/G","Caucasian = 0.1; Black = 0.11","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086636","FLT1","13","13","27872795","28974795","intron","intron","94470","94470","C/G","Caucasian = mono; Black = 0.2","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086729","FLT1","13","13","27944292","29046292","intron","intron","22973","22973","C/T","Caucasian = mono; Black = 0.25","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17086741","FLT1","13","13","27950083","29052083","intron","intron","17182","17182","A/C","Caucasian = mono; Black = 0.54","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17557600","ENG","9","9","129637043","130597222","intron","intron","19825","19825","C/*T*","Caucasian = 0.85; Black = 0.06","Black = 0.057","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17625898","FLT1","13","13","27830829","28932829","intron","intron","136436","136436","A/G/T","Caucasian = 0.48; Black = 0.87","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs17697305","VEGFC","4","4","177843644","177606650","intron","intron","107245","107245","C/T","Caucasian = 0.6; Black = 0.68","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs1800956","ENG","9","9","129626441","130586620","coding","coding","30427","30427","C/G","_","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2147188","FLT1","13","13","27809979","28911979","intron","intron","157286","157286","A/G","Caucasian = mono; Black = 0.93","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2286612","VEGFB","11","11","63750805","63994229","coding NUDT22","coding NUDT22","-8036","-7826","A/C","Caucasian = 0.38; Black = 0.46","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2296187","FLT1","13","13","27791340","28893340","intron","intron","175925","175925","C/G","Caucasian = 0.29; Black = 0.64","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2296188","FLT1","13","13","27791483","28893483","intron","intron","175782","175782","C/T","Caucasian = 0.13; Black = 0.19","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2296190","FLT1","13","13","27793523","28895523","intron","intron","173742","173742","C/G","Caucasian = 0.88; Black = 0.42","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2296192","FLT1","13","13","27817461","28919461","intron","intron","149804","149804","C/T","Caucasian = 0.78; Black = 0.91","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2429458","VEGFB","11","11","63749281","63992705","intron TRPT1","intron TRPT1","-9560","-9350","A/G","Caucasian = mono; Black = 0.44","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs2900256","ENG","9","9","129650265","130610444","intron","intron","6603","6603","C/T","Caucasian = mono; Black = 0.5","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3024994","VEGFA","6","6","43851484","43743506","intron","intron","5554","5561","C/T","Caucasian = ; Black = 0.29","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025010","VEGFA","6","6","43855554","43747576","intron","intron","9624","9631","C/T","Caucasian = 0.87; Black = 0.8","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025019","VEGFA","6","6","43856963","43748985","intron","intron","11033","11040","A/G","Caucasian = mono; Black = 0.86","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025023","VEGFA","6","6","43857467","43749489","intron","intron","11537","11544","A/G","Caucasian = mono; Black = 0.85","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025030","VEGFA","6","6","43858564","43750586","intron","intron","12634","12641","C/G","Caucasian = 0.48; Black = 0.62","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025034","VEGFA","6","6","43859168","43751190","intron","intron","13238","13245","G/T","Caucasian = mono; Black = 0.63","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3025035","VEGFA","6","6","43859336","43751358","intron","intron","13406","13413","C/T","Caucasian = 0.91; Black = 0.41","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs307826","FLT4","5","5","179983608","180051002","coding","coding","25622","25622","G/*A*","Caucasian = 0.02; Black = 0.78","Caucasian = .007","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3088111","FLT1","13","13","27858667","28960667","intron","intron","108598","108598","C/T","Caucasian = 0.72; Black = ","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs35874891","FLT4","5","5","179982413","180049807","coding","coding","26817","26817","A/G","Caucasian = mono; Black = 0.99","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3739817","ENG","9","9","129626508","130586687","coding","coding","30360","30360","A/G","Caucasian = 0.36; Black = 0.57","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3741403","VEGFB","11","11","63756104","63999528","intron NUDT22","intron DNAJC4","-2737","-2527","A/G","Caucasian = 0.76; Black = 0.68","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3751395","FLT1","13","13","27856954","28958954","intron","intron","110311","110311","A/C","Caucasian = 0.65; Black = 0.42","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3751397","FLT1","13","13","27858592","28960592","intron","intron","108673","108673","A/T","Caucasian = 0.79; Black = 0.21","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3755975","VEGFC","4","4","177862489","177625495","intron","intron","88400","88400","A/G","Caucasian = 0.47; Black = 0.94","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3775189","VEGFC","4","4","177884970","177647976","intron","intron","65919","65919","A/G","Caucasian = 0.57; Black = 0.2","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3775194","VEGFC","4","4","177860870","177623876","intron","intron","90019","90019","C/G","Caucasian = 0.22; Black = 0.57","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3775195","VEGFC","4","4","177858103","177621109","intron","intron","92786","92786","A/C/T","Caucasian = 0.35; Black = 0.43","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3775202","VEGFC","4","4","177848204","177611210","intron","intron","102685","102685","A/G","Caucasian = 0.69; Black = 0.58","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3794396","FLT1","13","13","27790652","28892652","intron","intron","176613","176613","C/G","Caucasian = mono; Black = 0.12","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3794399","FLT1","13","13","27790891","28892891","intron","intron","176374","176374","G/T","Caucasian = 0.83; Black = 0.4","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3794402","FLT1","13","13","27822831","28924831","intron","intron","144434","144434","C/G","Caucasian = 0.57; Black = 0.23","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs3936415","FLT1","13","13","27817329","28919329","intron","intron","149936","149936","A/G","Caucasian = 0.82; Black = 0.2","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4146612","VEGFC","4","4","177914014","177677020","intron","intron","36875","36875","A/G","Caucasian = 0.37; Black = 0.66","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4557213","VEGFC","4","4","177926126","177689132","intron","intron","24763","24763","A/G","Caucasian = 0.5; Black = 0.14","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4604006","VEGFC","4","4","177845768","177608774","intron","intron","105121","105121","C/T","Caucasian = 0.43; Black = 0.63","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4672","VEGFB","11","11","63766454","64009878","coding FKBP2","coding FKBP2","7613","7823","A/G","Caucasian = 0.53; Black = 0.12","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4836585","ENG","9","9","129652203","130612382","intron","intron","4665","4665","A/C","Caucasian = 0.7; Black = 0.45","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs4837192","ENG","9","9","129654732","130614911","intron","intron","2136","2136","A/G","Caucasian = 0.51; Black = 0.71","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs553513","VEGFC","4","4","177875557","177638563","intron","intron","75332","75332","C/T","Caucasian = 0.65; Black = 0.32","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs633561","VEGFB","11","11","63753904","63997328","coding NUDT22","coding NUDT22","-4937","-4727","C/T","Caucasian = 0.48; Black = 0.47","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs6491283","FLT1","13","13","27875738","28977738","intron","intron","91527","91527","A/G","Caucasian = 0.77; Black = 0.39","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs670084","FLT1","13","13","27947783","29049783","intron","intron","19482","19482","G/*T*","Caucasian = 0.2; Black = 0.08","Black = 0.069","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs674834","FLT1","13","13","27954304","29056304","intron","intron","12961","12961","G/T","Caucasian = mono; Black = 0.9","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs678714","FLT1","13","13","27964056","29066056","intron","intron","3209","3209","A/T","Caucasian = 0.81; Black = 0.37","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs679791","FLT1","13","13","27959776","29061776","intron","intron","7489","7489","G/T","Caucasian = 0.61; Black = 0.22","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs6815174","VEGFC","4","4","177865998","177629004","intron","intron","84891","84891","C/T","Caucasian = mono; Black = 0.29","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs6816640","VEGFC","4","4","177927761","177690767","intron","intron","23128","23128","A/G","Caucasian = 0.37; Black = 0.69","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs6838834","VEGFC","4","4","177890591","177653597","intron","intron","60298","60298","T/*C*","Caucasian = mono; Black = 0.03","Black = .032","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs6857752","VEGFC","4","4","177919682","177682688","intron","intron","31207","31207","C/T","Caucasian = 0.5; Black = 0.15","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs689142","VEGFC","4","4","177898804","177661810","intron","intron","52085","52085","A/G","Caucasian = 0.73; Black = 0.87","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7034078","ENG","9","9","129635918","130596097","intron","intron","20950","20950","C/T","Caucasian = mono; Black = 0.96","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7139483","FLT1","13","13","27878480","28980480","intron","intron","88785","88785","C/T","Caucasian = mono; Black = 0.63","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs718273","FLT1","13","13","27941140","29043140","intron","intron","26125","26125","A/G","Caucasian = 0.94; Black = 0.26","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs720661","FLT1","13","13","27776543","28878543","intron","intron","190722","190722","C/T","Caucasian = mono; Black = 0.47","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs722503","FLT1","13","13","27895051","28997051","intron","intron","72214","72214","G/*A*","Caucasian = 0.03; Black = 0.64","Caucasian = .034","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7319123","FLT1","13","13","27858467","28960467","intron","intron","108798","108798","A/C","Caucasian = mono; Black = 0.59","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7319213","FLT1","13","13","27779463","28881463","intron","intron","187802","187802","C/G","Caucasian = mono; Black = 0.24","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7323184","FLT1","13","13","27936710","29038710","intron","intron","30555","30555","C/T","Caucasian = 0.18; Black = 0.71","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7326277","FLT1","13","13","27774213","28876213","downstream","3'UTR","193052","193052","C/T","Caucasian = 0.16; Black = 0.63","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7335588","FLT1","13","13","27882501","28984501","intron","intron","84764","84764","A/*G*","Caucasian = mono; Black = 0.02","Black = 0.013","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7337610","FLT1","13","13","27860665","28962665","intron","intron","106600","106600","C/T","Caucasian = 0.91; Black = 0.67","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7337866","FLT1","13","13","27949620","29051620","intron","intron","17645","17645","A/G","Caucasian = mono; Black = 0.55","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7440052","VEGFC","4","4","177931537","177694543","intron","intron","19352","19352","A/G","Caucasian = 0.5; Black = 0.15","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7664413","VEGFC","4","4","177845700","177608706","intron","intron","105189","105189","T/*C*","Caucasian = 0.05; Black = 0.68","Caucasian = 0.036","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7982957","FLT1","13","13","27807869","28909869","intron","intron","159396","159396","A/T","Caucasian = 0.75; Black = 0.4","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7987291","FLT1","13","13","27792205","28894205","intron","intron","175060","175060","A/G","Caucasian = 0.82; Black = 0.78","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7987649","FLT1","13","13","27792414","28894414","intron","intron","174851","174851","A/G","Caucasian = 0.7; Black = 0.46","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7992940","FLT1","13","13","27921920","29023920","intron","intron","45345","45345","G/T","Caucasian = 0.9; Black = 0.8","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7995813","FLT1","13","13","27805156","28907156","intron","intron","162109","162109","C/T","Caucasian = ; Black = 0.37","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7995976","FLT1","13","13","27839059","28941059","intron","intron","128206","128206","A/C","Caucasian = 0.75; Black = 0.56","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs7999615","FLT1","13","13","27919010","29021010","intron","intron","48255","48255","C/T","Caucasian = 0.81; Black = 0.15","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs833068","VEGFA","6","6","43850504","43742526","intron","intron","4574","4581","G/*A*","Caucasian = 0.75; Black = 0.06","Black = 0.053","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs833070","VEGFA","6","6","43850603","43742625","intron","intron","4673","4680","A/G","Caucasian = 0.6; Black = 0.48","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs880703","FLT1","13","13","27790042","28892042","intron","intron","177223","177223","A/G","Caucasian = mono; Black = 0.4","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs880704","FLT1","13","13","27789880","28891880","intron","intron","177385","177385","T/*G* ","Caucasian = mono; Black = 0.09","Black = 0.087","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9319425","FLT1","13","13","27790984","28892984","intron","intron","176281","176281","T/*C*","Caucasian = 0.7; Black = 0.07","Black = 0.07","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9319427","FLT1","13","13","27870163","28972163","intron","intron","97102","97102","A/G","Caucasian = 0.4; Black = 0.21","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9369425","VEGFA","6","6","43918951","43810973","downstream AK097853 ","downstream AK097853 ","73021","73028","A/G","_","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9472138","VEGFA","6","6","43919739","43811761","downstream AK097853 ","downstream AK097853 ","73809","73816","C/T","_","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9508016","FLT1","13","13","27793068","28895068","intron","intron","174197","174197","A/G","Caucasian = 0.86; Black = 0.34","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs950860","FLT1","13","13","27775878","28877878","intron","intron","191387","191387","G/T","Caucasian = 0.87; Black = 0.81","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9513070","FLT1","13","13","27777838","28879838","intron","intron","189427","189427","A/G","Caucasian = 0.4; Black = 0.88","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9513085","FLT1","13","13","27818922","28920922","intron","intron","148343","148343","C/T","Caucasian = 0.18; Black = 0.57","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9513089","FLT1","13","13","27835418","28937418","intron","intron","131847","131847","A/G","Caucasian = 0.6; Black = 0.43","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9513099","FLT1","13","13","27876373","28978373","intron","intron","90892","90892","C/T","Caucasian = 0.82; Black = 0.94","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9554320","FLT1","13","13","27784926","28886926","intron","intron","182339","182339","A/C","Caucasian = 0.12; Black = 0.44","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20223440","rs9582036","FLT1","13","13","27783407","28885407","intron","intron","183858","183858","A/C","Caucasian = 0.27; Black = 0.77","_","Srinivas SK et al. (Elovitz MA)","2010","Candidate gene approach; prospective case-control study","American Journal of Obstetrics & Gynecology","Caucasian, Black","blood sample","216 (184 Black, 32 Caucasian)","_","_","390","control subjects were women who delivered at term (>=37 weeks of gestation) without preeclampsia. ","_","Elevated blood pressure with proteinuria","_","_","_","_","26.2 +/- 6.2 Black , 33.4 +/- 5.7 Caucasian","25.5 +/- 6 Black, 32.3 +/- 5.2 Caucasian","_","_","_","_","Black 30.9 +/- 9.8, Caucasian 26.8 +/- 6","Black 29.9 +/- 8, Caucasian 25.4 +/- 5.8","_","_","_","_",">=140/90 mm Hg on 2 measurements >=6 hours apart with >=1+ ","140","90","_"
"20400461","rs1800629","TNF","6","6","31651009","31543030","upstream","upstream","-319","-319","A/G","_","NS","van Dijk M et al. (Lye SJ)","2010","Candidate gene approach","Human Molecular Genetics","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"20448640","rs1024323","GRK4","4","4","2975840","3006042","coding","coding","40700","40700","A/G","0.748 genotype, 0.417 allele","_","Sun CJ (Zhang WY)","2010","Candidate gene approach","Hypertension Research","Chinese, Asian","blood sample","105","88 Severe PE, 17 Mild PE","_","103","_","_","Mild PE was defined as systolic blood pressure (SBP) >=140mmHg or diastolic blood pressure (DBP) >=90 mm Hg after 20 weeks of gestation on at least two occasions 6 or more hours apart. In addition, proteinuria was defined as 4300 mg per 24-h collection or persistent 1+ protein measurement on urine dipstick. The diagnosis of severe PE required the basic features of mild PE as well as some indication of additional problems with either the mother or the baby, including: (i) very high blood pressure (>160 mm Hg SBP or 110 mm Hg DBP) and (ii) proteinuria 45 g per 24-h collection. Only women with the aforementioned criteria within their first and not subsequent pregnancies were included in the study. ","The women with normal pregnancies were chosen as healthy controls based on comparable age, Han origin and geographical location. No family history of PE","_","_","Subjects with a clinical history of primary liver and kidney disease, essential hypertension, diabetes mellitus, rheumatism, tumors and those who used drugs within the preceding 24 h were excluded from the study.","30.36 +/- 4.99","29.13 +/- 3.04","_","_","_","_","_","23.88 +/- 4.05","2106.77 +/- 882.72","3308.13 +/- 483.15","_","_","Mild PE: 4300 mg per 24-h collection or persistent 1+ protein measurement on urine dipstick; Severe PE: 45 g per 24-h collection","140","90","_"
"20448640","rs1801058","GRK4","4","4","3008947","3039149","coding","coding","73807","73807","C/T","0.435 genotype, 0.969 allele","NS","Sun CJ (Zhang WY)","2010","Candidate gene approach","Hypertension Research","Chinese, Asian","blood sample","105","88 Severe PE, 17 Mild PE","_","103","_","_","Mild PE was defined as systolic blood pressure (SBP) >=140mmHg or diastolic blood pressure (DBP) >=90 mm Hg after 20 weeks of gestation on at least two occasions 6 or more hours apart. In addition, proteinuria was defined as 4300 mg per 24-h collection or persistent 1+ protein measurement on urine dipstick. The diagnosis of severe PE required the basic features of mild PE as well as some indication of additional problems with either the mother or the baby, including: (i) very high blood pressure (>160 mm Hg SBP or 110 mm Hg DBP) and (ii) proteinuria 45 g per 24-h collection. Only women with the aforementioned criteria within their first and not subsequent pregnancies were included in the study. ","The women with normal pregnancies were chosen as healthy controls based on comparable age, Han origin and geographical location. No family history of PE","_","_","Subjects with a clinical history of primary liver and kidney disease, essential hypertension, diabetes mellitus, rheumatism, tumors and those who used drugs within the preceding 24 h were excluded from the study.","30.36 +/- 4.99","29.13 +/- 3.04","_","_","_","_","_","23.88 +/- 4.05","2106.77 +/- 882.72","3308.13 +/- 483.15","_","_","Mild PE: 4300 mg per 24-h collection or persistent 1+ protein measurement on urine dipstick; Severe PE: 45 g per 24-h collection","140","90","_"
"20462372","rs7799039","LEP","7","7","127666018","127878782","upstream","upstream","-2548","-2548","G/*A*","<0.05 genotype, <0.0001 allele","_","Sugathadasa BH et al. (Wijesundere AP)","2010","Candidate gene approach","Hypertension Pregnancy","_","_","62","Third Trimester","_","63","Third Trimester","_","Pregnancy-induced hypertension was defined as persistent (6 or more hours apart) blood pressure of at least 140/90 mmHg arising after 20 weeks of gestation. Preeclampsia was diagnosed when there was proteinuria in addi- tion to elevated blood pressure. Proteinuria was defined as urine protein concentration >300 mg/l or more (or 1+ on a urine dipstick) in at least two random specimens collected at least 4 hours apart in the absence of urinary tract infection. ","All women had a naturally conceived singleton pregnancy. Women with diabetes mellitus, gestational diabetes, chronic hypertension, renal disease, polycystic ovarian syndrome, hirsutism or menstrual cycle disturbances and women previously treated for infertility were excluded from the study. ","_","_","Women with diabetes mellitus, gestational diabetes, chronic hypertension, renal disease, polycystic ovarian syndrome, hirsutism or menstrual cycle disturbances and women previously treated for infertility were excluded from the study. ","30.16 +/- 0.70","30.14 +/- 0.70","_","_","_","_","28.7 +/- 0.66","24.78 +/- 0.47","_","_","_","_","Proteinuria was defined as urine protein concentration >300 mg/l or more (or 1+ on a urine dipstick) in at least two random specimens collected at least 4 hours apart in the absence of urinary tract infection. ","140","90","_"
"20664545","rs1501299","ADIPOQ","3","3","188053816","186571122","intron","intron","10660","10660","A/C","NS","NS","Youpeng B et al. (Rong Z)","2010","Candidate gene approach","Hypertension Research","Han Chinese","_","107","20 Mild PE, 87 Severe PE","_","81","_","_","_","_","80.4","81.5","_","_","_","30.0 +/- 4.5","_","_","_","22.5 +/- 2.9 Mild PE, 21.6 +/- 2.4 Severe PE","20.1 +/- 1.8","_","_","35.4 +/- 1.2 Mild PE, 34.9 +/- 1.6 Severe PE","35.4 +/- 1.2","_","_","_","_"
"20664545","rs2241766","ADIPOQ","3","3","188053585","186570891","coding","coding","10429","10429","G/T","NS","_","Youpeng B et al. (Rong Z)","2010","Candidate gene approach","Hypertension Research","Han Chinese","_","107","20 Mild PE, 87 Severe PE","_","81","_","_","_","_","80.4","81.5","_","_","_","30.0 +/- 4.5","_","_","_","22.5 +/- 2.9 Mild PE, 21.6 +/- 2.4 Severe PE","20.1 +/- 1.8","_","_","35.4 +/- 1.2 Mild PE, 34.9 +/- 1.6 Severe PE","35.4 +/- 1.2","_","_","_","_"
"20691413","rs10066650","SLCO4C1","5","5","101615272","101587373","intron","intron","44880","44880","*G*/T","0.002 Black, 0.41 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs10282940","SLC30A8","8","8","118257006","118187825","3'UTR","3'UTR","40489","40489","*A*/G","0.04 Black, 0.92 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs11878780","SLC8A2","19","19","52637406","47945594","intron","intron","29528","29713","C/*T*","0.01 Black, 0.36 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs12493289","SLC25A20","3","3","48880164","48905160","intron","intron","31242","31266","*A*/G","0.005 Black, 0.02 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs16855638","SLC2A2","3","3","172201057","170718363","intron","intron","26405","26405","A/*C*","0.05 Black, NACaucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs16960681","SLC12A1","15","15","46306357","48519065","intron","intron","20568","20568","C/*T*","0.05 Black, NA Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2020936","SLC6A4","17","17","25574939","28550813","intron","intron","11902","12141","*A*/G","0.05 Black, 0.74 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2074107","SLC4A1","17","17","39693501","42337975","intron","intron","7527","7527","A/*G*","0.004 Black, 0.86 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2074108","SLC4A1","17","17","39691674","42336148","intron","intron","9354","9354","C/*T*","0.02 Black, 0.24 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2099107","SLC12A3","16","16","55502287","56944786","intron","intron","45668","45668","*A*/G","0.05 Black, 0.48 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2458814","SLC9A3","5","5","571488","518488","intron","intron","5959","6061","A/*G*","0.12 Black, 0.02 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs274558","SLC22A5","5","5","131749072","131721173","coding","coding","15773","15773","*C*/T","0.39 Black, 0.05 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs2857078","SLC4A1","17","17","39685696","42330170","intron","intron","15332","15332","*A*/C","<0.001 Black, 0.75 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs3756711","SLC9A3","5","5","538928","485928","intron","intron","38519","38621","*C*/T","0.03 Black, 0.47 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs3784614","SLC12A1","15","15","46309207","48521915","intron","intron","23418","23418","C/*T*","0.02 Black, NA Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs3811976","SLCO4C1","5","5","101598134","101570235","3'UTR","3'UTR","62018","62018","A/*G*","0.05 Black, 0.38 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs4957061","SLC9A3","5","5","574095","521095","intron","intron","3352","3454","C/*T*","0.68 Black, 0.002 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs5905178","SLC6A14","X","X","115501405","115587377","intron","intron","19588","19631","*A*/G","0.56 Black, 0.04 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs5905289","SLC6A14","X","X","115504856","115590828","3'UTR","3'UTR","23039","23082","C/*T*","0.6 Black, 0.03 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs6860754","SLCO4C1","5","5","101646406","101618507","intron","intron","13746","13746","C/*T*","0.008 Black, 0.41 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs7209090","SLC4A1","17","17","39704250","42348724","upstream","upstream","-3222","-3222","A/*G*","0.03 Black, 0.62 Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20691413","rs8032941","SLC12A1","15","15","46302143","48514851","intron","intron","16354","16354","A/*G*","0.02 Black, NA Caucasian","_","Morrison AC et al. (Puschett JB)","2010","Candidate gene approach","American Journal of Obstetrics & Gynecology","Caucasian, Black","_","218","31 Caucasian, 181 Black","_","413","85 Caucasian, 303 Black","_","Cases were identified based on prespecified maternal criteria for preeclampsia according to standard criteria of the American College of Obstetrics and Gynecology.10 Preeclampsia was defined as elevated blood pressure (>=140/90 mm Hg on 2 measurements >=6 hours apart or >=160/105 mm Hg on presentation) with new onset of proteinuria. Women who had gestational hypertension or chronic hypertension with superimposed preeclampsia were also eligible to be cases.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","140","90","_"
"20818954","rs4986790","TLR4","9","9","119515122","120475301","coding","coding","8692","8842","A/G","0.44 genotype, 0.44 allele","_","Xie F (von Dadelszen P)","2010","Candidate gene approach","Hypertension Pregnancy","_","_","94","_","_","176","_","_","Preeclampsia was defined as the development of hypertension (blood pres- sure >= 140/90 mmHg) and proteinuria (>=300 mg/24 h, >=30 mg protein/mmol creatine, or >=2+ dipstick proteinuria) after 20 weeks gestation (1). Women with preeclampsia were subclassified as having had either early-onset (clini- cal diagnosis <34+0 weeks gestation) or late-onset (>=34+0 weeks gestation)","_","68","60","_","33 (19-43)","32 (24-42)","_","_","_","_","32.14 +/- 6.99","26.92 +/- 3.96","1794 (359-4400)","3422 (2730-4615)","_","_","_","_","_","_"
"20818954","rs4986791","TLR4","9","9","119515422","120475601","coding","coding","8992","9142","C/T","0.31 genotype, 0.14 allele","_","Xie F (von Dadelszen P)","2010","Candidate gene approach","Hypertension Pregnancy","_","_","94","_","_","176","_","_","Preeclampsia was defined as the development of hypertension (blood pres- sure >= 140/90 mmHg) and proteinuria (>=300 mg/24 h, >=30 mg protein/mmol creatine, or >=2+ dipstick proteinuria) after 20 weeks gestation (1). Women with preeclampsia were subclassified as having had either early-onset (clini- cal diagnosis <34+0 weeks gestation) or late-onset (>=34+0 weeks gestation)","_","68","60","_","33 (19-43)","32 (24-42)","_","_","_","_","32.14 +/- 6.99","26.92 +/- 3.96","1794 (359-4400)","3422 (2730-4615)","_","_","_","_","_","_"
"20818954","rs5743708","TLR2","4","4","154845766","154626316","coding","coding","20876","20876","A/G","0.094 genotype, 0.098 allele","NS","Xie F (von Dadelszen P)","2010","Candidate gene approach","Hypertension Pregnancy","_","_","94","_","_","176","_","_","Preeclampsia was defined as the development of hypertension (blood pres- sure >= 140/90 mmHg) and proteinuria (>=300 mg/24 h, >=30 mg protein/mmol creatine, or >=2+ dipstick proteinuria) after 20 weeks gestation (1). Women with preeclampsia were subclassified as having had either early-onset (clini- cal diagnosis <34+0 weeks gestation) or late-onset (>=34+0 weeks gestation)","_","68","60","_","33 (19-43)","32 (24-42)","_","_","_","_","32.14 +/- 6.99","26.92 +/- 3.96","1794 (359-4400)","3422 (2730-4615)","_","_","_","_","_","_"
"20927378","rs16972194","TNFSF13B","13","13","107718961","108920960","upstream","upstream","-1016","-1016","A/G","Australian/ New Zealander = 0.380 (QTDT P-val = 0.015); Norwegian = 0.421","_","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs16972197","TNFSF13B","13","13","107719891","108921890","upstream","upstream","-86","-86","C/G","Australian/ New Zealander = 0.380 (QTDT P-val = 0.015); Norwegian = 0.357","_","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs36206504","TNFSF13B","13","13","107719568","108921567","upstream","upstream","-409","-409","A/C","Australian/ New Zealander = 0.714 (QTDT P-val = 0.162)","NS","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs36206505","TNFSF13B","13","13","107719583","108921582","upstream","upstream","-394","-394","A/G","Australian/ New Zealander = 0.125 (QTDT P-val = 0.618)","_","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs56124946","TNFSF13B","13","13","107720643","108922642","intron","intron","666","666","C/G","Australian/ New Zealander = 0.380 (QTDT P-val = 0.015); Norwegian = 0.737","_","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs61972017","TNFSF13B","13","13","107757113","108959112","intron","intron","37136","37136","A/C","Australian/ New Zealander = 1.000 (QTDT P-val = 0.197)","_","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"20927378","rs9514828","TNFSF13B","13","13","107719373","108921372","upstream","upstream","-604","-604","C/T","Australian/ New Zealander = 0.406 (QTDT P-val = 0.915)","NS","Fenstad MH et al. (Moses EK)","2010","Candidate gene approach","PLoS One","Australian, New Zealander, Norwegian","blood sample","140","_","_","146","_","_","new onset proteinuria, >=0.3 g/d and either an increase from baseline blood pressure of 15/25 mmHg or absolute values >=140/90 mmHg on at least two occasions 6 h or more apart","_","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3 g/d","140 or an increase from baseline blood pressure of 15 mmHg","90 or an increase from baseline blood pressure of 25 mmHg","_"
"21129839","rs1049353","CNR1","6","6","88910353","88853634","coding","coding","1422","22133","A/G","0.19 AA, 0.15 AG, 0.75 GG","_","Bienertova-Vasku J et al. (Vasku V)","2011","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","Czech, European","_","115","_","_","145","_","_","_","_","43.5","54.5","_","30.24 +/- 5.47","27.43 +/- 5.26","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"21129839","rs12720071","CNR1","6","6","88907899","88851180","3'UTR","3'UTR","3876","24587","A/G","0.55 AA, 0.56 AG, 0.59 GG","_","Bienertova-Vasku J et al. (Vasku V)","2011","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","Czech, European","_","115","_","_","145","_","_","_","_","43.5","54.5","_","30.24 +/- 5.47","27.43 +/- 5.26","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"21129839","rs806368","CNR1","6","6","88906818","88850099","3'UTR","3'UTR","4957","25668","C/T","0.02 CC, 1.72 CT, 0.22 TT","_","Bienertova-Vasku J et al. (Vasku V)","2011","Candidate gene approach","European Journal of Obstetrics & Gynecology and Reproductive Biology","Czech, European","_","115","_","_","145","_","_","_","_","43.5","54.5","_","30.24 +/- 5.47","27.43 +/- 5.26","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"21174581","rs10158674","DAAH1","1","1","85588721","85816133","coding BCL10","coding BCL10","72550","73546","C/T","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","7964","7967","G/T","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs233115","DAAH1","1","1","85559564","85786976","3'UTR","3'UTR","2808","2808","C/T","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs2695121","NR1H2","19","19","55572552","50880740","intron","intron","1249","1249","C/T","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs3918227","NOS3 (eNOS)","7","7","150331878","150700945","intron","intron","12799","12802","A/C","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs5442","GNB3","12","12","6825124","6954863","coding","coding","5489","5489","A/G","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21174581","rs7120118","NR1H3","11","11","47242865","47286289","intron","intron","5559","6822","C/T","NS","_","Best LG et al. (Anderson CM)","2010","Candidate gene approach","Hypertension Pregnancy","American Indian","_","101","_","_","198 and 110 population-based controls among an American Indian population","_","_","At least three blood pressure values above either 140 mmHg systolic or 90 mmHg diastolic. Absence of a prior (during the year prior toconception and the rst 20 weeks of gestation) diagnosis of or treatment for hypertension is required. Proteinuria","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 (1030)","3393 (601)","_","_","24-hr excretion of>300 mg, or at least two +1 dipstick measurements","140","90","_"
"21304959","rs4633","COMT","22","22","18330234","19950234","coding","coding","20926","20972","C/T","0.214","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","PLoS One","_","_","528","_","528","575","_","575","No previous history of hypertension, cardiovascular, or renal disease before pregnancy and blood pressure values exceeding 140/90 mmHg after the 20th week of gestation, confirmed by two consecutive readings at least six hours apart, with blood pressure reverting to normal within two months after delivery. The subjects were considered to have a physiological pregnancy if they did not have obstetrical, medical, or surgical complications of pregnancy, and delivered a term (>38 weeks) neonate with a birth weight above the 10th percentile for gestational age","_","_","_","Subjects who had chronic hypertension of any etiology before pregnancy without superimposed consequent pre-eclampsia were not included in the study, as they might carry such genetic variants that are protective against pre-clampsia development.","26.3 +/- 7.5","21.6 +/- 6.2","_","_","_","_","26.4 +/- 5.4","24.5 +/- 4.4","2805.7 +/- 815.7","3423.2 +/- 303.0","_","_","_","_","_","_"
"21304959","rs4680","COMT","22","22","18331270","19951270","coding","coding","21962","22008","A/G","0.373","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","PLoS One","_","_","528","_","528","575","_","575","No previous history of hypertension, cardiovascular, or renal disease before pregnancy and blood pressure values exceeding 140/90 mmHg after the 20th week of gestation, confirmed by two consecutive readings at least six hours apart, with blood pressure reverting to normal within two months after delivery. The subjects were considered to have a physiological pregnancy if they did not have obstetrical, medical, or surgical complications of pregnancy, and delivered a term (>38 weeks) neonate with a birth weight above the 10th percentile for gestational age","_","_","_","Subjects who had chronic hypertension of any etiology before pregnancy without superimposed consequent pre-eclampsia were not included in the study, as they might carry such genetic variants that are protective against pre-clampsia development.","26.3 +/- 7.5","21.6 +/- 6.2","_","_","_","_","26.4 +/- 5.4","24.5 +/- 4.4","2805.7 +/- 815.7","3423.2 +/- 303.0","_","_","_","_","_","_"
"21304959","rs4818","COMT","22","22","18331206","19951206","coding","coding","21898","21944","C/G/T","0.091","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","PLoS One","_","_","528","_","528","575","_","575","No previous history of hypertension, cardiovascular, or renal disease before pregnancy and blood pressure values exceeding 140/90 mmHg after the 20th week of gestation, confirmed by two consecutive readings at least six hours apart, with blood pressure reverting to normal within two months after delivery. The subjects were considered to have a physiological pregnancy if they did not have obstetrical, medical, or surgical complications of pregnancy, and delivered a term (>38 weeks) neonate with a birth weight above the 10th percentile for gestational age","_","_","_","Subjects who had chronic hypertension of any etiology before pregnancy without superimposed consequent pre-eclampsia were not included in the study, as they might carry such genetic variants that are protective against pre-clampsia development.","26.3 +/- 7.5","21.6 +/- 6.2","_","_","_","_","26.4 +/- 5.4","24.5 +/- 4.4","2805.7 +/- 815.7","3423.2 +/- 303.0","_","_","_","_","_","_"
"21304959","rs6269","COMT","22","22","18329951","19949951","intron","intron","20643","20689","A/G","0.104","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","PLoS One","_","_","528","_","528","575","_","575","No previous history of hypertension, cardiovascular, or renal disease before pregnancy and blood pressure values exceeding 140/90 mmHg after the 20th week of gestation, confirmed by two consecutive readings at least six hours apart, with blood pressure reverting to normal within two months after delivery. The subjects were considered to have a physiological pregnancy if they did not have obstetrical, medical, or surgical complications of pregnancy, and delivered a term (>38 weeks) neonate with a birth weight above the 10th percentile for gestational age","_","_","_","Subjects who had chronic hypertension of any etiology before pregnancy without superimposed consequent pre-eclampsia were not included in the study, as they might carry such genetic variants that are protective against pre-clampsia development.","26.3 +/- 7.5","21.6 +/- 6.2","_","_","_","_","26.4 +/- 5.4","24.5 +/- 4.4","2805.7 +/- 815.7","3423.2 +/- 303.0","_","_","_","_","_","_"
"21343950","rs1127745","ACOX2","3","3","58487276","58512236","coding","coding","10942","10942","C/T","0.0045 cis-regulation, 0.8671 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs13434020","ACOX2","3","3","58487939","58512899","intron","intron","9779","9779","G/T","0.0045 cis-regulation, 0.8671 triglycerides","NS","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs4317122","ACOX2","3","3","58473882","58498842","intron","intron","24074","24087","C/T","0.0815 cis-regulation, 0.0161 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs4387990","ACOX2","3","3","58491422","58516382","intron","intron","6534","6547","A/C","0.6437 cis-regulation, 0.6499 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs4681689","ACOX2","3","3","58477747","58502707","intron","intron","20209","20222","A/C","0.0464 cis-regulation, 0.0051 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs4681690","ACOX2","3","3","58490605","58515565","intron","intron","7351","7364","G/T","0.2628 cis-regulation, 0.4463 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs6795193","ACOX2","3","3","58472818","58497778","intron","intron","25138","25151","C/T","0.2337 cis-regulation, 0.2082 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21343950","rs7651276","ACOX2","3","3","58481889","58506849","intron","intron","16067","16080","C/T","0.3747 cis-regulation, 0.1731 triglycerides","_","Johansson A et al. (Blangero J)","2011","Candidate gene approach","European Journal of Human Genetics","Norwegian, Caucasian","decidua basalis tissue","37","Pregnant women delivered by cesarean section","_","58","_","_","PE was defined as persistent hypertension (blood pressure of >=140/90mmHg) plus proteinuria (>=0.3g per day or >=1+ according to a dipstick test) on at least two occasions, developing after 20 weeks of pregnancy","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_",">=0.3g per day or >=1+ according to a dipstick test on at least 2 occasions","140","90","_"
"21564405","rs1799752","ACE","17","17","58919622","61565890","intron","intron","11457","11469","Insertion/*Deletion*","0.09","_","Aggarwal S et al. (Agarwal S)","2011","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Indian","blood sample","200","_","_","200","_","_","PE was diagnosed from the presence of blood pressure 140/ 90 mm Hg and proteinuria 0.3 g in a 24-hour urine specimen or urine dipstick 1+ or more that occurred after 20 weeks of gestation. All patients with eclampsia, HELLP syndrome and other complications of PE were included.","Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","_","_","Patients with hypertension diagnosed before 20 weeks and pre-existing chronic hypertension were excluded. Women with hypertension detected for the first time in pregnancy after 20 weeks or after delivery, but with no previous records, were also excluded. Women with gestational hypertension were also excluded as this entity may be of varied etiological origin. Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","25.8 (18-45)","25 (18-40)","_","_","_","_","_","_","_","_","34 +/- 5","38 +/- 3","_","_","_","_"
"21564405","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","*C*/T","0.012","NS","Aggarwal S et al. (Agarwal S)","2011","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Indian","blood sample","200","_","_","200","_","_","PE was diagnosed from the presence of blood pressure 140/ 90 mm Hg and proteinuria 0.3 g in a 24-hour urine specimen or urine dipstick 1+ or more that occurred after 20 weeks of gestation. All patients with eclampsia, HELLP syndrome and other complications of PE were included.","Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","_","_","Patients with hypertension diagnosed before 20 weeks and pre-existing chronic hypertension were excluded. Women with hypertension detected for the first time in pregnancy after 20 weeks or after delivery, but with no previous records, were also excluded. Women with gestational hypertension were also excluded as this entity may be of varied etiological origin. Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","25.8 (18-45)","25 (18-40)","_","_","_","_","_","_","_","_","34 +/- 5","38 +/- 3","_","_","_","_"
"21564405","rs2232708","G1691A","14","14","93824556","94754803","coding","coding","_","_","*A*/G","0.02","_","Aggarwal S et al. (Agarwal S)","2011","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Indian","blood sample","200","_","_","200","_","_","PE was diagnosed from the presence of blood pressure 140/ 90 mm Hg and proteinuria 0.3 g in a 24-hour urine specimen or urine dipstick 1+ or more that occurred after 20 weeks of gestation. All patients with eclampsia, HELLP syndrome and other complications of PE were included.","Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","_","_","Patients with hypertension diagnosed before 20 weeks and pre-existing chronic hypertension were excluded. Women with hypertension detected for the first time in pregnancy after 20 weeks or after delivery, but with no previous records, were also excluded. Women with gestational hypertension were also excluded as this entity may be of varied etiological origin. Chronic hypertension and concomitant diabetes or renal and cardiovascular diseases were regarded as exclusion criteria for cases and controls.","25.8 (18-45)","25 (18-40)","_","_","_","_","_","_","_","_","34 +/- 5","38 +/- 3","_","_","_","_"
"21569342","rs17408150","ERAP2","5","5","96265013","96239257","coding","coding","23990","27614","A/T","Chilean: Maternal = 0.752, Fetal = 1","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","NS","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs2549782","ERAP2","5","5","96256755","96230999","coding","coding","15732","19356","*G*/T","Chilean: Maternal = 0.393, Fetal = 0.751, Black: Maternal = 0.133, Fetal = 0.009","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs4633","COMT","22","22","18330234","19950234","coding","coding","20926","20972","C/T","NS","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs4680","COMT","22","22","18331270","19951270","coding","coding","21962","22008","A/G","NS","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs4818","COMT","22","22","18331206","19951206","coding","coding","21898","21944","C/G/T","NS","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21569342","rs6269","COMT","22","22","18329951","19949951","intron","intron","20643","20689","A/G","NS","_","Hill LD et al. (Strauss JF 3rd)","2011","Candidate gene approach","BMC Medical Genetics","Black, Chilean","maternal blood, cord blood, and neonatal cheek swab","952","528 Chilean dyads, 424 Black women, 375 Black neonates","903","987","575 Chilean dyads, 412 Black women, 462 Neonates","1037","Preeclampsia was defined based on the presence of gestational hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg) and proteinuria (>=300 mg in a 24-hour urine collection, two or more dipstick measurement of 1+, or one or more dipstick measurement >=2+) according to ACOG[1] and the National High Blood Pressure Education Program","Patients were considered to have a normal pregnancy outcome if they did not have any medical, obstetrical, or surgical complication, and delivered a term neonate (>=37 weeks) of appropriate birth weight for gestational age without complications.","_","_","Exclusion criteria included: (1) known major fetal anomaly or demise; (2) multi-fetal pregnancy; (3) serious maternal medical illness (renal insufficiency, congestive heart disease, etc.); (4) refusal to provide written informed consent; and (5) a clinical emergency, which prevented counseling of the patient about participating in the study, such as fetal distress or maternal hemorrhage.","26.3 +/- 7.5 Chilean, 26.0 +/- 6.3 Black","26.1 +/- 6.2 Chilean, 25.3 +/- 5.9 Black","_","_","_","_","26.4 +/- 5.4 Chilean, 30.9 +/- 8.7 Black","24.5 +/- 4.4 Chilean, 29.7 +/- 7.9 Black","2805.7 +/- 815.7 Chilean, 2431.1 +/- 893.8 Black","3423.3 +/- 303.0 Chilean, 3292.1 +/- 462.4 Black","36.8 +/- 3.4 Chilean, 36.0 +/- 3.7 Black","38.7 +/- 1.1 Chilean, 39.5 +/- 1.3 Black","_","_","_","_"
"21575227","rs1570360","VEGFA","6","6","43845807","43737829","upstream","upstream","-134","-134","A/G","0.57 GG, 0.54 A allele","_","Garza-Veloz I et al. (Martinez-Fierro ML)","2011","Candidate gene approach","BMC Pregnancy Childbirth","_","_","78","_","_","86","_","_","Women between 15-38 years old with singleton pregnancy, 16-38 gestation weeks (GW), who lived in the metropolitan area of Monterrey, were eligible to participate. Two recordings of diastolic blood pressure of 90 mmHg at least 4 h apart in previously normotensive women and proteinuria of 300 mg or more in 24 h, or two readings of at least ++ on dipstick analyses. PE was considered severe if blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient was on bed rest, and proteinuria of 5 g or higher in a 24-hour urine specimen or 3+ or greater in two random urine samples collected at least 4 hours apart were present","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","30.76","28.13","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","25 (17-36)","27 (115-38)","_","_","_","_","_","_","_","_","32 (16-38)","34 (17-37)","_","_","_","_"
"21575227","rs2010963","VEGFA","6","6","43846327","43738349","5'UTR","5'UTR","154","154","C/G","0.79 GG, 0.77 C allele","_","Garza-Veloz I et al. (Martinez-Fierro ML)","2011","Candidate gene approach","BMC Pregnancy Childbirth","_","_","78","_","_","86","_","_","Women between 15-38 years old with singleton pregnancy, 16-38 gestation weeks (GW), who lived in the metropolitan area of Monterrey, were eligible to participate. Two recordings of diastolic blood pressure of 90 mmHg at least 4 h apart in previously normotensive women and proteinuria of 300 mg or more in 24 h, or two readings of at least ++ on dipstick analyses. PE was considered severe if blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient was on bed rest, and proteinuria of 5 g or higher in a 24-hour urine specimen or 3+ or greater in two random urine samples collected at least 4 hours apart were present","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","30.76","28.13","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","25 (17-36)","27 (115-38)","_","_","_","_","_","_","_","_","32 (16-38)","34 (17-37)","_","_","_","_"
"21575227","rs25648","VEGF","6","6","43846954","43738976","coding","coding","_","_","C/T","0.53 CC, 0.70 T allele","<0.05","Garza-Veloz I et al. (Martinez-Fierro ML)","2011","Candidate gene approach","BMC Pregnancy Childbirth","_","_","78","_","_","86","_","_","Women between 15-38 years old with singleton pregnancy, 16-38 gestation weeks (GW), who lived in the metropolitan area of Monterrey, were eligible to participate. Two recordings of diastolic blood pressure of 90 mmHg at least 4 h apart in previously normotensive women and proteinuria of 300 mg or more in 24 h, or two readings of at least ++ on dipstick analyses. PE was considered severe if blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient was on bed rest, and proteinuria of 5 g or higher in a 24-hour urine specimen or 3+ or greater in two random urine samples collected at least 4 hours apart were present","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","30.76","28.13","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","25 (17-36)","27 (115-38)","_","_","_","_","_","_","_","_","32 (16-38)","34 (17-37)","_","_","_","_"
"21575227","rs699947","VEGFA","6","6","43844366","43736388","upstream","upstream","-1307","-1307","A/C","0.31 CC, 0.34 A allele","NS","Garza-Veloz I et al. (Martinez-Fierro ML)","2011","Candidate gene approach","BMC Pregnancy Childbirth","_","_","78","_","_","86","_","_","Women between 15-38 years old with singleton pregnancy, 16-38 gestation weeks (GW), who lived in the metropolitan area of Monterrey, were eligible to participate. Two recordings of diastolic blood pressure of 90 mmHg at least 4 h apart in previously normotensive women and proteinuria of 300 mg or more in 24 h, or two readings of at least ++ on dipstick analyses. PE was considered severe if blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient was on bed rest, and proteinuria of 5 g or higher in a 24-hour urine specimen or 3+ or greater in two random urine samples collected at least 4 hours apart were present","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","30.76","28.13","Exclusion criteria included multiple pregnancies, pregnancies with structural or chromosomic fetus malformations detected by ultrasound, chronic hypertension, chronic renal disease, gestational diabetes mellitus, and underlying medical diseases such as rheumatoid arthritis, and systemic lupus erythematosus.","25 (17-36)","27 (115-38)","_","_","_","_","_","_","_","_","32 (16-38)","34 (17-37)","_","_","_","_"
"21713426","rs2070744","NOS3 (eNOS)","7","7","150321011","150690078","intron","intron","369830","369830","C/T","0.068","_","Salimi S et al. (Yaghmaei M)","2012","Candidate gene approach","Archives of Medical Research","Iranian","_","123","25 Persian, 44 Baloch, 31 Afghan","_","142","39 Persian, 42 Baloch, 19 Afghan","_","Preeclampsia was defined as increased blood pressure (>=140 mmHg systolic or >=90 mmHg diastolic on 2 or more measurements at least 6 h apart) and with significant proteinuria >=0.3 g/24 h or >=+1 on a urine dipstick in a woman after 20 weeks of gestation","Exclusion criteria included twin or multiple pregnancies or any evidence of previous medical disease.","43","30","_","28 +/- 7.8","26.5 +/- 6.2","_","_","_","_","_","_","2789 +/- 829","2947 +/- 648","36.6 +/- 3.6","37.8 +/- 3.6","_","_","_","_"
"21808598","rs1799752","ACE","17","17","58919622","61565890","intron","intron","11457","11469","Insertion/*Deletion*","0.0001 ID+DD, 0.36 AC+CC","_","Salimi S et al. (Naghavi A)","2011","Candidate gene approach","Journal of Biomedical Biotechnology","Persian, Balooch, Afghan","_","125","_","_","132","_","_","Preeclampsia was defined as increased blood pressure (>=140mmHg systolic or >=90mmHg diastolic on 2 or more measurements at least 6h apart) and with significant proteinuria >=0.3g/24h or >=+1 on a urine dipstick in a woman after 20 weeks of gestation","Exclusion criteria included twin or multiple pregnancies or any evidence of previous medical disease.","45","32","Exclusion criteria included twin or multiple pregnancies or any evidence of previous medical disease.","27.2 +/- 7.8","26.2 +/- 6.2","_","_","_","_","_","_","2789 +/- 829","2955 +/- 646","_","_","significant proteinuria >=0.3g/24h or >=+1 on a urine dipstick","140","90","_"
"21820612","rs662","PON1","7","7","94775381","94937445","coding","coding","16399","16439","A/G","0.040 QR, 0.208 RR, 0.027 QR+RR","_","Yaghmaei M et al. (Ghavami S)","2011","Candidate gene approach, case-control study","Archives of Medical Research","Iranian","blood sample","105","_","_","84","_","_","Preeclampsia was diagnosed at the Department of Obstetrics and Gynecology by gestational hypertension (BP >140/90 mmHg) accompanied by proteinuria (urine protein >300 mg/24 h or >1+) after the 20th week of pregnancy.","Patients with pregestational hypertension, systemic lupus erythematosus, diabetes mellitus, twin/multiple pregnancies, recurrent miscarriages, or other chronic diseases were excluded from the study. ","45","32","Patients with pregestational hypertension, systemic lupus erythematosus, diabetes mellitus, twin/multiple pregnancies, recurrent miscarriages, or other chronic diseases were excluded from the study. ","27.89 +/- 7.92","25.83 +/- 6.43","_","_","_","_","_","_","2632 +/- 692","30020 +/- 743","36.26 +/- 5.13","37.7 +/- 2.99","urine protein >300 mg/24 h or >1+","140","90","_"
"22004660","rs1130864","CRP","1","1","157949714","159683090","3'UTR","3'UTR","1289","1289","C/T","0.665","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22004660","rs1205","CRP","1","1","157948856","159682232","3'UTR","3'UTR","1527","1527","G/A","0.695","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22004660","rs1800451","MBL2","10","10","54201231","54531225","coding","coding","235","235","C/T","0.684","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22004660","rs231775","CTLA4","2","2","204440958","204732713","coding","coding","204","202","A/G","0.702","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22004660","rs3093077","CRP","1","1","157946259","159679635","downstream","downstream","4744","4744","T/G","0.374","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22004660","rs3783550","IL1A","2","2","113249355","113532884","intron","intron","10087","10087","A/C","0.682","_","Best LG et al. (Anderson CM)","2012","Candidate gene approach","American Journal of Reproductive Immunology"," American Indian","_","66","Among the 66 cases, 48 (73%) met criteria for severe PE. Of those with severe PE, 44 (91%) had at least two blood pressure measurements over 160 systolic or 110 diastolic, 16 (33%) had 3+ proteinuria by dipstick or over 5 gm per 24-hr collection, and 12 individuals met both criteria. ","_","130","_","_","_","_","_","_","_","23.21 (5.63)","23.74 (5.01)","_","_","_","_","30.61 +/- 6.90","26.99 +/- 6.16","3031 +/- 1030","3393 +/- 601","_","_","24-hr excretion of >300 mg, or at least two +1 dipstick measurements","140","90","_"
"22029530","rs2279238","NR1H3","11","11","47238599","47282023","coding","coding","1293","2556","A/G","C/T 0.551; T/T 0.288","_","Mouzat K et al. (Gris JC)","2011","Candidate gene approach","BMC Medical Genetics","Caucasian, Black, Asian","blood sample","155","All privigravidae. 36 of the 155 preeclampsia patients had developed a severe form according to current definitions, before 34 weeks of gestation in nine cases. There were 11 cases of HELLP","_","305","All privigravidae","_","The inclusion criterion for the patients was preeclampsia during a natural pregnancy, defined as gravidic hypertension (systolic blood pressure [BP] > 140 mm Hg, diastolic BP > 90 mm Hg, a rise in systolic BP > 30 mm, or a rise in diastolic BP > 15 mm Hg on at least two measurements 6 hours apart) after 20 weeks, associated with significant proteinuria (> 300 mg/24 h).","_","100","100","_","30 +/- 7 (23-37)","29 +/- 7 (23-36)","_","_","_","_","22.80 +/- 2.45 (17.74-29.40)","22.46 +/- 2.60 (16.32-28.50)","_","_","_","_","_","140","90","_"
"22029530","rs2695121","NR1H2","19","19","55572552","50880740","intron","intron","1249","1249","C/T","T/C 0.049 C/C 0.039","_","Mouzat K et al. (Gris JC)","2011","Candidate gene approach","BMC Medical Genetics","Caucasian, Black, Asian","blood sample","155","All privigravidae. 36 of the 155 preeclampsia patients had developed a severe form according to current definitions, before 34 weeks of gestation in nine cases. There were 11 cases of HELLP","_","305","All privigravidae","_","The inclusion criterion for the patients was preeclampsia during a natural pregnancy, defined as gravidic hypertension (systolic blood pressure [BP] > 140 mm Hg, diastolic BP > 90 mm Hg, a rise in systolic BP > 30 mm, or a rise in diastolic BP > 15 mm Hg on at least two measurements 6 hours apart) after 20 weeks, associated with significant proteinuria (> 300 mg/24 h).","_","100","100","_","30 +/- 7 (23-37)","29 +/- 7 (23-36)","_","_","_","_","22.80 +/- 2.45 (17.74-29.40)","22.46 +/- 2.60 (16.32-28.50)","_","_","_","_","_","140","90","_"
"22029530","rs35463555","NR1H2","19","19","55569491","50877679","upsteam","upstream","-1812","-1812","A/G","G/A 0.295; A/A 0.500","_","Mouzat K et al. (Gris JC)","2011","Candidate gene approach","BMC Medical Genetics","Caucasian, Black, Asian","blood sample","155","All privigravidae. 36 of the 155 preeclampsia patients had developed a severe form according to current definitions, before 34 weeks of gestation in nine cases. There were 11 cases of HELLP","_","305","All privigravidae","_","The inclusion criterion for the patients was preeclampsia during a natural pregnancy, defined as gravidic hypertension (systolic blood pressure [BP] > 140 mm Hg, diastolic BP > 90 mm Hg, a rise in systolic BP > 30 mm, or a rise in diastolic BP > 15 mm Hg on at least two measurements 6 hours apart) after 20 weeks, associated with significant proteinuria (> 300 mg/24 h).","_","100","100","_","30 +/- 7 (23-37)","29 +/- 7 (23-36)","_","_","_","_","22.80 +/- 2.45 (17.74-29.40)","22.46 +/- 2.60 (16.32-28.50)","_","_","_","_","_","140","90","_"
"22029530","rs7120118","NR1H3","11","11","47242865","47286289","intron","intron","5559","6822","C/T","T/C 0.742; C/C 0.485","_","Mouzat K et al. (Gris JC)","2011","Candidate gene approach","BMC Medical Genetics","Caucasian, Black, Asian","blood sample","155","All privigravidae. 36 of the 155 preeclampsia patients had developed a severe form according to current definitions, before 34 weeks of gestation in nine cases. There were 11 cases of HELLP","_","305","All privigravidae","_","The inclusion criterion for the patients was preeclampsia during a natural pregnancy, defined as gravidic hypertension (systolic blood pressure [BP] > 140 mm Hg, diastolic BP > 90 mm Hg, a rise in systolic BP > 30 mm, or a rise in diastolic BP > 15 mm Hg on at least two measurements 6 hours apart) after 20 weeks, associated with significant proteinuria (> 300 mg/24 h).","_","100","100","_","30 +/- 7 (23-37)","29 +/- 7 (23-36)","_","_","_","_","22.80 +/- 2.45 (17.74-29.40)","22.46 +/- 2.60 (16.32-28.50)","_","_","_","_","_","140","90","_"
"22051068","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","363798","363798","G/T","0.237","_","Zdoukopoulos N et al. (Zintzaras E)","2011","Candidate gene approach","BMC Pregnancy Childbirth","Caucasian","blood sample","103","_","_","176","_","_","Preeclampsia was defined as new hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure >=90 mmHg) and substantial proteinuria (>300 mg in 24 h) at or after 20 weeks' gestation","Women with previous renal disease, diabetes, or history of metabolic disorders were excluded from the patient sample.","72.5","44.3","Women with previous renal disease, diabetes, or history of metabolic disorders were excluded from the patient sample.","30.64 +/- 6.32","29.60 +/- 5.18","_","_","_","_","_","_","2266.5 +/- 839","2078.0 +/- 572","_","_",">300 mg in 24 h","140","90","_"
"22051068","rs2070744","NOS3 (eNOS)","7","7","150321011","150690078","intron","intron","369830","369830","C/T","0.868","_","Zdoukopoulos N et al. (Zintzaras E)","2011","Candidate gene approach","BMC Pregnancy Childbirth","Caucasian","blood sample","103","_","_","176","_","_","Preeclampsia was defined as new hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure >=90 mmHg) and substantial proteinuria (>300 mg in 24 h) at or after 20 weeks' gestation","Women with previous renal disease, diabetes, or history of metabolic disorders were excluded from the patient sample.","72.5","44.3","Women with previous renal disease, diabetes, or history of metabolic disorders were excluded from the patient sample.","30.64 +/- 6.32","29.60 +/- 5.18","_","_","_","_","_","_","2266.5 +/- 839","2078.0 +/- 572","_","_",">300 mg in 24 h","140","90","_"
"22082154","rs3184504","SH2B3","12","12","110368990","111884607","coding","coding","40856","40856","C/T","0.25","_","Di Gaetano C et al. (Matullo G)","2011","Case-control study","Journal of Maternal-Fetal and Neonatal Medicine","Italian","Maternal blood sample","198","_","_","265","_","_","PE was diagnosed on the basis of the presence of both hyperten- sion (blood pressure >=140/90 mmHg) and significant proteinuria (>=0.3 g in a 24-hour urine specimen) after 20 weeks of gestation in previously normotensive and non-proteinuric subjects, according to the definition of the American College of Obstetricians and Gynaecologists ","All the controls were normotensive women with a negative history for cardiovascular disease and diabetes, presenting normal fetal growth (birth weight between the 10th and the 90th centile) and with a regular postpartum course. Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","78.7","59.8"," Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","_","_","_","_","_","_","_","_","2028.98 +/- 942.04","3214.71 +/- 468.05","34.05 +/- 4.42","39.1 +/- 1.6",">=0.3 g in a 24-hour urine specimen","140","90","_"
"22082154","rs638791","ATXN2","12","12","110473618","111989235","intron","intron","48245","48245","C/T","0.94","_","Di Gaetano C et al. (Matullo G)","2011","Case-control study","Journal of Maternal-Fetal and Neonatal Medicine","Italian","Maternal blood sample","198","_","_","265","_","_","PE was diagnosed on the basis of the presence of both hyperten- sion (blood pressure >=140/90 mmHg) and significant proteinuria (>=0.3 g in a 24-hour urine specimen) after 20 weeks of gestation in previously normotensive and non-proteinuric subjects, according to the definition of the American College of Obstetricians and Gynaecologists ","All the controls were normotensive women with a negative history for cardiovascular disease and diabetes, presenting normal fetal growth (birth weight between the 10th and the 90th centile) and with a regular postpartum course. Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","78.7","59.8"," Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","_","_","_","_","_","_","_","_","2028.98 +/- 942.04","3214.71 +/- 468.05","34.05 +/- 4.42","39.1 +/- 1.6",">=0.3 g in a 24-hour urine specimen","140","90","_"
"22082154","rs648997","ATXN2","12","12","110461158","111976775","intron","intron","60705","60705","A/G","0.42","_","Di Gaetano C et al. (Matullo G)","2011","Case-control study","Journal of Maternal-Fetal and Neonatal Medicine","Italian","Maternal blood sample","198","_","_","265","_","_","PE was diagnosed on the basis of the presence of both hyperten- sion (blood pressure >=140/90 mmHg) and significant proteinuria (>=0.3 g in a 24-hour urine specimen) after 20 weeks of gestation in previously normotensive and non-proteinuric subjects, according to the definition of the American College of Obstetricians and Gynaecologists ","All the controls were normotensive women with a negative history for cardiovascular disease and diabetes, presenting normal fetal growth (birth weight between the 10th and the 90th centile) and with a regular postpartum course. Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","78.7","59.8"," Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","_","_","_","_","_","_","_","_","2028.98 +/- 942.04","3214.71 +/- 468.05","34.05 +/- 4.42","39.1 +/- 1.6",">=0.3 g in a 24-hour urine specimen","140","90","_"
"22082154","rs695871","ATXN2","12","12","110521382","112036999","coding","coding","481","481","C/G","0.94","_","Di Gaetano C et al. (Matullo G)","2011","Case-control study","Journal of Maternal-Fetal and Neonatal Medicine","Italian","Maternal blood sample","198","_","_","265","_","_","PE was diagnosed on the basis of the presence of both hyperten- sion (blood pressure >=140/90 mmHg) and significant proteinuria (>=0.3 g in a 24-hour urine specimen) after 20 weeks of gestation in previously normotensive and non-proteinuric subjects, according to the definition of the American College of Obstetricians and Gynaecologists ","All the controls were normotensive women with a negative history for cardiovascular disease and diabetes, presenting normal fetal growth (birth weight between the 10th and the 90th centile) and with a regular postpartum course. Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","78.7","59.8"," Pregnancies carrying fetuses with abnormal karyotype, malformations, and infections were excluded from the study","_","_","_","_","_","_","_","_","2028.98 +/- 942.04","3214.71 +/- 468.05","34.05 +/- 4.42","39.1 +/- 1.6",">=0.3 g in a 24-hour urine specimen","140","90","_"
"22132335","rs9939609","FTO","16","16","52378027","53820526","_","_","-14407091","-14179569","A/T","TT Genotype 0.199; T allele freq 0.321","_","Klemetti M et al. (Laivuori H)","2011","Candidate gene approach","Journal of Pregnancy","Finnish","blood sample","485","_","_","449","_","_","PE was defined as the development of hypertension and new-onset proteinuria. Systolic blood pressure >= 160_mmHg and/or diastolic blood pressure >= 110_mmHg was classified as severe PE. The criteria for severe PE used in this study do not include the severity of proteinuria as quantitative measurements of proteinuria were not available for all cases.","_","_","_","_","28.0 primiparous, 31.8 multiparous","27.6 primiparous, 31.0 multiparous","_","_","_","_","23.7 primiparous, 24.4 multiparous","22.4 primiparous, 23.4 multiparous","2400 primiparous, 2382.6 multiparous","3537.8 primiparous, 3635.0 multiparous","_","_","0.3_g/l or >=0.5_g/24 hours or dipstick >= + representing values >=0.3_g/l","140","90","_"
"22136955","rs13385","HBEGF","5","5","139693061","139712877","3'UTR","3'UTR","13297","13311","C/T","0.26 CT, 0.56 TT","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22136955","rs1862176","HHEX","5","5","139710627","139730443","upstream HBEGF","upstream HBEGF","-4269","-4255","A/G","0.71 GA, 0.96 GG, 0.73 GA/AA","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22136955","rs2074611","HBEGF","5","5","139702528","139722344","coding","coding","3830","3844","A/C/G/T","0.55 CT, 0.65 TT","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22136955","rs2074613","HBEGF","5","5","139694747","139714563","intron","intron","11611","11625","A/G","0.99 GA, 0.99 AA","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22136955","rs2237076","HBEGF","5","5","139701014","139720830","intron","intron","5344","5358","A/G","0.056 GA, 0.77 AA, 0.096 GA/AA","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22136955","rs4150196","HBEGF","5","5","139706824","139726640","upstream","upstream","-466","-452","A/G","0.36 AG, 0.14 GG","_","Harendra GG et al. (Dissanayake VH)","2012","Case-control disease association study","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","_","175","_","_","171","_","_","hypertension of >=140/90 mm Hg on two occasions 6 h apart occurring after 20 weeks of gestation in a previously normotensive woman together with proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day) not associated with urinary tract infection or ruptured membranes.","_","_","_","_","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","21.0 +/- 3.3","20.7 +/- 3.2","_","_","35 (32,38)","39 (38,40)","proteinuria of >=1+ on the urine protein heat coagulation test (HCT; equivalent to 500 mg/day)","140","90","_"
"22177086","rs1424954","ACVR2A","2","2","148317263","148600793","upstream","upstream","-1776","-1776","A/G","0.871 genotype, 0.806 allele","_","Lokki AI et al. (Laivuori H)","2011","Candidate gene approach","BMC Research Notes","Finnish","blood sample","485","_","_","449","_","_","PE was defined as systolic blood pressure >= 140 mmHg and diastolic blood pressure >= 90 mmHg with new-onset proteinuria (0.3 g/l or >= 0.5 g/24 h or dipstick >= + representing values >= 0.3 g/l) after 20 weeks of gestation in a previously normotensive woman (slightly modified from ACOG criteria)","_","66.2","58.8","_","27.7 +/- 5.4 primiparous, 31.8 +/- 5.2 multiparous","27.6 +/- 4.7 primiparous, 31.0 +/- 4.9 multiparous","_","_","_","_","23.8 +/- 4.5 primiparous, 24.6 +/- 4.4 multiparous","22.2 +/- 3.1 primiparous, 23.2 +/- 3.7 multiparous","2399.9 +/- 934.6 primiparous, 2382.6 +/- 863.2 multiparous","3537.8 +/- 404.0 primiparous, 3635.0 +/- 412.8 multiparous","35.7 +/- 3.9 primiparous, 35.5 +/- 3.5 multiparous","39.9 +/- 1.5 primiparous, 40.0 +/- 1.2 multiparous","new-onset proteinuria (0.3 g/l or >= 0.5 g/24 h or dipstick >= + representing values >= 0.3 g/l)","140, severe 160","90, severe 110","_"
"22246292","rs1884082","SERPINA3","14","14","94148429","95078676","5'UTR","5'UTR","43","43","G/*T*","<0.001","_","Chelbi ST et al. (Vaiman D)","2012","Candidate gene approach","Human Molecular Genetics","French, Caucasian","dissected placenta subchorial zone","36","The samples of patients included in the study were collected between 2739 weeks of gestation.","_","14","The samples of controls included in the study were collected between 3739 weeks of gestation","_","Systolic pressure >140 mmHg, diastolic pressure >90 mmHg and proteinuria >=0.3 g/24 h. The inclusion criteria used for IUGR were reduction in fetal growth during gestation with a birth weight below the 10th percentile.","Exclusion criteria included obesity, chronic hypertension, diabetes, renal diseases, multiple pregnancies and smoking habits.","100","100","Exclusion criteria included obesity, chronic hypertension, diabetes, renal diseases, multiple pregnancies and smoking habits.","_","_","_","_","_","_","_","_","_","_","27-39","37-39","proteinuria >=0.3 g/24 h. ","140","90","We classified the patients into three groups: (i) isolated PE (PE), (ii) PE associated with IUGR (PE + IUGR), and (iii) vascular IUGR (IUGR)"
"22246292","rs4934","SERPINA3","14","14","94150555","95080802","coding","coding","2169","2169","A/*G*","0.016","_","Chelbi ST et al. (Vaiman D)","2012","Candidate gene approach","Human Molecular Genetics","French, Caucasian","dissected placenta subchorial zone","36","The samples of patients included in the study were collected between 2739 weeks of gestation.","_","14","The samples of controls included in the study were collected between 3739 weeks of gestation","_","Systolic pressure >140 mmHg, diastolic pressure >90 mmHg and proteinuria >=0.3 g/24 h. The inclusion criteria used for IUGR were reduction in fetal growth during gestation with a birth weight below the 10th percentile.","Exclusion criteria included obesity, chronic hypertension, diabetes, renal diseases, multiple pregnancies and smoking habits.","100","100","Exclusion criteria included obesity, chronic hypertension, diabetes, renal diseases, multiple pregnancies and smoking habits.","_","_","_","_","_","_","_","_","_","_","27-39","37-39","proteinuria >=0.3 g/24 h. ","140","90","We classified the patients into three groups: (i) isolated PE (PE), (ii) PE associated with IUGR (PE + IUGR), and (iii) vascular IUGR (IUGR)"
"22314435","rs1799987","CCR5","3","3","46386938","46411934","intron","intron","302","302","A/*G*","0.002 A/A, 0.000 A/G, G/G NS","_","Gurdol F et al. (Cakmakoglu B)","2012","Candidate gene approach","Archives of Gynecology and Obstetrics","Caucasian","peripheral whole blood sample","74","_","_","128","_","_","Preeclampsia was defined as a blood pressure of >=140/90 mmHg on two different occasions >4 h apart in previously normotensive women, associated with proteinuria in >300 mg/L in a 24-h collection in the absence of urinary tract infection.","normotensive women who had previously undergone >=2 term pregnancies unaffected by preeclampsia","_","0","_","_","_","_","_","_","_","_","_","_","_","_","_"," >300 mg/L in a 24-h collection in the absence of urinary tract infection.","140","90","_"
"22432041","rs10183524","INHBB","2","2","120826347","121109877","upstream","upstream","-245","-245","A/G","0.9829","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs1044499","CHMP2B","3","3","87381764","87299074","coding","coding","22662","22662","A/C","0.00000866","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs11126375","RAB10","2","2","26198290","26344786","intron","intron","87813","88058","A/G","0.00000913","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs11902591","INHBB","2","2","120822472","121106002","intron","intron","2284","2284","A/G","0.6068","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs12711941","INHBB","2","2","120839852","121123382","downstream","downstream","19664","19664","G/T","0.000000426","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs13419301","INHBB","2","2","120819041","121102571","upstream","upstream","-1147","-1147","T/C","0.4803","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs17024019","INHBB","3","3","87340112","87257422","upstream CHMP2B","upstream CHMP2B","-33480076","-33846296","A/G","0.00000957","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs2279720","CHMP2B","3","3","87359388","87276698","coding","coding","286","286","A/G","0.00000866","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs2453274","GTDSPL2","15","15","42561493","44774201","intron","intron","_","_","C/T","0.00000232","0.040 QR, 0.106 RR, 0.084 QR+RR","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs2826538","INHBB","21","21","21110605","22188734","upstream LINC00320","upstream LINC00320","-99709583","-98914984","C/T","0.00000593","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs4328642","INHBB","2","2","120823319","121106849","coding","coding","3131","3131","C/T","0.6662","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs45624437","INHBB","2","2","120824651","121108181","3'UTR","3'UTR","4463","4463","T/C","0.00987","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs4952830","ATP6V1E2","2","2","46600466","46746962","5'UTR","5'UTR","134","134","A/C","0.00000674","NS","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs57802235","INHBB","2","2","120825913","121109443","downstream","downstream","5725","5725","A/G","0.5788","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs6542736","INHBB","2","2","107782133","108415701","upstream LOC729121","upstream LOC729121","-13038055","-12688017","A/G","0.00000731","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs6660579","CNIH3","1","1","222983214","224916591","intron","intron","112413","112413","C/T","0.0000078","NS","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs7568413","INHBB","2","2","120826081","121109611","downstream","downstream","5893","5893","C/T","_","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs7576192","INHBB","2","2","120834500","121118030","downstream","downstream","14312","14312","A/G","0.000000148","NS","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs7578624","INHBB","2","2","120818948","121102478","upstream","upstream","-1240","-1240","C/G","0.508","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs7677523","C4orf37","4","4","99184718","98965695","intron","intron","98696","98696","C/T","0.00000951","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22432041","rs9332419","RAB10","2","2","26175543","26322039","intron","intron","65066","65311","A/G","0.00000617","_","Johnson MP et al. (Moses EK)","2012","Genome-wide association study (GWAS)","PLoS One","Australian, Norwegian, Finnish","blood sample","471","_","_","547","_","_","Women were considered preeclamptic if they were previously normotensive and if they, on at least two occasions six or more hours apart, had after 20 weeks gestation (i) a rise in systolic blood pressure (SBP) of at least 25 mmHg and/or a rise from baseline diastolic blood pressure (DBP) of at least 15 mmHg, or (ii) SBP>=140 mmHg and/or DBP>=90 mmHg. Additionally, significant new onset proteinuric levels were either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol. Preeclamptic women who also experienced convulsions or unconsciousness in their perinatal period were classified as having eclampsia.","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","Women with pre-existing hypertension or other medical conditions known to predispose for preeclampsia (e.g. renal disease, diabetes, twin pregnancies or fetal chromosomal abnormalities) were excluded.","_","_","_","_","_","_","_","_","_","_","_","_"," either >=0.3 g/l in a 24 hour specimen, at least a 2+ proteinuria dipstick reading from a random urine collection or a spot protein:creatine ratio >=0.03 g/mmol.","140","90","_"
"22475780","rs4680","COMT","22","22","18331270","19951270","coding","coding","21962","22008","*A*/G","0.031 genotype, 0.015 allele","NS","Liang S et al. (Bai H)","2012","Candidate gene approach","Archives of Medical Research","Chinese, Asian","_","187","_","_","189","_","_","Preeclampsia was defined as systolic blood pressure >140 mmHg and/ or diastolic blood pressure >90 mmHg on two occasions O6 h apart after 20 weeks of gestation but before the onset of labor, plus proteinuria of >2+ (dipstick method) or >0.3 g/24 h (American College of Obstetricians and Gyne- cologists, 1996). Severe preeclampsia was defined as a high- er blood pressure >160 mmHg systolic or >110 mmHg diastolic on two occasions >6 h apart, and a proteinuria level >5 g/24 h or >3+ by dipstick testing on at least two separate occasions ","We excluded those patients with gestational hypertension, history of hypertension, diabetes mellitus before/during pregnancy","_","_","We excluded those patients with gestational hypertension, history of hypertension, diabetes mellitus before/during pregnancy","29.22 +/- 6.17","28.51 +/- 3.73",">0.05","69.98 +/- 8.58","_","_","<0.05","_","_","_","35.59 +/- 3.52","38.39 +/- 2.11","PE: proteinuria of >2+ (dipstick method) or >0.3 g/24 h; Severe PE: proteinuria level >5 g/24 h or >3+ by dipstick testing on at least two separate occasions ","140","90","_"
"22540831","rs1800595","F5","1","1","167776971","169510347","coding","coding","45422","45422","A/G","0.4","_","Dissanayake VH et al. (Jayasekara RW)","2012","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","venous blood sample","175","_","_","171","_","_","Pre-eclampsia was defined as hypertension of >=140/90 mmHg on two occasions 6 hapart occurring after 20 weeks of gestation in a previously normotensive woman along with proteinuria of >1+ on the urine protein heat coagulation test (HCT, equivalent to 500 mg protein/day), which was not associated with urinary tract infection or ruptured membranes.","All control subjects had two or more living children and did not have a previous history of pregnancy loss.","_","0","Exclusion criteria included: non-Sinhalese or women of mixed ethnicity, current pregnancy fathered by a non-Sinhalese man; renal disease, chronic hypertension, or persistent proteinuria (dened as >=1+ on the HCT in the first three urine samples tested in pregnancy with or without urinary tract infection); ischemic heart disease, cerebrovascular accidents, insulin- ornon-insulin-dependent diabetes mellitus; body mass index (BMI)  >=+30 kg/m2 based on height and weight measured at the antenatal booking visit, or postpartumin the case of unbooked pregnancies (to minimize phenotypic heterogeneity, as obesity itself is a risk factor for pre-eclampsia); a previous abortion after 12 weeks of gestation (because the uterus mimics a parous uterus due to uterine vascular re-modeling); and hydatidiform mole, multiple pregnancy, or gestational diabetes in the current pregnancy","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"22540831","rs1801131","MTHFR","1","1","11777062","11854475","coding","coding","11640","11685","A/C","0.54 AC, 0.73 CC","NS","Dissanayake VH et al. (Jayasekara RW)","2012","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","venous blood sample","175","_","_","171","_","_","Pre-eclampsia was defined as hypertension of >=140/90 mmHg on two occasions 6 hapart occurring after 20 weeks of gestation in a previously normotensive woman along with proteinuria of >1+ on the urine protein heat coagulation test (HCT, equivalent to 500 mg protein/day), which was not associated with urinary tract infection or ruptured membranes.","All control subjects had two or more living children and did not have a previous history of pregnancy loss.","_","0","Exclusion criteria included: non-Sinhalese or women of mixed ethnicity, current pregnancy fathered by a non-Sinhalese man; renal disease, chronic hypertension, or persistent proteinuria (dened as >=1+ on the HCT in the first three urine samples tested in pregnancy with or without urinary tract infection); ischemic heart disease, cerebrovascular accidents, insulin- ornon-insulin-dependent diabetes mellitus; body mass index (BMI)  >=+30 kg/m2 based on height and weight measured at the antenatal booking visit, or postpartumin the case of unbooked pregnancies (to minimize phenotypic heterogeneity, as obesity itself is a risk factor for pre-eclampsia); a previous abortion after 12 weeks of gestation (because the uterus mimics a parous uterus due to uterine vascular re-modeling); and hydatidiform mole, multiple pregnancy, or gestational diabetes in the current pregnancy","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"22540831","rs1801133","MTHFR","1","1","11778964","11856377","coding","coding","9738","9783","C/T","0.24 CT, 0.63 TT","_","Dissanayake VH et al. (Jayasekara RW)","2012","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","venous blood sample","175","_","_","171","_","_","Pre-eclampsia was defined as hypertension of >=140/90 mmHg on two occasions 6 hapart occurring after 20 weeks of gestation in a previously normotensive woman along with proteinuria of >1+ on the urine protein heat coagulation test (HCT, equivalent to 500 mg protein/day), which was not associated with urinary tract infection or ruptured membranes.","All control subjects had two or more living children and did not have a previous history of pregnancy loss.","_","0","Exclusion criteria included: non-Sinhalese or women of mixed ethnicity, current pregnancy fathered by a non-Sinhalese man; renal disease, chronic hypertension, or persistent proteinuria (dened as >=1+ on the HCT in the first three urine samples tested in pregnancy with or without urinary tract infection); ischemic heart disease, cerebrovascular accidents, insulin- ornon-insulin-dependent diabetes mellitus; body mass index (BMI)  >=+30 kg/m2 based on height and weight measured at the antenatal booking visit, or postpartumin the case of unbooked pregnancies (to minimize phenotypic heterogeneity, as obesity itself is a risk factor for pre-eclampsia); a previous abortion after 12 weeks of gestation (because the uterus mimics a parous uterus due to uterine vascular re-modeling); and hydatidiform mole, multiple pregnancy, or gestational diabetes in the current pregnancy","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"22540831","rs6025","F5","1","1","167785672","169519048","coding","coding","36721","36721","A/G","0.12","_","Dissanayake VH et al. (Jayasekara RW)","2012","Candidate gene approach","Journal of Obstetrics and Gynaecology Research","Sinhalese, Asian","venous blood sample","175","_","_","171","_","_","Pre-eclampsia was defined as hypertension of >=140/90 mmHg on two occasions 6 hapart occurring after 20 weeks of gestation in a previously normotensive woman along with proteinuria of >1+ on the urine protein heat coagulation test (HCT, equivalent to 500 mg protein/day), which was not associated with urinary tract infection or ruptured membranes.","All control subjects had two or more living children and did not have a previous history of pregnancy loss.","_","0","Exclusion criteria included: non-Sinhalese or women of mixed ethnicity, current pregnancy fathered by a non-Sinhalese man; renal disease, chronic hypertension, or persistent proteinuria (dened as >=1+ on the HCT in the first three urine samples tested in pregnancy with or without urinary tract infection); ischemic heart disease, cerebrovascular accidents, insulin- ornon-insulin-dependent diabetes mellitus; body mass index (BMI)  >=+30 kg/m2 based on height and weight measured at the antenatal booking visit, or postpartumin the case of unbooked pregnancies (to minimize phenotypic heterogeneity, as obesity itself is a risk factor for pre-eclampsia); a previous abortion after 12 weeks of gestation (because the uterus mimics a parous uterus due to uterine vascular re-modeling); and hydatidiform mole, multiple pregnancy, or gestational diabetes in the current pregnancy","27.0 +/- 5.3","27.1 +/- 5.1","_","_","_","_","_","_","_","_","_","_","_","_","_","_"
"22638611","rs1047303","HSD3B1","1","1","119858768","120057245","coding","coding","7420","7420","A/C","0.2820 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs1819698","HSD3B2","1","1","119767041","119965518","3'UTR","3'UTR","7746","7776","A/G","0.3348 genotype, 0.4523 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs1870049","CYP19A1","15","15","49412514","51625222","intron","intron","5573","5573","C/T","0.7991 genotype, 0.7451 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs2854964","HSD3B2","1","1","119762901","119961378","intron","intron","3606","3636","A/T","0.9814 genotype, 0.8589 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs3765945","HSD3B1","1","1","119852968","120051445","intron","intron","1620","1620","C/T","0.4594 genotype, 0.9892 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs4646","CYP19A1","15","15","49290135","51502843","3'UTR","3'UTR","127952","127952","A/C","0.1574 genotype, 0.0958 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs6203","HSD3B1","1","1","119858680","120057157","coding","coding","7332","7332","C/T","0.2299 genotype, 0.4672 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs700518","CYP19A1","15","15","49316403","51529111","coding","coding","101684","101684","A/G","0.0885 genotype, 0.0325 allele","NS","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs700519","CYP19A1","15","15","49295259","51507967","coding","coding","122828","122828","C/T","0.4211 genotype, 0.5104 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22638611","rs936306","CYP19A1","15","15","49366889","51579597","intron","intron","51198","51198","C/T","0.1707 genotype, 0.5397 allele","_","Shimodaira M et al. (Yamamoto T)","2012","Candidate gene approach","Endocrine","Japanese, Asian","_","69","_","_","155","_","_","PE was defined as hypertension with proteinuria occurring after the 20th week of gestation, but resolving by the 12th week postpartum. Subjects were diagnosed with hypertension if they had a systolic blood pressure (SBP) above 140 mmHg and/or a diastolic blood pressure (DBP) above 90 mmHg on repeated prelabor measurements. We ascertained that all PE and GH patients were normotensive before 20 weeks of gestation and that they also had blood pressures that returned to normal in the puerperium. The proteinuria criteria was greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3. These criteria are compatible with the fundamental characteristics of HP established by the International Society of the Study of Hypertension in Pregnancy (ISSHP)","_","52.1","0","_","30.00 +/- 5.63","29.48 +/- 5.03","_","_","_","_","26.76 +/- 3.99","24.69 +/- 2.60","1991.1 +/- 112.2","3004.5 +/- 454.8","34.54 +/- 4.14","38.67 +/- 2.02","greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.greater than 1+ on a dipstick test, greater than 2+ protein on a voided urine sample, and greater than 300 mg on a 24 h urine specimen or a protein/creatinine ratio of 0.3.","140","90","_"
"22676277","rs1010","VAMP8","2","2","85662492","85808981","3'UTR","3'UTR","4334","4368","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1051740","EPHX1","1","1","224086255","226019632","coding","coding","6657","21836","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs10811661","_","9","9","22124093","22134093","downstream CDKN2B-AS1","downstream CDKN2B-AS1","_","_","A/C","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs10850234","UBE3B","12","12","108399077","109914694","intron","intron","-744","-744","A/C","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1111875","HHEX","10","10","94452861","94462881","downstream","downstream","13201","13201","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs13146272","CYP4V2","4","4","187357204","187120210","coding","coding","7537","7537","A/C","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1417121","AKT3","1","1","241735972","243669349","intron","intron","337235","337235","C/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1523127","NR1I2","3","3","120983728","119501038","upstream","upstream","-518","-518","G/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1654433","GP6","19","19","60242123","55550311","upstream","upstream","-679","-679","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1799983","NOS3 (eNOS)","7","7","150327043","150696110","coding","coding","363798","363798","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1801690","APOH","17","17","61638746","64208284","coding","coding","17272","17272","C/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs1979277","SHMT1","17","17","18172820","18232095","coding","coding","34761","34761","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs2036914","F11","4","4","187429474","187192480","intron","intron","5363","5363","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs2231137","ABCG2","4","4","89280137","89061113","coding","coding","18898","18898","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs2236711","_","11","11","130244493","130739283","downstream SNX19","downstream SNX19","_","_","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs229526","C1QTNF6","22","22","35911367","37581421","coding","coding","3095","3095","C/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs3765407","LUZP1","1","1","23291960","23419373","coding","coding","76144","76144","C/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs3812475","TRMT12","8","8","125532430","125463249","coding","coding","202","202","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs3820059","C1orf114","1","1","167657777","169391153","coding","coding","5517","5517","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs3900940","F11","3","3","109630417","108147727","coding MYH15","coding MYH15","-77793694","-79039390","C/T","<0.05","NS","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs4279134","USP19","3","3","49131679","49156675","5'UTR","5'UTR","1538","1696","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs4416547","WFS1","4","4","6344867","6293966","intron","intron","22390","22390","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs5742620","IGF1","12","12","101393729","102869599","intron","intron","4779","4779","A/C","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs670659","RGS7","1","1","239228397","241161774","intron","intron","358704","358704","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs7439293","PALLD","4","4","169914060","169677485","intron","intron","259269","259269","A/G","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs7578597","THADA","2","2","43586326","43732822","coding","coding","90363","90363","C/T","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22676277","rs8050136","FTO","16","16","52373775","53816274","intron","intron","78400","78400","A/C","<0.05","_","Lykke JA et al. (Langhoff-Roos J)","2012","Retrospective nested case-cohort, candidate SNPs","ACTA Obstetricia et Gynecologica Scandinavica","Danish","maternal blood sample","263","_","_","1851","_","_","2002 ACOG definitions (15): preeclampsia (new onset hypertension of at least 140 / 90 mmHg combined with proteinuria) in the presence of one of thefollowing: a systolic blood pressure t160 mmHg, diastolic blood pressure t110mmHg, severe proteinuria of 5g/24 h or >2+ on dipstick, severe headaches,thrombocytopenia (platelet count <100,000 per Pl), persistent epigastric /right upperquadrant pain or abnormal liver enzymes (aspartate aminotransferase ASAT t 100IU/l or LDH 1000 IU/l). HELLP syndrome was defined as a combination ofincreased LDH and ASAT, and thrombocytopenia irrespective of hypertension.Eclampsia was diagnosed if convulsions developed in preeclamptic women","_","75","50","_","30","30","_","_","_","_","25","23","2245+/-921","3558+/-589","35.28+/-3.86","39.86+/1.86","Severe proteinuria of 5g/24 h or >2+ on dipstick","140","90","_"
"22713493","rs1137101","LEPR","1","1","65831100","66058512","coding","coding","172195","172382","A/G","0.311 genotype, 0.372 allele","_","Tennekoon KH et al. (Wijesundera A)","2012","Candidate gene approach","BMC Research Notes","Sinhalese, Asian","blood sample","33","_","_","_","_","_","Criteria for diagnosing PE/PIH have beendescribed before [14]. Persistent (6 or more hours apart) blood pressure of at least 140/90mmHg arising after 20 weeks of gestation was considered as PIH. Urine proteinconcentration >300 mg/l or more (or 1+ on a urine dipstick) in addition to hypertension wasconsidered as pre-eclampsia.","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","_","Urine proteinconcentration >300 mg/l or more (or 1+ on a urine dipstick)","140","90","_"
"22748001","rs10743565","IFLTD1","12","12","25551845","25660578","intron","intron","45600","45639","A/G","0.0000164","_","Zhao L (Dewan AT)","2012","Genome-wide association study (GWAS)","BMC Pregnancy Childbirth","Caucasian","buccal sample","177","_","_","116","_","_","Primiparas who had no indication of hypertension on their infants birth certificate. PE was defined according to National Heart, Lung and Blood Institute (NHLBI) guidelines ashaving de novo hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg on two or more occasions at least six hours apart after the 20th week of gestation)and accompanying proteinuria (urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg).","Potential controls were excluded if their medical records includedany indication of high blood pressure (systolic blood pressure >=140 mmHg or diastolic bloodpressure >=90 mmHg) in the prenatal or postpartum period, two or more high blood pressurereadings in the intrapartum period, or any indication of proteinuria during pregnancy (1+ ondipstick protein testing on two or more occasions).","100","100","Potential cases were excluded if pre-existing hypertension could not be ruled out,only partial criteria for PE were met, or a definitive diagnosis could not be made due toincomplete information. Also excluded if age <18 years at delivery; non-English-speaking; history of an autoimmune disease (e.g. systemiclupus erythematosus, insulin-dependent diabetes mellitus, rheumatoid arthritis); recurrentspontaneous abortion (>3 sequential pregnancy losses); chronic hypertension; pluralgestations; major congenital anomalies; infant death; or seriously ill infant.","27.53 +/- 5.01","27.54 +/- 5.17","_","_","_","_","_","_","_","_","_","_","Urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg","140","90","_"
"22748001","rs1426409","KIAA1239","4","4","36850338","37173943","_","upstream","_","-72746","C/T","0.00000314","_","Zhao L (Dewan AT)","2012","Genome-wide association study (GWAS)","BMC Pregnancy Childbirth","Caucasian","buccal sample","177","_","_","116","_","_","Primiparas who had no indication of hypertension on their infants birth certificate. PE was defined according to National Heart, Lung and Blood Institute (NHLBI) guidelines ashaving de novo hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg on two or more occasions at least six hours apart after the 20th week of gestation)and accompanying proteinuria (urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg).","Potential controls were excluded if their medical records includedany indication of high blood pressure (systolic blood pressure >=140 mmHg or diastolic bloodpressure >=90 mmHg) in the prenatal or postpartum period, two or more high blood pressurereadings in the intrapartum period, or any indication of proteinuria during pregnancy (1+ ondipstick protein testing on two or more occasions).","100","100","Potential cases were excluded if pre-existing hypertension could not be ruled out,only partial criteria for PE were met, or a definitive diagnosis could not be made due toincomplete information. Also excluded if age <18 years at delivery; non-English-speaking; history of an autoimmune disease (e.g. systemiclupus erythematosus, insulin-dependent diabetes mellitus, rheumatoid arthritis); recurrentspontaneous abortion (>3 sequential pregnancy losses); chronic hypertension; pluralgestations; major congenital anomalies; infant death; or seriously ill infant.","27.53 +/- 5.01","27.54 +/- 5.17","_","_","_","_","_","_","_","_","_","_","Urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg","140","90","_"
"22748001","rs17686866","ESRRG","1","1","215251887","217185264","upstream","upstream","-288457","-288450","A/C","0.0000038","_","Zhao L (Dewan AT)","2012","Genome-wide association study (GWAS)","BMC Pregnancy Childbirth","Caucasian","buccal sample","177","_","_","116","_","_","Primiparas who had no indication of hypertension on their infants birth certificate. PE was defined according to National Heart, Lung and Blood Institute (NHLBI) guidelines ashaving de novo hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg on two or more occasions at least six hours apart after the 20th week of gestation)and accompanying proteinuria (urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg).","Potential controls were excluded if their medical records includedany indication of high blood pressure (systolic blood pressure >=140 mmHg or diastolic bloodpressure >=90 mmHg) in the prenatal or postpartum period, two or more high blood pressurereadings in the intrapartum period, or any indication of proteinuria during pregnancy (1+ ondipstick protein testing on two or more occasions).","100","100","Potential cases were excluded if pre-existing hypertension could not be ruled out,only partial criteria for PE were met, or a definitive diagnosis could not be made due toincomplete information. Also excluded if age <18 years at delivery; non-English-speaking; history of an autoimmune disease (e.g. systemiclupus erythematosus, insulin-dependent diabetes mellitus, rheumatoid arthritis); recurrentspontaneous abortion (>3 sequential pregnancy losses); chronic hypertension; pluralgestations; major congenital anomalies; infant death; or seriously ill infant.","27.53 +/- 5.01","27.54 +/- 5.17","_","_","_","_","_","_","_","_","_","_","Urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg","140","90","_"
"22748001","rs9831647","LMCD1","3","3","8546109","8571109","intron","intron","27599","27599","A/G","0.00000936","_","Zhao L (Dewan AT)","2012","Genome-wide association study (GWAS)","BMC Pregnancy Childbirth","Caucasian","buccal sample","177","_","_","116","_","_","Primiparas who had no indication of hypertension on their infants birth certificate. PE was defined according to National Heart, Lung and Blood Institute (NHLBI) guidelines ashaving de novo hypertension (systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg on two or more occasions at least six hours apart after the 20th week of gestation)and accompanying proteinuria (urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg).","Potential controls were excluded if their medical records includedany indication of high blood pressure (systolic blood pressure >=140 mmHg or diastolic bloodpressure >=90 mmHg) in the prenatal or postpartum period, two or more high blood pressurereadings in the intrapartum period, or any indication of proteinuria during pregnancy (1+ ondipstick protein testing on two or more occasions).","100","100","Potential cases were excluded if pre-existing hypertension could not be ruled out,only partial criteria for PE were met, or a definitive diagnosis could not be made due toincomplete information. Also excluded if age <18 years at delivery; non-English-speaking; history of an autoimmune disease (e.g. systemiclupus erythematosus, insulin-dependent diabetes mellitus, rheumatoid arthritis); recurrentspontaneous abortion (>3 sequential pregnancy losses); chronic hypertension; pluralgestations; major congenital anomalies; infant death; or seriously ill infant.","27.53 +/- 5.01","27.54 +/- 5.17","_","_","_","_","_","_","_","_","_","_","Urine protein concentration >=300 mg/L, equivalent to dipstickprotein test value of 1+ from two or more specimens collected at least four hours apart; oneor more urinary dipstick values of 2+ near the end of pregnancy; one or more catheterizeddipstick value of 1+ during delivery hospitalization; or a 24-hour urine collection with protein>300 mg","140","90","_"
""
